|
|
·|û¡Ghung120110149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
|
¥«³õº¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009 6634 ªYÄ£ ªÑ¥»: 3.832»õ ¥Dn·~°È: ¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo ¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤) ¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤) Ä~Äò©¹¤U¬Ý...! ============================================================================= ²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ) ¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ« 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.µL¦w¥þ©Ê°ÝÃD ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x ¬ãµo¶¥¬q: 1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á 2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ Àø®Ä¤ÀªR¡G 1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n 2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009) ============================================================================= ²£«~02¡GSNP-630 ¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢ ²£«~Àu¶Õ: 1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE) 2.¥«³õº¨£·sÃÄ(First-in-class) 3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x 4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~ ¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C Ävª§¤O: 1.¦h«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢ 2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A°§C¨x¯× 3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡ 4.µL¦w¥þ©Ê°ÝÃD ¬ãµo¶¥¬q: 1.Á{§É«e 2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C 3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C Àø®Ä¤ÀªR¡G 1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05 ============================================================================= ²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯) ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯) ²£«~Àu¶Õ: 1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê 2.¸Ñ¨M¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs) 3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ« 2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^ 3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O ¬ãµo¶¥¬q: 1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç 2.¤w¥Ó½ÐUSFDA¼Ï纽Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D 3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç ============================================================================= ²£«~04¡GSNP-830/ SNP-840 ¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B««×¯kµh) ²£«~Àu¶Õ: 1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è 2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q ¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ Ävª§¤O: 1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è 2.½Æ¤è¤w¥Ñ¬ü°êFDAn¨D°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä 3.¦³¨Ï¥Î±M§Q¡A¥iקï©Î§R°£FDA¨x¬rĵ»y 4.¥i¼W¥[¤AñQÓi×ô¾¯¶q ¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A°§C¦¨Å}°Æ§@¥Î 5.¤GªÌ¾Ü¤@±ÂÅv 6.¥i¼W¥[¥«¦û²v ¬ãµo¶¥¬q: 1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ýn¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ ============================================================================= ***************************************************************************** SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G 1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005 ============================================================================= ***************************************************************************** ¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G 1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv 2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv 3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv ============================================================================= ***************************************************************************** ¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@p¹º §Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó ¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ùȱo´Á«Ý¡A¦³¾÷·|¬O ¤U¤@Ó ¦X¤@ ÄÆªÑ ----------------------------------------------------------------------------- ¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×) |
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/7/25 ¤W¤È 08:18:46²Ä 3925 ½g¦^À³
|
ÆWÆW©ñ¤G¤Ñ¡Aj¤½¥q¨S©ñ¤~¹ï¡A¥[³t°Q½×¦¬ÁÊ·sÃĮסC§C¼Ð¤~¬O±ÂÅv |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/20 ¤U¤È 11:53:27²Ä 3924 ½g¦^À³
|
§R°£¨x·l¶Ëĵ§i¡A¥«¦û²v¤j¼W! FDAªº¶Â®Ø¨x·l¶Ëĵ§i¯à¥[µù·íµM¤]¯à§R°£--->FDA ¦³°Ê¾÷§åã³Ð·s©M¦³®ÄªºÃĪ«¡A¯S§O¬O·í³o¨ÇÃĪ«¸Ñ¨M¤F¥¼º¡¨¬ªº»Ý¨D©Î¥Nªí¬Û¹ï©ó¨ä¥LªvÀø´À¥N«~ªº«¤j¶i¨B®É¡C [¬Û¦PªºÃĪ«¾÷Âà]:[¦w¥ß¥Í©Z]§R°£¨x·l¶Ëĵ§i¡A¥«¦û²v¤j¼W! VS.[ªi¥Í©Z]¤£¯à§R°£¨x·l¶Ëĵ§i¡A¥«¦û²v¤j´î! §R°£¨x·l¶Ëĵ§i«á¾P°â¤j¼Wªº2¤äÃĪ«(ambrisentan ¦w¥ß¥Í©Z»P¥ï¥§§JÄõChantix)¡A²Ä3¤ä´â´á¥µ¥FDA¦P·N§R°£¶Â®Øĵ§i¦ôp¾P°âÃB¤]·|¤j¼W¡C 1.FDA ÃĪ«¦w¥þ³q°T¡GLetairis¡]ambrisentan ¦w¥ß¥Í©Z¡^¤ù¾¯¤¤§R°£¨x·l¶Ëĵ§i(¦w¥ß¥Í©Zªº§Q¥Î²v¤j´T¼W¥[¡Aªi¥Í©Zªº§Q¥Î²v¤U°¡^ www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-liver-injury-warning-be-removed-letairis-ambrisentan-tablets 2.2024.7.18--ã¤J»P¦w¥þ¡ÐFDA ÃĪ«¼f§åÃøÃD jamanetwork.com/journals/jamanetworkopen/fullarticle/2821345 FDA ¦³°Ê¾÷§åã³Ð·s©M¦³®ÄªºÃĪ«¡A¯S§O¬O·í³o¨ÇÃĪ«¸Ñ¨M¤F¥¼º¡¨¬ªº»Ý¨D©Î¥Nªí¬Û¹ï©ó¨ä¥LªvÀø´À¥N«~ªº«¤j¶i¨B®É¡C¥t¤@¤è±¡AFDA »Ýn°§C·ÀI¡A¥H«KÁ`ªº¨Ó»¡¡A¨Ï¥Î¨ã¦³¼ç¦b¦w¥þ°ÝÃDªºÓ§OÃĪ«¬O¦³¥²nªº¡C ...§@ªÌµo²{¡AÀHµÛ®É¶¡ªº±À²¾¡A¨ú®ø¹ï¦w¥ß¥Í©ZªººÊ´ún¨D¹ï¾ãÓERA ÃĪ«Ãþ§O¥«³õ¥÷ÃB²£¥Í¤F«¤j¼vÅT ¡]¦w¥ß¥Í©Zªº§Q¥Î²v¤j´T¼W¥[¡Aªi¥Í©Zªº§Q¥Î²v¤U°¡^¡A¦P¼Ë¡]¦b¸û¤pµ{«×¤W¡^¼vÅT¤F¹ï¦w¥ß¥Í©ZªººÊ´ú¡C §ÙµÒÃĪ«¥ï¥§§JÄõ¡]Chantix¡F½÷·ç¡^ªº±¡ªp¦³©Ò¤£¦P¡C 2006 ¦~Àò±o§åã«á¡A¤H̳̪ì¼ö±¡°ªº¦¡A¨Ã±o¨ì¤F¼sªxÃöª`¡C¨ì 2008 ¦~¡A¦³Ãö¶}©lªA¥Î¥ï¥§§JÄõ«á¥X²{¦Û±þ©ÀÀY©M¥ø¹Ï¦Û±þªº³ø§i¾ÉP FDA ¦¬¨ì¤F´X¥÷¦w¥þ¿Ô¸ß³qª¾¡A¨Ã³Ì²×µo¥X¤F¶Â®Øĵ§i¡CÀH«á¥ï¥§§JÄõªº¨Ï¥Î«æ¼@´î¤Ö¡A³B¤è²v«ùÄò¤U°¡Aª½¨ìÀH«á¹ï¥ï¥§§JÄõªº¦w¥þ©Êµû¦ô¨Ã¥¼ÃÒ¹ê¦Û±þ·ÀI¼W¥[¡AFDA ©ó2016 ¦~12 ¤ë¨ú®ø¤F¶Â®Øĵ§i¡C²v¤j´T¼W¥[ FDA ¥¿¦b«·sµû¦ô¥Ø«e´â´á¥ REMS n¨Dªº·ÀI©M¯q³B....»P[¦w¥ß¥Í©Z]ªº±¡ªp¤@¼Ë¡A§Ú̧Ʊæ´ú¸Õn¨DªºÅܤƱN¾ÉP TRS ±wªÌ¤j¶q¨Ï¥Î´â´á¥¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/18 ¤W¤È 09:02:02²Ä 3923 ½g¦^À³
|
SNP-810»PSNP-610[¥ÌÅS¾J°®ò]¾÷¨î! 2021.5.18--¹ï¤AñQ®ò°ò×ô¤¤¬r¤Þ°_ªº°ª®ò¦å¯g www.tandfonline.com/doi/full/10.1080/15563650.2021.1933512 ¹ï¤AñQ®ò°ò×ô¤Þ°_ªº[¨x¬r©Ê]¥i¾ÉP[°ª®ò¦å¯g]¡A¦ý©|¤£²M·¡®ò¿@«×¤É°ª¬O§_¹w¥ÜµÛ¸£¯fÅÜ¡C ...Á`¦@¯Ç¤J 102 ¦ì±wªÌ¡A¨ä¤¤ 75 ¦ì¥X²{®ò¿@«×¤É°ª¡C´N¶E®É¡A40% (30/75) ªº±wªÌ¿@«×°ª©ó 100 µmol/L¡C ------------------------------------------------------------------------------------------------- 2018.1.10--¸z¹D¥ÌÅS¾J¹ï«æ¶E°ª®ò¦å¯g¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜÄY«µ{«×ªº¼vÅT µ²½×:¸z¤º[¥ÌÅS¾J]¹ï©ó´î¤Ö«æ¶E«Ç CLD ±wªÌªº [°ª®ò¦å¯g]¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜ»P±`³WªvÀø¤@¼Ë¦³®Ä¥B¦w¥þ¡C¦P ¼Ë¡A¥ÌÅS¾J¤ñ¶Ç²ÎªvÀø¦³§ó¦nªº@¨ü©Ê¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/17 ¤U¤È 10:06:40²Ä 3922 ½g¦^À³
|
[®ò]¤ô¥¤w³QÃÒ©ú¬O«æ©Ê¥¢¥NÀv©ÎºC©Ê¨x°IºÜ«æ©Ê±wªÌ¦º¤`²vªº¿W¥ß¹w´ú¦]¤l¡C 2022.7.21-¦å¼ß [®ò] ¤ô¥¥i¹w´úÁ{§Ééwªº¨xµw¤Æªù¶E±wªÌ¦]¨xŦ¬ÛÃö¨Öµo¯g¦Ó¦í°|ªº±¡ªp©M¦º¤`²v www.journal-of-hepatology.eu/article/S0168-8278(22)02947-6/fulltext ¤èªk §Ú̬ã¨s¤F¨Ó¦Û 3 Ó¿W¥ß¨xŦ³æ¦ìªº 754 ¦WÁ{§Ééwªº¨xµw¤Æªù¶E±wªÌ¡C±N°ò½u®ò¤ô¥®Õ¥¿¦Ü°Ñ¦Ò¹êÅç«Çªº¥¿±`¤W (AMM-ULN)¡C¥Dn²×ÂI¬O¦]¨xŦ¬ÛÃö¨Öµo¯g¦Ó¦í°|¡]²Óµß·P¬V¡BÀR¯ß¦±±i¥X¦å¡B©úÅã¨x©Ê¸£¯f©Î¸¡¤ô·sµo©Î´c¤Æªº½Æ¦X²×ÂI¡^¡C¨Ï¥Î§Ö³t²Î¤@ÀH¾÷´ËªL¶i¦æ¦hÅܶqÄvª§·ÀI¯Ü®z©Ê¤ÀªR¨Ó¹w´ú¨Öµo¯g©M¦º¤`²v¡C¨Ï¥Î¿W¥ß¤T¯Å¨xŦ¤¤¤ß 130 ¦W¨xµw¤Æ±wªÌªº«e¤©Ê¼Æ¾Ú¶i¦æ¤F¥~³¡ÅçÃÒ¡C µ²½× ®ò¬OÁ{§Ééwªº¨xµw¤Æªù¶E±wªÌ¦]¨xŦ¬ÛÃö¨Öµo¯g©M¦º¤`²v¦í°|ªº¿W¥ß¹w´ú¦]¤l¡A¦b¹w´ú¨Öµo¯g¤è±¤ñ¶Ç²Î¹w«áµû¤À¿ö²{§ó¦n¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/17 ¤U¤È 09:31:23²Ä 3921 ½g¦^À³
|
§ó¥¿¬O:Sig.0.051 / Sig.<0.001 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/17 ¤U¤È 09:25:14²Ä 3920 ½g¦^À³
|
www.sinewpharma.com/Upload/202312/news_2023122709124108.pdf SNP-6:ªÎD«¬(BMI>30)Sig.0.0051 / [«D] ªÎD«¬(BMI<30)Sig.<0.001 ÃöÁä¥i¯à¦b[¥ÌÅS¾J°®ò]¾÷¨î:(°µÓ¬ö¿ý¡A¤é«áÀ˵ø¥Î) 1.2023.4.25-[®ò]¦b NAFLD ¤¤ªº§@¥Î¡G¤@Ó¤£´M±`ªº¶ûºÃ¤H www.ncbi.nlm.nih.gov/pmc/articles/PMC10326708/ ¦h«¾¹©x¯gª¬¥H¤Î NAFLD ±q»´«×¯×ªÕÅÜ©ÊÂàÅܬ°¯×ªÕ©Ê¨xª¢¡B¨xµw¤Æ©M¨x²ÓMÀùªº¾÷¨î©|¤£§¹¥þ²M·¡¡C NAFLD ¤¤§¿¯À´`Àô¬¡©Ê¨ü¨ì·l®`¡A¥i¯à¬O¥Ñ©óªíÆ[¿ò¶ÇÅܤƩM¨x²ÓM¦Ñ¤Æ¼W¥[¾ÉP°ª®ò¦å¯g¡C °ª®ò¦å¯g¦³¼sªxªºt±¼vÅT¡A¾ÉP¨xÅÖºû¤Æ¡B¦Ù¤Ö¯g¡B§K¬Ì¤ÏÀ³¨ü·l¡BPÀù©Ê¼W¥[©M»{ª¾»Ùê¡C §ÚÌ»{¬°§¿¯À´`Àô¬¡©Ê°§C¾ÉPªº®ò²Ö¿n·|¾ÉP NAFLD ªº¯gª¬©M¶i®i¡C °®ò¥i¯à¬O±±¨î NAFLD ¯gª¬©M¹w¨¾¶i®iªº¤@ºØ·sªºªvÀøµ¦²¤¡C 2.2022.3.1-«D°sºë©Ê¯×ªÕ¨xªº¨x·l¶Ë»P§¿¯À´`Àô»Ã¯À¥¢½Õ¦³Ãö www.nature.com/articles/s41598-022-06614-9 ¨xŦ¬Ot³d±q¦å²G¤¤²¾°£´á¥H¦X¦¨§¿¯À¥H«K±Æ¥XÅé¥~ªº¥Dn¾¹©x¡C·í [®ò]¥¼¯à¦¨¥\¦a±q¥Íª«Å餤²M°£®É¡A[°ª®ò¦å¯g]¥i¯à ·|¾ÉP±q¨xŦ¨ì¤j¸£ªº¤£¦Pµ²ªG¡C [®ò]¬O¥i¯à°Ñ»P NAFLD ¶i®iªºÃöÁä¤À¤l¡A§ó¨ãÅé¦a»¡¡A³z¹L¨x¬Pª¬²ÓM¬¡¤Æ°Ñ»P¨xÅÖºû¤Æµo®i¡C 3.2022.3.17-®ò²M°£¾¯¥i«ì´_.... www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.808497/full ¸g¹L 20 ¶gªº«Ø¼Ò«á¡AHFD ²Õªº©Ò¦³¤p¹«¤£¶È¥X²{ NASH¡AÁÙ¥X²{¦Ù¦×´î¤Ö©ÊªÎD¡C¾¨ºÞ³o¨Ç¤p¹«ªºÅ髨S¦³©úÅãÅܤơA ¦ý¥¦Ìªí²{¥XÅé¯×¶q¼W¥[©M¦Ù¦×©úÅã´î¤Ö¡A³o»P [«DªÎD] NAFLDªº¯S¼x¬Û¦ü¡C §Ú̪º¼Æ¾Úªí©ú¡A¯×ªÕ©Ê¨xª¢¤Þ°_ªº[°ª®ò¦å¯g] ¥i¯à¦b¦Ù¤Ö¯gªºµo¥Í¤¤µo´§§@¥Î¡C 4.2018.1.10--¸z¹D¥ÌÅS¾J¹ï«æ¶E°ª®ò¦å¯g¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜÄY«µ{«×ªº¼vÅT www.sciencedirect.com/science/article/abs/pii/S0735675718300329 µ²½×:¸z¤º[¥ÌÅS¾J]¹ï©ó´î¤Ö«æ¶E«Ç CLD ±wªÌªº [°ª®ò¦å¯g]¡B®ñ¤ÆÀ£¤O©M¨x©Ê¸£¯fÅÜ»P±`³WªvÀø¤@¼Ë¦³®Ä¥B¦w¥þ¡C¦P ¼Ë¡A¥ÌÅS¾J¤ñ¶Ç²ÎªvÀø¦³§ó¦nªº@¨ü©Ê¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/15 ¤W¤È 10:34:59²Ä 3919 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 07:42:31²Ä 3794 ½g¦^À³ ¸É¥R»¡©ú³o¬q(¤T´â½©¿}§Ö³tÅãµÛ¼W¥[²ÓM¤ºATP¤ô¥).... -------------------------------------------------------------------------------------------- 1.2024.2.8--ATP ³z¹L½Õ¸`³æÅéºc¶H¨Ó¨¾¤î[³J¥Õ½è»E¶°] www.cell.com/biophysj/abstract/S0006-3495(23)01231-6 ¬ã¨s¤Hûµo²{ATP¤£¶È¥i¥H¨¾¤î·sªº³J¥Õ½è»E¶°Åé¡AÁÙ¥i¥H·»¸Ñ¥ý«e¦s¦bªº³J¥Õ½è»E¶°Åé¡A 2.2023.10.20-¤TÁC»Ä¸¢苷 (ATP) ©M³J¥Õ½è»E¶°¦b¦~ÄÖ¬ÛÃöªºµø¤O«Â¯Ù©Ê²´³¡¯e¯f¤¤ªº§@¥Î www.ncbi.nlm.nih.gov/pmc/articles/PMC10609282/ °ª ATP ¿@«×¦s¦bªº±¡ªp¤U¡AATP §@¬°¥Íª«¤ô·»§Uªø¾¯µo´§§@¥Î¡A±q¦Ó¨¾¤î³J¥Õ½è»E¶°¨Ãºû«ù³J¥Õ½è·»¸Ñ«×¡C µ²½×:§Ö³tÅãµÛ¼W¥[²ÓM¤ºATP¤ô¥-->¨¾¤î³J¥Õ½è»E¶°Åé»P·»¸Ñ³J¥Õ½è»E¶°Åé! ¤T´â½©¿}³o¾÷¨î»P¥ÌÅS¾J¥Î¦bªü¯÷®üÀq¯g¡B©¬ª÷´Ë¤ó¯g©M 2 «¬¿}§¿¯fªº§í¨î»P·»¸Ñ³J¥Õ½è»E¶°®ÄªG??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/15 ¤W¤È 10:06:36²Ä 3918 ½g¦^À³
|
1. www.movementdisorders.org/MDS/Scientific-Issues-Committee-Blog/Mannitol-Treatment-for- Parkinsons-Disease.htm Arkadir ³Õ¤h¡A±z¯à´yz¤@¤U±z¦b©¬ª÷´Ë¤ó¯g±wªÌ¤¤´ú¸Õ¥ÌÅS¾Jªº¸gÅç©Mp¹º¶Ü¡H ¤j½Ã¡Pªü¥d}º¸¡]David Arkadir¡^¡AÂå¾Ç³Õ¤h¡F«¢¹FÂÄÂåÀø¤¤¤ß©M§Æ§B¨Ó¤j¾Ç¡A¥H¦â¦CC¸ô¼»§N ¤H̤£Â_´£¥X«D±M§Qª«½è¡A¨Ò¦p¥ÌÅS¾J¡A¦³¥i¯à´î½w©¬ª÷´Ë¤ó¯gªº¶i®i¡A¬Æ¦Ü°fÂ੬ª÷´Ë¤ó¯g¡C³o¨Ç«Øij¬O°ò©ó±wªÌ©MÂå¥ÍªºÓ¤H¸gÅç¡B²z½×°²³]¡B¬y¦æ¯f¾Ç¬ã¨s¥H¤ÎÅé¥~©ÎÅ餺°Êª«¹êÅç¡C¦b§V¤O¦³¤O¦a´ú¸Õ¦¹Ãþª«½è¹ï¤HÅ骺¯u¹ê®ÄªG¤§«e¡A»Ýn¦³¡uÁ{¬É½è¶q¡vªºÃÒ¾Ú¡C¦ý§Y¨Ï²Ö¿n¤F¨¬°÷ªºÃÒ¾Ú¡A¦b³\¦h±¡ªp¤U¡A¤@¨Ç«D±M§Qª«½è¤]¥Ã»·¤£·|³Q´ú¸Õ¡C±q¥ÌÅS¾Jªº¬G¨Æ¤¤§ÚÌ¥i¥H¤F¸Ñ«D±M§Qª«½è¥i¯àªº©R¹B¡C 2.2021.6.23-¥ÌÅS¾J¡A¤@ºØ¿}¡AÅý§Ú«Àò·s¥Í¡I parkinsonsnewstoday.com/forums/forums/topic/mannitol-a-sugar-has-given-me-back-my-life/¦b³oÓºô¯¸¤W¾\Ū¤F¦³Ãö¥ÌÅS¾Jªº¹êÅç«á¡A§Ú¨M©w¹Á¸Õ¤@¤U¡C´X¶g«á¡A§Úªº¤@¨Ç©¬ª÷´Ë¯gª¬®ø¥¢¤F¡C´N¹³§Ú¨«¸ô®É¦A¦¸¦Û°ÊÂ\°Ê¤âÁu¤@¼Ë¡C¦b¸g¾ú¤F¤Q¦~ªº©¬ª÷´Ë¼³§JÁy¤§«á¡A§Úªºªí±¡¤S¦^¨Ó¤F¡C§Úªº¦r¸ñ¦A¦¸²M´·¥i¿ë¡C §Ú»Äµhªº¨Åé·Pı¦n¦h¤F¡C §Ú·NÃѨì¡A¥Ñ©ó³oºØ¿}¤wÀò±o FDA §åã¨Ã¥B¥i¥H¦bÂdÂiÁʶR¡A¦]¦¹¤½¥q´X¥G¨S¦³°Ê¤O´ú¸Õ©M¾P°â¥ÌÅS¾J.... --------------------------------------------------------------------------------------------- µ²½×:1.¨S±M§Q«OÅ@¡AÃļt·íµM¨S¿³½ì! 2.³æÃÄ18g¾¯¶q°ª¡AG¸z¹D¯gª¬Åý¤H©Ó¨ü¤£¤F (½Æ¤èÀ³¸Ó®ÄªG§óÅãµÛ¥B¯à§ïµ½¥ÌÅS¾J°ª¶q¾ÉPªºG¸z¹D¯gª¬) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/15 ¤W¤È 09:43:18²Ä 3917 ½g¦^À³
|
2022.1.3-¤fªA¥ÌÅS¾JªvÀø©¬ª÷´Ë¤ó¯gªº¦w¥þ©Ê©M@¨ü©Ê¡B¾¯¶q¼W¥[¡BÂùª¼¸ÕÅç www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.716126/full ¥ÌÅS¾J¬O¤@ºØ¤ÑµM°sºë¿}¡A³Ìªñ³Q«Øij§@¬°©¬ª÷´Ë¤ó¯gªº¼ç¦b¯e¯f½w¸Ñ¾¯¡C G¸z¹D¯gª¬¨î¤F¾¯¶qªº¼W¥[¡C ©¬ª÷´Ë¤ó¯g±wªÌ¨C¤Ñ¤fªA 18 §J¥ÌÅS¾J¬O¦w¥þªº¡A¦ý¥u¦³¤T¤À¤§¤Gªº±wªÌ¯à°÷@¨ü³o¶µ³Ì¤j¾¯¶q¡C¦b³]p¥¼¨ÓªºÀø®Ä¸ÕÅç®ÉÀ³¦Ò¼{³o¨Çµo²{¡C --------------------------------------------------------------------------------------------------- G¸z¹D¯gª¬¨î¤F¾¯¶qªº¼W¥[--->°Æ§@¥Î¹Ã¦R©Ô¨{¤l.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/15 ¤W¤È 09:33:00²Ä 3916 ½g¦^À³
|
ªYÄ£(¥ÌÅS¾J+¤T´â½©¿}+¸t¯ó×ô)»P´¶´ç¤j¾Çµoªíªº¤p¤À¤l¾÷¨î(¤]¥Î©ó2«¬¿}§¿¯f)À³¸Ó¬O¤@¼Ë¡C ¥ÌÅS¾J¥i¥H¨¾¤î¤j¸£¤¤¦³¬r³J¥Õ½èªº»E¶°¡C 1.2013-english.tau.ac.il/impact/mannitol ¯S©Ôºû¤Ò¤j¾Ç¤À¤l·L¥Íª«¾Ç©M¥Íª«§Þ³N«Y¥H¤ÎSagol ¯«¸g¬ì¾Ç¾Ç°|ªºEhud Gazit ©M Daniel Segal¥H¤Î¥L̪º¦P¨Æ Ronit Shaltiel-Karyo ³Õ¤h©M³Õ¤h¥Í Moran Frenkel-Pinter µo²{¥ÌÅS¾JÁÙ¥i¥H¨¾¤î³J¥Õ½èµ²¶ô£\-¬ðIJ®Ö³J¥Õ¦b¤j¸£¤¤§Î¦¨¡Ð³oÓ¹Lµ{¬O©¬ª÷´Ë¤ó¯gªº¯S¼x¡C 2.2019-°ò©ó¥ÌÅS¾Jªº·s«¬¤p¤À¤l¥i§í¨î¤Úª÷´Ë¤ó¯g¤¤ £\-¬ðIJ®Ö³J¥Õ¾ý¯»¼Ë³J¥Õªº»E¶° www.ncbi.nlm.nih.gov/pmc/articles/PMC6438916/ 3.2024.1.18-´¶´ç¤j¾Çªº¬ã¨s¤Hû³Ð³y¤F¤À¤l¤Æ¦Xª«¨Ó§í¨î»Pªü¯÷®üÀq¯g¡B©¬ª÷´Ë¤ó¯g©M 2 «¬¿}§¿¯f¬ÛÃöªº³J¥Õ½è»E¶° ¡u¦b²Ä 2 «¬¿}§¿¯f¤¤¡A¤j¬ù 70% ªº¯f¨Ò¯A¤Î¤@ºØºÙ¬°¯Ø®q¾ý¯»¼Ë¦h肽 (IAPP) ªº¿E¯À¡A¥¦·|¦b¯Ø¸¢¤¤¿n»E¡A¡vFortin »¡¡C ¡uªü¯÷®üÀq¯g©M©¬ª÷´Ë¤ó¯g¤À§O»P tau ³J¥Õ©M £\-¬ðIJ®Ö³J¥Õ¦b¤j¸£¯S©w°Ï°ì¿n»Eªº¹Î¶ô¦³Ãö¡C¬Y¨Ç§Î¦¡ªº¥¢´¼¯gªº¯S¼x¬O¤j¸£¤¤¦P®É¦s¦b tau ³J¥Õ©M £\-¬ðIJ®Ö³J¥Õ»E¶°¡C 2 «¬¿}§¿¯f©M¯«¸g°h¤Æ©Ê¯e¯f¤§¶¡¤]¦s¦bÃöÁp¡G³Ìªñªº¬ã¨sµo²{¯Ø¸¢©M¤j¸£¤¤¦s¦b¤£¤î¤@ºØ»E¶°³J¥Õ¡Aªí©ú³o¨Ç·î§Î³J¥Õ¨ã¦³©Ò¿×ªº¡§¥æ¤e¼½ºØ¡¨®ÄÀ³¡C ....¬ã¨s¤Hû¥i¥H±N´¶´ç¤j¾Ç¶}µoªº³o¨Ç¤Æ¦Xª«»P[¨Å¿}¡B¥ÌÅS¾J©M·L´¹ÅÖºû¯À] µ¥ÃĪ«¸üÅéµ²¦X°_¨Ó¡A³z¹L¦hºØ³~®|µ¹ÃÄ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/14 ¤U¤È 10:42:46²Ä 3915 ½g¦^À³
|
®¼¦n©_¥ÌÅS¾J(¥´¶}¦å¸£«Ì»Ù + ¶t°²»¡)/¤T´â½©¿}(¤¤Â_TCR°T¸¹ + T1R3¿E°Ê¾¯)/¸t¯ó×ô(ÅãµÛ´î»´¤p¹«ªºA£]»E¶°©M[Tau]¹L«×ÁC»Ä¤Æ)¥Î¦bªü¯÷®üÀq¯gªvÀø¨ó¦P®ÄÀ³¦h¤j? --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/10/22 ¤W¤È 09:59:53²Ä 3494 ½g¦^À³ ³Ìªñªº¬ã¨sªí©ú¡A²¢¨ý¨üÅ鲧¤G»EÅéT1R2+T1R3 ¦b»{ª¾¥\¯à¤¤µo´§µÛ¦ÜÃö«nªº§@¥Î¡A³oªí©ú²¢¨ý¨üÅé°T¸¹¶Ç¾É¥\¯à»Ùê ¥i¯à¬O¬Y¨Ç¤j¸£¯f²z¤¤»{ª¾»Ùꪺ°ò¦¡C 1.2018--T1R3ºV°£¤p¹«ªº¾Ç²ß¡B°O¾Ð©MªÀ·|¦æ¬°§ïÅÜ»P¯«¸g¤¸¥\¯à»Ù꦳Ãöwww.ncbi.nlm.nih.gov/pmc/articles/PMC5500814/ 2.2015-²¢¨ý¨üÅé°T¸¹ºôµ¸¡G¹ï»{ª¾¥\¯àªº¥i¯à¼vÅTwww.ncbi.nlm.nih.gov/pmc/articles/PMC4306214/ 3. 2021.11.28-DIGMBIO ªº DM3100 °w¹ïªü¯÷®üÀq¯gªº¡§¨ýı·P¨ü¾¹(¹v¦VT1K3) ...¦bÁ{§É«e¬ã¨s¤¤¡A³Á¾¢µÑ¨úª«Åã¥Ü¥X¯«¸g«OÅ@©M§Ü¥¢´¼§@¥Î¡C¥¦´î®z¤F SH-SY5Y ¤HÃþ¯«¸g¥À²ÓM½F²ÓM¤¤ £]-¾ý¯»¼Ë ³J¥Õ»¤¾Éªº²ÓM¬r©Ê©M²ÓMä¤`¡A¤]«ì´_¤F¤T«°ò¦]Âà´Þ°Êª«¼Ò«¬¡]3xTg AD ¤p¹«¡^ªº»{ª¾»Ùê¡C¦b¤@¶µ¹ï 70 ¦W¦³¥DÆ[ °O¾Ð»Ùꪺ¦Ñ¦~¤H¶i¦æªº¤p«¬ÀH¾÷¹ï·Ó¸ÕÅ礤¡A¥¦§ïµ½¤Fµøı°O¾Ð¡C DM3100pµe©ó2021¦~5¤ë³QÁú°ê¥¢´¼¯g¬ã¨s¤¤¤ß¿ï¬°ªvÀøªºÁ{§É«e¬ã¨s¤§¤@¡C ¦P®É¡A¸Ó¤½¥qp¹º¦b©ú¦~§¹¦¨Á{§É«e¬ã¨s«á¡A©ó2023¦~±Ò°ÊDM3100ªvÀøADªº¤@´ÁÁ{§É¸ÕÅç.... ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/5/4 ¤W¤È 11:26:12²Ä 3154 ½g¦^À³ 2023.5.4-°I°h³t«×´î½w35% §¨Óªü¯÷®üÀq¯g·sÃıN³t°e¼f! ªüº¸¯ý®üÀq¯fªº[¶t]°²»¡!!! ¾ý¯»¼Ë³J¥ÕªºÖߩʳJ¥Õ½è¶ô³q±`¬O¾ÉPªüº¸¯ý®üÀq¯fªº¸o»íº×º¡C¦ý®Ú¾Úµoªí¦b¬ã¨s´Á¥Z¡m²ÓM¡n©M¡m¯«¸g¤¸¡n¤Wªº¨â¶µ¬ã¨s¡A¯u¥¿ªº¸o»íº×º¥i¯à¬O¶t¡C ¤º½èºô©M½u²ÉÅ餧¶¡ªºCyp2e1©Î ¶t ©Î ROS ¦êÂZ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/14 ¤U¤È 10:36:57²Ä 3914 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤U¤È 05:46:20²Ä 3884 ½g¦^À³ ^°ê¦P¦æ¥h¦~µoªíªº[¤T´â½©¿}]¾÷¨îÀ°¤FªYÄ£¤j¦£!!! °ª¿@«×ªº¤T´â½©¿}¥i¯à¾ÉPPLC-£^1»P(¬¡¤Æªº¡^T²ÓM¨üÅ骺ªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡A[§í¨îCD4+ CD8+ T ²ÓM¼W´Þ] ---------------------------------------------------------------------------------------------------- 1.2020.1.8-Nature¥D¥Z-¬ã¨s´¦¥ÜCD8 T²ÓM¦bªü¯÷®üÀq¯g¤¤ªº§@¥Îwww.nature.com/articles/s41586-019- 1895-7 .... ³æ²ÓM RNA ©w§ÇÅã¥Ü¡A³o¨Ç²ÓM¤¤ªºTCR°T¸¹¶Ç¾É[¼W±j]¡Cȱoª`·Nªº¬O¡A³z¹L¦b²Ä¤T²Õ¤¤¨Ï¥Î¦hºØ³æ²ÓM TCR ©w§Çµ¦²¤¡A§Ú̦bªü¯÷®üÀq¯g±wªÌªº¸£¯áÅè²G¤¤µo²{¤F§J¶©ÂX¼Wªº CD8 + T EMRA²ÓM¡C 2. 2023.9.22-T²ÓM¯ÓºÜ»Pªü¯÷®üÀq¯gªº»{ª¾ª¬ºA©M¾ý¯»¼Ë³J¥Õ²Ö¿n¦³Ãöwww.nature.com/articles/s41598- 023-42708-8 ¥O¤HÅå³Yªº¬O¡A§ÚÌÆ[¹î¨ì¾ý¯»¼Ë³J¥Õ¶§©Ê¡B»{ª¾¥¿±`ªº¨ü¸ÕªÌ¤¤¥\¯à©Ê CD4 +©M CD8 + T ²ÓM¼W¥[¡A¦Ó¾ý¯»¼Ë³J¥Õ ¶§©Ê»´«×»{ª¾»Ùê¨ü¸ÕªÌªº¥\¯à©ÊCD4 + ©MCD8 + T ²ÓM«h[ÅãµÛ¼W¥[]¡C«nªº¬O¡A·í±N T ²ÓM¥\¯à»P MMSE ½T©wªº »{ª¾ª¬ºA¶i¦æ¤ñ¸û®É¡A±o¤À³Ì§Cªº±wªÌªº¯ÓºÜ²ÓM¼Æ¶q³Ì¦h¡C Ó¤Hµ²½×:¤T´â½©¿}¥i¯à¾ÉPT²ÓM¨üÅé(TCR)[¤¤Â_]°T¸¹¶Ç¿é¡A§í¨îCD4+ CD8+T²ÓM¤À¤Æ»P¼W´Þªº¾÷¨î¯àªvÀøªü¯÷®üÀq¯g! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/12 ¤U¤È 02:52:09²Ä 3913 ½g¦^À³
|
¥ÌÅS¾JÅãµÛ¼W¥[AMPK--ÅãµÛ¼W¥[ACCÁC»Ä¤Æ(¥¢¬¡)«P¶i CD8 + TIL «ù¤[©Ê©M [¸~½F±±¨î] ---------------------------------------------------------------------------------------------------- CD8 + T ²ÓM¤¤[AMPKªº¯Ê¥F] ·|³z¹L»¤¾É³J¥ÕÁC»Ä酶¤¶¾Éªº²ÓM¦º¤`¨Ó[§í¨î]¨ä[§Ü¸~½F]¥\¯à www.oncotarget.com/article/3501/text/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/12 ¤U¤È 02:44:39²Ä 3912 ½g¦^À³
|
2022.2.1-¥H ACC ¬°¼Ð¹vªº NASH ªvÀø·s³~®| ...¦b²³¦h§Ü NASH ¼Ð¹v¤¤¡AACC ³Qµø¬°³Ì¦³«e³~ªºÔ¿ïÃĪ«¤§¤@¡A¦]¬°®Ú¾Ú FDA ©w¸qªº NASH ÃĪ«¶}¾v«ü«n¡A¨ä§í¨î¾¯¦ü¥G¹F¨ì¤F³Ì°ª²×ÂI¡]§Y¸Ñ¨M¯×ªÕ©Ê¨xª¢©M§ïµ½ÅÖºû¤Æ¡^.... ----------------------------------------------------------------------------------------------- ACC §í¨î¾¯½T¹ê¦³Á{§ÉÀø®Ä¡A¦ý°Æ§@¥Î¹L¤j¤F¨Ç¡C ¥ÌÅS¾JÅãµÛ¼W¥[AMPK->ÅãµÛ¼W¥[ACCÁC»Ä¤Æ(¥¢¥h¬¡©Ê)ªº°Æ§@¥ÎÀ³¸Ó¸û§C¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/12 ¤U¤È 02:15:45²Ä 3911 ½g¦^À³
|
¥ÌÅS¾J+¤T´â½©¿}¹ïCD8 +ªºÂùºÞ»ô¤U:¤@Ó¶ÂÁy§í¨î¤@Ó¥ÕÁy«P¶i! ¤T´â½©¿}(§í¨îCD4+ CD8+ T ²ÓM¼W´Þ)+ ¥ÌÅS¾JÅãµÛ¼W¥[ACCÁC»Ä¤Æ(¥¢¬¡) «P¶i CD8 + TIL [«ù¤[©Ê©M¸~½F±±¨î] SNP-6±±¨î±qÀYªº¯×ªÕ(DNL)¥Í¦¨-->These preclinical and phase 2 clinical data demonstrated that SNP-630 and its metabolites can suppress NASH fibrosis through DNL inhibition and inflammation. ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/27 ¤U¤È 01:25:35²Ä 3861 ½g¦^À³ ¥ÌÅS¾J¥i¯à«ì´_¨ã¦³¦h¥\¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²ÓM¾÷¨î??? --------------------------------------------------------------------------------------- 1.2024.3.14-ACCªýê¸~½F·LÀô¹Ò¤¤CD8 + T²ÓM¯×½è§Q¥Î www.cell.com/cell-metabolism/fulltext/S1550-4131(24)00055-X §í¨î ACC «P¶i CD8 + TIL «ù¤[©Ê©M¸~½F±±¨î ACC ±±¨îµÛ±qÀYªº¯×ªÕ¥Í¦¨(DNL) ACC §í¨î«·s³s±µ CD8 + T ²ÓM¥NÁ §Ú̪º¼Æ¾Ú´¦¥Ü¤FACC½Õ¸`ªºLD(¯×ºw)Àx¦s©M²Ö¿n¬O¸~½F¤¤CD8 + T ²ÓM¥\¯à»ÙꪺÅX°Ê¦]¯À¡C 2.ACC³z¹L¥i°fÁC»Ä¤Æ§Ö³t½Õ¸`¡FÁC»Ä¤Æ¨Ï ACC ¥¢¥h¬¡©Ê¡A¦Ó¥hÁC»Ä¤Æ«h¬¡¤Æ¦¹»Ã¯À pubmed.ncbi.nlm.nih.gov/7915280/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/12 ¤W¤È 10:09:29²Ä 3910 ½g¦^À³
|
www.mdpi.com/2073-4409/10/4/768 §Ú̪º¼Æ¾Úªí©ú¡AD-¥ÌÅS¾JÅãµÛ¼W¥[ AMPK ªºªí¹F©MÁC»Ä¤Æ....ÅãµÛ¼W¥[¤FACCªºÁC»Ä¤Æ©MUCP1ªºªí¹F ------------------------------------------------------------------------------------------- ¥ÌÅS¾JÅãµÛ¼W¥[UCP1-AMPKªí¹F²£¼ö½Õ¸`! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/12 ¤W¤È 09:57:15²Ä 3909 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:45:04²Ä 3906 ½g¦^À³ FDA ©|¥¼§åã¥ô¦ó¤@ºØ²£¼ö½Õ¸`¾¯(´îªÎ)! §¨Ó»P¿Õ©M¿Õ¼w¤£¥i¯à µ´¹ï¤£¥i¯à ¬Ý¤WªvÀøªÎDªº [¥Í¼ö³~®|] ¤¤³Ì¼öªùªº¼Ð¹v??? ------------------------------------------------------------------------------------------ §¨Ó¦´N¬Ý¤WªvÀøªÎDªº[¥Í¼ö³~®|]¼Ð¹v!!( UCP1-AMPKªvÀø¬O¼W¥[²£¼ö´²µo¼ö¶q´N¹³¹B°Ê´îªÎ¡A»PGLP-1§í¨î¹¼¤§ó°·±d¦w¥þ!) 1.2022.10.12-¨ü¨ì§¨Ó«C·ý¡I»PNimbus ¦X§@¬ãµo¥NÁ¯e¯fªºAMPK ÃĪ«(±ÂÅvª÷4.96»õ¬ü¤¸) 2.2023.4.10--¡nAmplifier Therapeutics ±À¥XºÓAMPK¬¡¤Æ¾¯(§ó°·±dªº´À¥N«~)¨Ó¨ú¥NGLP-1´îªÎÃÄ! www.genetinfo.com/international-news/item/68226.html |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 10:16:34²Ä 3908 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:10:30²Ä 3904 ½g¦^À³ 2.2009--³o¨Çµ²ªGªí©ú¥ÌÅS¾J¨ã¦³°§CÅ餺¯×ªÕ¿n²Öªº§@¥Î www.jstage.jst.go.jp/article/jnsv/55/3/55_3_242/_article/-char/en ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:38:52²Ä 3905 ½g¦^À³ 2023.11.17-¤@ºØ·sµo²{ªº¬¡¤Æ UCP1 ªº¤Æ¦Xª«¥i§í¨îªÎD¤Î¨ä¬ÛÃö¥NÁ¯¿¶Ãonlinelibrary.wiley.com/doi/10.1002/oby.23948 ------------------------------------------------------------------------------------------------- ³o2½g³£¬O¤é¥»¹Î¶¤µoªí(¤£½T©w¦¨ûÃöÁp©Ê)¡A¦ôp¬O2009¦~¨SºÆ´îªÎÃÄ¡Aªñ¦~´îªÎÃÄ«¨[°_Ú´]¦A¦¸¬ãµo! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:53:48²Ä 3907 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2023/7/6 ¤W¤È 08:48:51²Ä 3292 ½g¦^À³ ¤@ÃÄ´I¡A¤@ÃĽa¡C 杨¨q伟团队¦b¥N谢酶¥Í²z©Ê¥\¯à¬ã¨s¤è±¨ú±o进®i ¬ã¨s进¤@¨B证实¡ACyp2e1°ò¦]ºV°£¤p¹«¦å²MFGF21ªº¤ô¥显µÛ¤É°ª...产热°ò¦] [Ucp1µ¥ªºªí达显µÛ¼W°ª]¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/5/22 ¤U¤È 09:28:53²Ä 3204 ½g¦^À³ CYP2E1ªí¹F»PUCP1....ªºªí¹F§et¬ÛÃö! 1.2023.5.19--UCP1 ¶§©Ê¯×ªÕ²ÓM¤¤ªºCtnnb1 /£]-³sÀô³J¥Õ¥¢¬¡¼W±j¤F¥Õ¦â¯×ªÕ²Õ´ªº½ÅÅÜ 2.2022-¤ý©ý课题组¦bBiochem Pharmacol发ªí¬ã¨s论¤å¡G细M¦â¯ÀP450 2E1°ò¦]ºV°£©Î§í¨î³q过调节¯à¶q®ø¯Ó预¨¾°ª¯×饮 ¹诱导ªÎD Cyp2e1¯Ê¥F¥i¥H³q¹L«P¶i¯×ªÕ»Ä¥NÁ©M¼W¥[¯×ªÕ²ÓMªº²£¼ö§@¥Î¨Ó¹w¨¾¶¼¹»¤¾ÉªºªÎD¤Î¨ä¬ÛÃöªº¯×ªÕ¨x©M¯Ø®q¯À©è§Ü¡C ---------------------------------------------------------------------------------------------- ¥ÌÅS¾J¼W¥[¤FCPT1 ©M UCP1 ªºªí¹F¡C²³©Ò©Pª¾¡ACPT1 ©M UCP1 ·|¼W¥[[²É½uÅ鬡©Ê] ¡A³z¹L[½ÅÅÜ]¼W¥[¯à¶q®ø¯Ó¡A°§C¯×ªÕ®ø¤Æ²v©MÅé¯×ªÕ²Ö¿n©M¯Ø®q¯À©è§Ü!!! ¤é¥»¹Î¶¤¤@ºØ·sµo²{ªº¬¡¤Æ UCP1 ªº¤Æ¦Xª«??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:45:04²Ä 3906 ½g¦^À³
|
FDA ©|¥¼§åã¥ô¦ó¤@ºØ²£¼ö½Õ¸`¾¯(´îªÎ)! §¨Ó»P¿Õ©M¿Õ¼w¤£¥i¯à µ´¹ï¤£¥i¯à ¬Ý¤WªvÀøªÎDªº [¥Í¼ö³~®|] ¤¤³Ì¼öªùªº¼Ð¹v??? ---------------------------------------------------------------------------------- 2023¦~9¤ë--UCP1 ¬¡¤Æ¡G§Q¥Î¦X¦¨©M¤ÑµM¨Ó·½ªº¤À¤lªvÀøªÎDªº¥Í¼ö³~®|¤¤³Ì¼öªùªº¼Ð¹v www.sciencedirect.com/science/article/abs/pii/S1359644623002337 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:38:52²Ä 3905 ½g¦^À³
|
2023.11.17-¤@ºØ·sµo²{ªº¬¡¤Æ UCP1 ªº¤Æ¦Xª«¥i§í¨îªÎD¤Î¨ä¬ÛÃö¥NÁ¯¿¶Ãonlinelibrary.wiley.com/doi/10.1002/oby.23948 µ²ªG §Ú̽T©w¤F¤@ºØ¬¡¤Æ UCP1 ªºÔ¿ï¤Æ¦Xª«¡C¸Ó¤Æ¦Xª«ªº¨ä¥Lªí¼xªí©ú¡A¥¦¯à»¤¾É¯×ªÕ²ÓM¤¤ªº²ÓM²£¼ö¡A¥B²ÓM¬r©Ê¥i©¿²¤¤£p¡C¦bÀH«áªº¶¼¹»¤¾ÉªÎD¼Ò«¬¤¤¡A¨Ï¥Î³oºØ¤Æ¦Xª«ªvÀøªº¤p¹«ªí²{¥XÅ髼W¥[³t«×¸ûºC¡B¯Ø®q¯À±Ó·P©Ê§ïµ½©M¯à¶q®ø¯Ó¼W¥[¡C¾÷²z¬ã¨sªí©ú¡A¸Ó¤Æ¦Xª«³z¹L´£°ª³Ì¤j©I§l¨Ó¼W¥[²É½uÅé¥Íª«¦X¦¨¡A³o³¡¤À¬O¥Ñ³J¥Õ¿E酶 A (PKA)-p38 µ·µõì¿E¬¡³J¥Õ¿E酶 (MAPK) «H¸¹³q¸ô¤¶¾Éªº¡C... µ²½×:©ÒŲ©wªº¤Æ¦Xª«¥i§@¬°ªvÀøªÎD¤Î¨ä¬ÛÃö¥NÁ¯¿¶Ãªº¼ç¦bªvÀøÃĪ«¡C ------------------------------------------------------------------------------------------------ ±N¤é¥»¹Î¶¤ªº¬ã¨s(¤W) ®M¤JÁú°ê¹Î¶¤(¤U)D-¥ÌÅS¾J³z¹L £]3-µÇ¤W¸¢¯À¨üÅé¨Ì¿à©Ê¾÷¨î»¤¾É´Ä¦â¯×ªÕ¼Ëªí«¬ Ó¤H¦ôp¤é¥»¹Î¶¤ªº¬ã¨s¤]¬O¥ÌÅS¾J! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤U¤È 09:10:30²Ä 3904 ½g¦^À³
|
¥ÌÅS¾J:³z¹L[½ÅÅÜ]¼W¥[¯à¶q®ø¯Ó¡A°§C¯×ªÕ®ø¤Æ²v©MÅé¯×ªÕ²Ö¿n!!! 1.2021.1.13--D-¥ÌÅS¾J³z¹L £]3-µÇ¤W¸¢¯À¨üÅé¨Ì¿à©Ê¾÷¨î»¤¾É´Ä¦â¯×ªÕ¼Ëªí«¬ www.mdpi.com/2073-4409/10/4/768 ¥ÌÅS¾J»¤¾É¤p¹«¼Ò«¬¤¤¥Õ¦â¯×ªÕ²ÓM½ÅÅÜ ¦¹¥~¡AD-¥ÌÅS¾JÁÙ¼W¥[¤F«n²É½uÅé¼Ð°Oª«ªºªí¹F¡A¨Ò¦p CPT1 ©M UCP1¡C²³©Ò©Pª¾¡ACPT1 ©M UCP1 ·|¼W¥[²É½uÅ鬡©Ê¡A±q¦Ó¼W±j´Ä¦â¯×ªÕ²ÓM¤¤ªº¯×ªÕ»Ä®ñ¤Æ 2.2009--³o¨Çµ²ªGªí©ú¥ÌÅS¾J¨ã¦³°§CÅ餺¯×ªÕ¿n²Öªº§@¥Î www.jstage.jst.go.jp/article/jnsv/55/3/55_3_242/_article/-char/en --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/5/27 ¤W¤È 11:15:56²Ä 2021 ½g¦^À³ ©³¤U1&2ªº½×¤å½T»{CYP2E1 ¯Ê¥F·|¿E¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡C(½ÅÅÜ:¥Õ¦â¯×ªÕ-->½Å¦â¯×ªÕ) ......³Ìªñªº¬ã¨s¶°¤¤¦b½Õ¸`«DŸ§Ý²£¼ö¥HªvÀøªÎD¯g...½Õ¸`²£¼ö[¯×ªÕ½ÅÅÜ]¡C³o¶µ¬ã¨sªº¤@ÓÅå¤Hµo²{¬O CYP2E1 ¯Ê¥F·|¿E¬¡¥Õ¦â¯×ªÕ[½ÅÅÜ]¡A¦ñÀHµÛ®Ö¤ß·Å«×©M¯à¶q®ø¯Óªº¼W¥[ 2.2020.10.28 Nature³o½g:www.nature.com/articles/s41586-020-2856-x ...¼Æ¾Úªí©úAldh1a1 / Cyp2e1 +²ÓMªí¹F¤@ºØ®Ç¤Àªc¦]¤l¡A¥¦§í¨î´Ä¦â¯×ªÕ²ÓMªº²£¼ö¥\¯à¡C 3.´îªÎ·s¤èªk¡I±N¯×ªÕ¡u½ÅÅÜ¡v¥i¼W¿U¯×®Ä²v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤W¤È 06:51:03²Ä 3903 ½g¦^À³
|
¥ÌÅS¾J§ïµ½Ån©ÊÅÖºû¤Æ¨ä[½T¤Á§@¥Î¾÷Âà©|¤£²M·¡]-->¥ÌÅS¾J¬¡¤ÆmKATP³q¹D??? £]²ÓM KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O®Éԫإ߷s¼Ò«¬¤F!!!(¿}§¿¯fªvÀø¾÷¨î) 2013.5.17-¯×®ñ¯ÀA₄¤¶¾Éªº[KATP¹[³q¹D¬¡¤Æ]¾ÉP[Ån©ÊÅÖºû¤Æ]®ð¹D¤W¥Ö×´_ journals.physiology.org/doi/full/10.1152/ajplung.00058.2013 ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 04:33:45²Ä 3829 ½g¦^À³ ¤£¬Ý60¦~ªºATP¤å¡C ¬Ý2024.5.17ªº½u¤WµøÀW(5¦ìªÎD©M¿}§¿¯f¾ÇªÌ) www.youtube.com/watch?v=Fo0pWsnDgwA £] ²ÓM KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O®Éԫإ߷s¼Ò«¬¤F!!! -------------------------------------------------------------------- ·s¼ҫ¬¦³ª§Ä³¡A²`¶ø¤£À´¥¿±`¡C ¸É¥R:¥ÌÅS¾J¬¡¤ÆmKATP³q¹D´£¨Ñ¤ßŦ«OÅ@§@¥Î¡Cwww.mdpi.com/1422-0067/22/5/2395 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/11 ¤W¤È 06:18:18²Ä 3902 ½g¦^À³
|
¥ÌÅS¾J(§l¤J°ªº¯³zÀ£ÃÄ«~400mg)µ²ºc²³æªº¤p¤À¤l-§ïµ½Ån©ÊÅÖºû¤Æ±wªÌªºªÍ¥\¯à! 1.2005¦~11¤ë7¤é¡A¼Ú·ù©eû·|±Â¤©·ç¨åStricent AB¥Î©óªvÀøÅn©ÊÅÖºû¤Æªº¥ÌÅS¾Jªº©t¨àÃĺٸ¹¡]EU/3/05/325¡^¡C ¦Û 2012 ¦~ 4 ¤ë 13 ¤é°_¡A¥ÌÅS¾J¦b¼Ú·ù³Q±ÂÅv¬° ¤ä®ðºÞ¾J ¦b 2011 ¦~ 11 ¤ë 8 ¤é¦Ü 9 ¤éªº·|ij¤W¡A©t¨àÃÄ©eû·|( COMP ) ¼f¬d¤F±N Bronchitol¡]¥ÌÅS¾J¡A¥H«eºÙ¬°¥ÌÅS¿} ¾J¡^§@¬°ªvÀøÅn©ÊÅÖºû¤Æªº©t¨àÃĪº»{©wEU/3/ 05/325 ¡C www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-05-325 2.2020.5.1-§l¤J¥ÌÅS¾JªvÀøÅn©ÊÅÖºû¤Æ www.ncbi.nlm.nih.gov/pmc/articles/PMC7195814/ ¥ÌÅS¾J¥i¼W¥[ÂH½¤ÅÖ¤ò²M°£²v¡A¦ý¨ä [½T¤Á§@¥Î¾÷Âà©|¤£²M·¡]¡C»P»Ýn³z¹L¼QÃú¾¹»¼°eªº²{¦³»s¾¯¬Û¤ñ¡A¥ÌÅS¾Jªº°®¯»»s ¾¯¥i¯à§ó¤è«K¥B§ó®e©ö¨Ï¥Î¡C§l¤J°®¯»¥ÌÅS¾JªvÀøÅn©ÊÅÖºû¤Æªº III ´Á¸ÕÅç¤w¸g§¹¦¨¡A²{¤w¦b¿D¬w©M¼Ú¬w¤@¨Ç°ê®a¤W¥«¡C ³o¬O¤§«eµû½×ªº§ó·s¡C 3.2020.11.2-Chiesi «Å¥¬ FDA §åã Bronchitol®¡]¥ÌÅS¾J¡^§l¤J¯»¥½ ---------------------------------------------------------------------------------------------- µ¥«Ý¤fªA400mg¥ÌÅS¾J+400mg¤T´â½©¿}¦bMASH»P¿}§¿¯f¤j©ñ¥ú©ú!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 07:28:56²Ä 3901 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/2 ¤W¤È 09:36:35²Ä 3870 ½g¦^À³ 2024.2.20-P©Rªº¯×ªÕ¡G¯ØŦ¤º¯×½è¾ÉP¯ØŦÀù ¦b©s¼wº¸ÀH¾÷¤Æ©M«e¤©Ê¶¤¦C¬ã¨s¤¤¡A1¯ØŦ¤º¯×ªÕ·|¼W¥[¯ØŦÀùªº·ÀI¡C³o¬°¯×½è»P¯ØŦÀù¯g¤§¶¡ªº¦]ªGÃö«Y´£¨Ñ¤F¦³»¡ªA¤Oªº¤HÃþÃÒ¾Ú¡A[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]¡C --------------------------------------------------------------------------------------------------- ¯ØŦP©Rªº¯×ªÕ--2«¬¿}§¿¯f»P¡uÀù¤ý¡v¯ØŦÀù [©s¼wº¸ÀH¾÷¤Æ]³Q»{¬°Ãþ¦ü©ó¡u¦ÛµMªºÀH¾÷¹ï·Ó¸ÕÅç¡v---¦]ªGÃö«Y¬OÅKÃÒ¦p¤sµL¥iÅG»é! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 07:08:30²Ä 3900 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:31:01²Ä 3898 ½g¦^À³ ³z¹L´î¤Ö¯ØŦ¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤Hûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f) -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 05:02:07²Ä 3830 ½g¦^À³ ¥ÌÅS¾J+¤T´â½©¿}ªº¾÷¨î??? 2024 ¦~ Rolf Luft ¼ú ------------------------------------------------------------------------------------------------- SNP-6§¹³Æ2¦ì¿}§¿¯fÅv«Â»¡ªº°fÂà¾÷¨î!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 06:54:00²Ä 3899 ½g¦^À³
|
Professor roy taylor¬O¯Ã¥d´µº¸¤j¾ÇÂå¾Ç©M¥NÁ¾ǺaÅA±Ð±Â ¡A¤]¬O^°ê¿}§¿¯f°òª÷·|¸ê§Uªº¬ã¨sû¡C ¦]¨ä¹ï¿}§¿¯f¬ã¨sªº°^Äm¦ÓºaÀòMBE 2023.1.6- www.diabetes.org.uk/about-us/news-and-views/professor-roy-taylor-awarded-mbe-services-diabetes-research -------------------------------------------------------------------------------------------------- ¤@³õ½w¸Ñ²©R ®õ°Ç±Ð±Â«á¨Óªº¬ã¨s¶i¤@¨B´¦¥Ü¤F 2 «¬¿}§¿¯f¬O¦p¦óµo®iªº¡A¥H¤Î¦p¦óÅý¯ØŦ¦A¦¸¤u§@¥H¨Ï²Ä 2 «¬¿}§¿¯f½w¸Ñ¡C ¦Û 2008 ¦~¥H¨Ó¡A§Ṳ́@ª½¤ä«ù®õ°Ç±Ð±Âªº¶}³Ð©Ê½w¸Ñ¬ã¨s¡C¦ý®õ°Ç±Ð±Âªºµo²{§ï¼g¤F²Ä 2 «¬¿}§¿¯fªº¬G¨Æ¡C ¨ì 2011 ¦~¡A¥Lªº¬ã¨sµ²ªGªí©ú¡A¤@¨Ç 2 «¬¿}§¿¯f±wªÌ¥i¥H³z¹L§C¼ö¶q¶¼¹Å髺޲zpµe´î»´Åé«¡A±q¦ÓÀò±o½w¸Ñ¡C¥L¶}µo¤F³Ð·sªº¬ã¨s§Þ³N¡A³o·N¨ýµÛ§ÚÌ¥i¥H©çÄá¨xŦ©M¯ØŦµ¥¾¹©x¤º³¡©M©P³òªº¯×ªÕ¤ô¥¹Ï¹³¡C ¥Lªº¥@¬Éº³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØŦ¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C ¥Lªº¥@¬Éº³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØŦ¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C ¥Lªº¥@¬Éº³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØŦ¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:31:01²Ä 3898 ½g¦^À³
|
www.sinewpharma.com/Upload/download/20240606-video.MP4 40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ ----------------------------------------------------------------------------------------- ³z¹L´î¤Ö¯ØŦ¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤Hûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f) www.ncl.ac.uk/press/articles/archive/2015/12/pancreasstudy/ ¥@¬É¿}§¿¯f¤j·|¤Wµoªí¡C¬ã¨sû®õ°Ç±Ð±Â(Professor Roy Taylor)¦b¤j·|¤W»¡¡G¡u²Ä¤G«¬¿}§¿¯f±wªÌ´î«¤§«á¡A¥i¥H´î¤Ö¯ØŦªº¦h¾l¯×ªÕ¡A«P¨Ï¯ØŦ¥\¯à«ì´_¥¿±`¡C¦]¦¹¡A¦pªG§A°Ý§Ú¡A¯f¤H»Ýn´î¤Ö´X¤½¤ç¤~¯à§ïµ½¿}§¿¯f¡Aµª®×´N¬O1¤½§J¡C¤£¹L¡A³o1¤½§J¥²¶·¬O¨Ó¦Û¯ØŦªº¯×ªÕ¡C¡v |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:21:46²Ä 3897 ½g¦^À³
|
SNP-610°§C29.5 U/L(³o¬O¤HÅéÁ{§É¼Æ¾Ú¡A¤£¬O°Êª«¹êÅç¼Æ¾Ú!) Type 2 diabetes or pre-diabetes Present, n=18 Not present, n=17 ----------------------------------------------------------------------------------------- §@ªÌ±o¥Xµ²½×¡A¨xŦ¯×ªÕ°ï¿n¥i¯à¬OÂà¤Æ¬°¿}§¿¯fªºÄ²µo¨Æ¥ó¡C¬°¤F¤ä«ù«á¤@ºØ¥i¯à©Ê¡A¤w¸gµo²{[ALT¤É°ª]¬Oµo¥Í 2 «¬¿}§¿¯fªº¦´Á¦MÀI¦]¯À¡A»PªÎD¡BÅé¯×ªÕ¤À§G¡B¦å¿}¡B¦å¯×¡BAST¡BÁx¬õ¯À¿@«×©M®a±Ú¥vµLÃö.... ----------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤U¤È 11:23:36²Ä 3841 ½g¦^À³ www.sinewpharma.com/Upload/202312/news_2023122509345208.pdf Type 2 diabetes or pre-diabetes Present, n=18 Not present, n=17 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:12:14²Ä 3896 ½g¦^À³
|
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i: ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? [oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f??? 2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610°§C29.5 U/L) 2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610°§C29.5 U/L) 2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610°§C29.5 U/L) ----------------------------------------------------------------------------------------------- 1. 2024.5.17-[2«¬¿}§¿¯fªºªvÀø¼Ò¦¡¬O®ÉÔÂàÅܤF] www.mdpi.com/1422-0067/25/10/5488#B55-ijms-25-05488 ....³oªí©ú²Ä2«¬¿}§¿¯f¡]¥Dn¡^¬O¥Ñ¨xŦ©M¯ØŦ¤º¹L¦hªº¯×ªÕ¤Þ°_ªº¡C ....¦]¦¹¡A¦´Á¹w¨¾/´î¤Ö[¨xŦ]©M[¯ØŦ]²§¦ì¯×ªÕ°ï¿n¥i¯à¦¨¬°²Ä¤G«¬¿}§¿¯fºÞ²zªº¥DnªvÀø¥Ø¼Ð¡C 2.2008.8.26- 2«¬¿}§¿¯fªºµo¯f¾÷Âà¡G°lÂܱqªv¡¨ì¯f¦]ªº¤Ï¦V¸ô®| link.springer.com/article/10.1007/s00125-008-1116-7 ¨xŦ©M¯Ø®q¤¤ªº[²§¦ì¯×ªÕ¨I¿n]¬O¨xŦ¯Ø®q¯À§Ü©Ê©M [£]²ÓM¥\¯à»Ùê]¬ÛÃö°ÊºA¯Ê³´ªº°ò¦¡C³o¨Ç¯Ê³´¦b§C¯à¶qÁý¾i±ø¥ó¤U¯à°÷ÅãµÛ°fÂà¡A¦b¦´Á¿}§¿¯f¤¤§¹¥þ°fÂà¡A -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/11/23 ¤U¤È 09:34:59²Ä 3543 ½g¦^À³ ALT °§C¶W¹L 17 U/L ¤w³QÃÒ©ú»P NASH ±wªÌªº²Õ´¾Ç¤ÏÀ³¬ÛÃö(ÅÖºû¤Æ§ïµ½)!-->SNP-610°§C29.5 U/L. www.ncbi.nlm.nih.gov/pmc/articles/PMC6617813/ ¶ø¨©Áx»Ä( InterceptªºOCA)¡B elafibranor©M§Q©Ô¾|肽(¿Õ©M¿Õ¼w)ªº¬ã¨s¤wÃÒ©ú¡A¦bNASHªvÀø¬ÛÃö²Õ´¾Ç§ïµ½©Î®ø°hªº±wªÌ¤¤¡AALT ·|¤U°¡A¦Ó¥B2«¬¿}§¿¯f©MNAFLD ±wªÌªºALT ¤U°»P¨xŦ¯×ªÕ´î¤Ö¦³Ãö.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤W¤È 10:08:25²Ä 3895 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/1 ¤U¤È 08:52:35²Ä 2370 ½g¦^À³ SNP-810µLµÇ¬r©Ê³oÓÀuÂI¡A¹ï©ó·m§ðNSAIDs¡]«DÃþ©T¾J®øª¢¤îµhÃÄ¡^ªº¥«³õ¥÷ÃB¤j¦³§U¤O! ¤îµhÃį}ÃaµÇŦ«OÅ@¾÷¨î!!! www.commonhealth.com.tw/article/74087 ½Ð·V¥Î¤îµhÃÄ¡IµÇŦ¬ì¦WÂå¨Iµh§i¥Õ ------------------------------------------------------------------------------------------------ 2024.7.2-¼³¼ö®§µh¹L¶q¾ÉP«æ©Ê[µÇ] ·l¶Ë¦ý[µL¨x¬r©Ê]¡G¯f¨Ò³ø§i intjem.biomedcentral.com/articles/10.1186/s12245-024-00662-w µ²½× Á`¤§¡A¼³¼ö®§µh [µÇ¬r©Ê] ¦Ó [¤£¨x¬r©Ê]¨Ã¤£¨u¨£¡A¥BÀ³ºÊ´ú±wªÌ¶W¹L 48 ¦Ü 72 ¤p®É¡C¾¨ºÞ NAC ¦b¨x¬r©Ê¤è±ªº§@¥Î²³©Ò©Pª¾¡A¦ý¨ä¦b¹w¨¾µÇ¬r©Ê¤è±ªº§@¥Î©|¥¼±o¨ìÃÒ¹ê¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/9 ¤U¤È 06:42:02²Ä 3894 ½g¦^À³
|
www.sinewpharma.com/Upload/download/20240606-video.MP4 40¤À:¤îµhÃÄ(«D³B¤èÃÄ)µ¦²¤©Ê¼Ú¬ü¤À¶}±ÂÅv -------------------------------------------------------------------------- ¬°¦ó¤À¶}±ÂÅv? ¥i¯à»P³o¦³Ãö«Y:2023.7.28www.gao.gov/assets/gao-23-106570.pdf ¬ü°êFDA[«D³B¤èÃÄ]¤¤±Æ¥L©Ê±ø´Ú(¥«³õ¿W¦ûÅv) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/9 ¤U¤È 06:11:11²Ä 3893 ½g¦^À³
|
1¦~5¿ªÌ¦p¹L¦¿¤§ÃV¡A5¦~1¿ªÌ«o¹éY¨°¬P! 2024.6.21-½ä¿ùÃä¡I¥x¿n¹q¡u¹H¬ù¥æ³Î2892¸U¡v¡@ºÃ¤Ö¦~ªÑ¯«¤@¤i½ß¥ú ------------------------------------------------------------------------------- ¦~»´¤H²×¨s¬O¦~»´¤H¡A¤Ó½Ä°Ê¤F¡CªÅ¤û®ð¨R¤Ñªº¥xG? ¤£¹L¦~»´¤]¬O¥»¿ú¡A¯d±o«C¤s¦b¤£©È¨S®ã¿N¡A§O§Ñ±Ð°V´N¦n~ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/9 ¤U¤È 05:34:31²Ä 3892 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/14 ¤W¤È 08:39:02²Ä 26 ½g¦^À³ ....º¡¤j¾÷²v´N¯à¤W¨ì³Ì³»¼h ¡A¦]¦¹(§Ú)Ä~Äò«ù¦³... -------------------------------------------------------------------------------- ...·ç»È¶°¤½¥¬ªº¾ÚÅã¥Ü¡A²b¸ê²£¦b300¸U¨ì3000¸U·s¥x¹ôªº¡u·Ç´I¸Î¼h960¸U¤H¡v¡A¥e¥þ¥x¤H¤f45%¡A±Nªñ¤@¥b... ------------------------------------------------------------------------------------------------- Ó¤Hµ²½×:P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡C(«ùªÑ>12¦~) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/9 ¤U¤È 05:19:47²Ä 3891 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 04:48:09²Ä 1550 ½g¦^À³ ...¼B³Ó«iµªÂЪí¥Ü....PȥثeÁÙ¥¼®³¨ì....©Ò¥HµLªk¤½¥¬¡C ¬O¯uª÷´N¤£©È¤õ·Ò¡A¤p´²¤á¤j©È¬Æ? ©ú¤ÑÃöt£x. ------------------------------------------------------------------------------------------------ §Ú¬J¬ÝªÅ´N¤£°µ¦h¤]¤£°µªÅ¡A°O¤£²M¬O¨º¦~¼o¤F¿Ä¸ê¨é¸ê®æ¡C P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡A[°í«ù¦Û§Ú§PÂ_]¡A±E±x¦Û¤vªº§ë¸ê¸`«µ! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/9 ¤U¤È 05:06:23²Ä 3890 ½g¦^À³
|
¡§1¦~5¿ªÌ¦p¹L¦¿¤§ÃV¡B5¦~1¿ªÌ«o¹éY¨°¬P¡¨(®©¤£¥X? ¦^·Q¤@¤U°ê¹©¿ÄÂ_¤W300.....) P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡AµLÄߪi°Ê¡A[°í«ù¦Û§Ú§PÂ_] ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 05:27:50²Ä 3807 ½g¦^À³ ¦p¦ó°í¦u¤º¤ßªº¡§§ë¸ê¸`«µ¡¨¡H ªÑ»ù¤Wº¦®É¿³¾Ä¡A§Ô¤£¦í·Qn¥[Ü¡F¤U¶^®É¤S¼~¼{¡A§Ô¤£¦í¤S»°ºò³Î¦×¡A¸¨³U爲¦w¡A©ó¬O¤@º¦´N¶R¡A¤@¶^´N½æªº¦æ爲µL´`Àô! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/7/9 ¤U¤È 04:19:59²Ä 3889 ½g¦^À³
|
ª½±µ¶}©ñªÑªFÁʶR¸Õ¥Î~~¯Â¯Âªº¤HÅé¸ÕÅç ¬Ý¬O¤£¬O¦pJp»¡ªº³o¦n¡A¶R¤F©ñµÛ¤~¦³«H¤ß |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/7/9 ¤W¤È 08:46:01²Ä 3888 ½g¦^À³
|
º©º©ªø¸ô¤¤¡A¬O©Ô¦^ÁÙ¬O³Ì«á¤W¨®¾÷·|? Â಴Q3n¨ì¤F¡A³oÀɯu¬O¿\¥ÉÁÙ¬O¥ÛÀY? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/6 ¤U¤È 11:35:41²Ä 3887 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 06:41:22²Ä 694 ½g¦^À³ ¥H²{¦bÃĪ«¤W¥«¼f¬dì«h¡AAPAP¬O¤£¥i¯à¦b¬ü°ê»P^°ê¤W¥«¡C SNP-810µL¨x¬r·s¾¯«¬·sÃÄ¥¿¬O³Ð·s¦w¥þ§ï²¡A¯àÀò±o¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n¤°»ò¿EÀy¹ªÀy??????? 2020¦~3¤ë27¤é¤t´¶Ã±¸pªº¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n´N¬On¸Ñ¨M³oÃþÃĪ«ªº°ÝÃD¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/4 ¤U¤È 05:35:26²Ä 461 ½g¦^À³ 1972¦~FDA¥l¶°¤F¤@²ÕÂå¥Í©M¬ì¾Ç®a¨Óµû¦ô¤îµhÃÄ(¥]¬A¹ï¤A酰®ò°ò×ô)..µ²ªGªá¤F48¦~©|¥¼¸Ñ¨M¨x¬r©Ê¡C Orz. 1. 2012¦~1¤ë24¤é ---FDA¤µ¤Ñ¤£·|§å...¹ï¤A酰®ò°ò×ô(APAP)¤]¬O¤@¼Ë¤£·|§åã¡]¦b¬ü°ê¡A¹L¶q¨Ï¥Î¬O¾ÉP¨x°IºÜªº¥Dnì¦]¡^ Analgesics have a spotty history of switching to OTC. According to common wisdom, the FDA would not approve aspirin today much less allow it to go OTC. The same could be said for acetaminophen (overdose of which is the leading cause of liver failure in the US) --------------------------------------------------------------------------------------------- ¥H²{¦bFDAÃĪ«©Ê¨x·l¶Ë¤W¥««eÁ{§É«ü«n¡AAPAP¹L¤£¤F¨x¬r©ÊªùÂe! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/6 ¤U¤È 09:51:18²Ä 3886 ½g¦^À³
|
·sÃĶ}µoªº®Ú¥»:¨ä¥Hªk¥O¨î«×¬°¸g¡B¹êÃÒ¬ì¾Ç(Á{§É¸ÕÅç)¬°½n¡AÁa¾î¥æ´¦¨¬ì§Þ»Pªk«ß¥æ¬yªºÀ³¥Î¬ì¾Ç¡C ÃĪ«¨x·l¶Ë«ü«n¤@Åé¾A¥Î! FDAÃĪ«©Ê¨x·l¶Ë¤W¥««eÁ{§Éµû¦ô¦æ·~«ü«n www.fda.gov/media/116737/download ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 07:26:47²Ä 3875 ½g¦^À³ 1.2024.4.15-¥[¤J £] ²ÓM¨ë¿EªvÀø[²Ä1«¬]¿}§¿¯fªº¸ÕÅç ¤@¶µ¸ÕÅ祿¦b©Û¶Ò±w¦³²Ä 1 «¬¿}§¿¯fªº¦¨¦~¤H¨Ó¬ã¨s BMF-219¡A³o¬O¤@ 2.2024.6.7-FDA ¹ï Biomea Fusion ªº BMF-219 ¿}§¿¯f¸ÕÅç¶i¦æ¥þ±Á{§ÉÀÁ¸m ¸Ó¨M©w¬O°ò©ó COVALENT-111 ¸ÕÅ礤µo²{ªº¼ç¦bÃĪ«¤Þ°_ªº[¨x¬r©Ê]¤ô¥¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/1 ¤U¤È 01:00:55²Ä 3748 ½g¦^À³ µL¨x¬rSNP-810(12g) VS. ¦³¨x¬rAPAP(4g)ªº[¾î¦V¤ñ¸û]: 4.FDA Drug Hepatotoxicity Steering Committee: .....(ALT) ≥3 times the upper limit of normal (ULN) and ALT/alkaline phosphatase (ALP) ratio ≥5 times ULN; cholestatic DILI by an ALP ≥2 times ULN and ALT/ALP ratio of ≤2 times ULN; and mixed DILI with ALT ≥3 times ULN, ALP ≥2 times ULN and ALT/ALP ratio <5 but >2 times ULN ¨x·l®`¤@¯ë©w¸q«üALT¶W¹L¥¿±`數ȤWªº3¿¥H¤W¡A§Y¶W¹L>3¿³q±`³Q»{¬°¨ã¦³Á{§É·N¸q¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤U¤È 06:40:25²Ä 3885 ½g¦^À³
|
1.[T1R3©MCaSR]¿}±Ó·P¨üÅé¦b¯ØŦ £] ²ÓMªº²ÓMªí±ªí¹F-->¤T´â½©¿}¬OT1R3¿E¬¡¾¯--¥i¯à«P¶i¯Ø¸¢£]²ÓMªº·s³¯¥NÁ¡C 2.¤T´â½©¿}[§í¨îCD4+ CD8+ T ²ÓM¼W´Þ] 쥻§ë¸êªYÄ£ªºÃöª`ÂI¡AÀ£®Ú¨S¬ÝªvÀø¿}§¿¯f³o¶ô¡A¤µ¤Ñ¯u¬O¡m¬ü¦nªº·N¥~¡n¡C -------------------------------------------------------------------------------------------------- 2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i: ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? [oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤U¤È 05:46:20²Ä 3884 ½g¦^À³
|
^°ê¦P¦æ¥h¦~µoªíªº[¤T´â½©¿}]¾÷¨îÀ°¤FªYÄ£¤j¦£!!! °ª¿@«×ªº¤T´â½©¿}¥i¯à¾ÉPPLC-£^1»P(¬¡¤Æªº¡^T²ÓM¨üÅ骺ªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡A[§í¨îCD4+ CD8+ T ²ÓM¼W´Þ] 2017.8.1-[1«¬¿}§¿¯f]¤¤ªº¦Û¨¤ÏÀ³©Ê T ²ÓM www.jci.org/articles/view/94549 §Ú̹ï¤HÃþT1Dªº²z¸Ñ¤¤¡A[£]²ÓM]ªº¯}Ãa¥Dn¬O¥Ñ§K¬Ì¤ÏÀ³ªº¾AÀ³©ÊÁuªº[CD4 +©MCD8 + T²ÓM] ÅX°Êªº§K¬Ì§ðÀ»¤Þ°_ªº ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 06:33:18²Ä 3850 ½g¦^À³ ¦A¬Ý¤@¦¸¥h¦~ªº[1«¬¿}§¿¯f]ªº¹Ú¦³¦h¤j! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤W¤È 08:29:16²Ä 3883 ½g¦^À³
|
www.sinewpharma.com/Upload/download/20240606-video.MP4 40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ µ²½×:±q¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ¡A8¦¨´N¬O¦³ÅãµÛ¼Æ¾Ú¬°¨Ì¾Ú! ---------------------------------------------------------------------------------------------- 2011.6.9--2«¬¿}§¿¯fªº°fÂà¡G£] ²ÓM¥\¯à¥¿±`¤Æ»P¯ØŦ©M¨xŦ¤T»Ä¥Ìªoà´î¤Ö¦³Ãö link.springer.com/article/10.1007/s00125-011-2204-7 ¥Ø«eªº¼Æ¾Ú´£¨Ñ¤F©ú½TªºÃÒ¾Ú¡A Åã¥Ü¯ØŦÁ`¯×ªÕªº´î¤Ö»P[£]²ÓM¥\¯àªº«ì´_]¦³Ãö¡C Åã¥Ü¯ØŦÁ`¯×ªÕªº´î¤Ö»P[£]²ÓM¥\¯àªº«ì´_]¦³Ãö¡C Åã¥Ü¯ØŦÁ`¯×ªÕªº´î¤Ö»P[£]²ÓM¥\¯àªº«ì´_]¦³Ãö¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤W¤È 07:59:17²Ä 3882 ½g¦^À³
|
¹ê²{¯u¥¿ªº¿}§¿¯f[ªv¡]¨ú¨M©ó«ì´_¥\¯à©Ê£]²ÓM½è¶q!!! ¦Ó«¤¤¤§«©Î³\¦bT1R3 ¯Ê¥¢-->[Âù¬Û]¯Ø®q¯À¤Àªc¨ü¨ìÅãµÛ§í¨î!!! ------------------------------------------------------------------------------------ 2024.1.26--¥\¯à²§½è©Ê£]²ÓM½Õ¸` [Âù¬Û] [Âù¬Û] [Âù¬Û]¯Ø®q¯À¤Àªc www.nature.com/articles/s42255-023-00964-y ...§Ú̶i¤@¨Bªí©ú¡ARR£]s ªº¥\¯à»Ùê¦b¿}§¿¯fªº¶i®i¤¤°_µÛ¦ÜÃö«nªº§@¥Î¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤W¤È 07:21:51²Ä 3881 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤U¤È 09:31:10²Ä 3878 ½g¦^À³ 2017.9.17-[¸²µå¿}±Ó·P¨üÅé] ¦b¯Ø®q¯À¤Àªc¤¤ªº§@¥Î µL½×¦p¦ó T1R3 ªºªí¹F¦bªÎD©M¿}§¿¯f¤¤[°§C]¡C½T©w¦b¤HÃþªÎD©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C --------------------------------------------------------------------------------------------- 2005.3.1-«C¤Ö¦~²Ä 2 «¬¿}§¿¯f¡G¯Ø®q¯À§Ü©Ê¡B£] ²ÓM°IºÜ¡A©Î¨âªÌݨã¡H diabetesjournals.org/care/article/28/3/638/27718/Youth-Type-2-DiabetesInsulin-resistance-cell µ²½× ³o¬O²Ä¤@¶µ°w¹ï«C¤Ö¦~ªº¬ã¨s¡AÅã¥Ü»P¬Û¤Ç°tªºªÎD¹ï·Ó¨ü¸ÕªÌ¬Û¤ñ¡A±w¦³²Ä 2 «¬¿}§¿¯fªº«C¤Ö¦~ªº¯Ø®q¯À±Ó·P©Ê©M¯Ø®q¯À¤Àªc§¡¨ü·l...¦ý¥O¤H¤£¦wªºÆ[¹îµ²ªG¬O¦b«Ü¤pªº®Éԯخq¯À¤Àªc´NÄY«¨ü·l¡]FPIS °§C¬ù75%¡FSPIS °§C¬ù50 %¡^¿}§¿¯f¯fµ{¬Û¹ï¸ûµu¡C³o¨Çµo²{ªº·N¸q¥i¯à¬O¦´Á»Ýn¯Ø®q¯À´À¥NÀøªk¨Óºû«ù¦å¿}±±¨î¡C Ó¤Hµ²½×:2005¦~¡]FPIS °§C¬ù75%¡FSPIS °§C¬ù50 %¡^?µª®×À³¸Ó¬O2017¦~£]²ÓMªºT1R3¯Ê¥¢(FPIS»PSPIS³£¨ü¨ìÅãµÛ§í¨î!!!) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤W¤È 06:21:39²Ä 3880 ½g¦^À³
|
£]²ÓM·s¥Í¡G¬@±Ï¿}§¿¯fªº[«á°_¤§¨q]<---->SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!? ¦A¬Ý¤@¦¸¦P¦æªº(¤T´â½©¿}T1R3¿E¬¡¾¯)¬ã¨s: 1.2024.5.21-¤G¤Q¦~¬ã¨s¡G²¢¨ý¨üÊ^¼v响¤HÊ^¥N谢¸²µå¿}ªº¤è¦¡ ¥L们发现¡A将TAS1R2-TAS1R3¿E动剂(¤T´â½©¿}) 2.Nature¥D¥Z¿¯¹²¢¨ý¾¯[¤T´â½©¿}]¬O T ²ÓM¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯ 3.2.¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²ÓM©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯ www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12 4.......... 5.......... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/5 ¤W¤È 06:08:02²Ä 3879 ½g¦^À³
|
SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!? §ó«nªº¬O¡A¦b [T1R3¯Ê¥¢] [T1R3¯Ê¥¢] [T1R3¯Ê¥¢]ªº¯Ø®q¤¤¡A ¯Ø®q¯À¤Àªcªº¨âÓ¶¥¬q: ²Ä¤@¬Û¯Ø®q¯ÀÄÀ©ñ(FPIS)»P²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ(SPIS)³£¨ü¨ì[ÅãµÛ§í¨î]!!! ³Ì¨Î¦å¿}±±¨î»Ýn²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C ³Ì¨Î¦å¿}±±¨î»Ýn²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C ³Ì¨Î¦å¿}±±¨î»Ýn²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C FPISÄÀ©ñ¹ï©ó¹ï§Ü¤É¿}¯À¹ï¸²µå¿}²£¥Íªº [§Ö³t] ¼vÅT«Ü«n¡A¦ÓSPISÄÀ©ñ¹ï©ó [ºû«ù] ³oºØ§í¨î¨Ã¼W¥[¸²µå¿}§Q¥Î²v«Ü «n¡C¯Ê¥FFPISÄÀ©ñ·|¾ÉPµu¼È¡]2¤p®É¡^©M¤¤«×¡]20-30 mg/dl¡^¦å¿}¯Ê³´¡A¦Ó¯Ê¥FSPISÄÀ©ñ·|¾ÉPªø´Á¥B¼@¯P¡]70-100 mg/dl¡^¦å¿}¯Ê³´¡C ------------------------------------------------------------------------------------------------ 1.2024.1.26--¥\¯à²§½è©Ê£]²ÓM½Õ¸` [Âù¬Û] [Âù¬Û] [Âù¬Û]¯Ø®q¯À¤Àªc www.nature.com/articles/s42255-023-00964-y µo²{©ö©óÄÀ©ñªº £] ²ÓM¡]RR£]¡^¬O¹ïÂù¬Û¸²µå¿}¨ë¿Eªº¯Ø®q¯À¤Àªc¦³¤£¦¨¤ñ¨Ò°^Ämªº¨È¸s¡C§Ú̶i¤@¨Bªí©ú¡ARR£]s ªº¥\¯à»Ùê¦b¿}§¿¯fªº¶i®i¤¤°_µÛ¦ÜÃö«nªº§@¥Î¡C 2.2023.2.27-²Ä¤@¬Û¯Ø®q¯À¤Àªc¡G¨äµû¦ô¯à§_«ü¾ÉªvÀø¤èªk¡H www.sciencedirect.com/science/article/pii/S1043276023000309 ...§ÚÌ®i¥Ü¤F²Ä¤@¬Û¯Ø®q¯À¤Àªc»P¸²µå¿}úAªº¬ÛÃö©Ê¡A¨Ã¤ÀªR¤F¨ä´î¤Ö¹ïÁ{§Éªí²{¡]¯S§O¬OÀ\«á°ª¦å¿}¡^©M¯e¯fµ²ªGªº ¼vÅT¡C¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²ÓM¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅÜªÌ ¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²ÓM¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅÜªÌ ¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²ÓM¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅܪ̡A |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤U¤È 09:31:10²Ä 3878 ½g¦^À³
|
2017.9.17-[¸²µå¿}±Ó·P¨üÅé] ¦b¯Ø®q¯À¤Àªc¤¤ªº§@¥Î dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.13013 ³o¨Çµ²ªGªí©ú[T1R3©MCaSR]ªº²§¤G»EÅé¬O [¸²µå¿}±Ó·P¨üÅé]ªº¥Dn¦¨¤À¡C ... ·í´ú¶q±q T1R3 ºV°£¤p¹«Àò±oªº¯Ø®q¤¤ªº¯Ø®q¯À¤Àªc®É¡A»P¥¿±`¤p¹«ªº¯Ø®q¬Û¤ñ¡A¸²µå¿}»¤¾Éªº¯Ø®q¯À¤Àªc³Q§í¨î¬ù 40%¡C§ó«nªº¬O¡A¦bT1R3¯Ê¥¢ªº¯Ø®q¤¤¡A¯Ø®q¯À¤Àªcªº²Ä¤@¶¥¬q©M²Ä¤G¶¥¬q³£¨ü¨ìÅãµÛ§í¨î ..µL½×¦p¦ó T1R3 ªºªí¹F¦bªÎD©M¿}§¿¯f¤¤[°§C]¡C½T©w¦b¤HÃþªÎD©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C T1R3 ªºªí¹F¦bªÎD©M¿}§¿¯f¤¤[°§C]¡C½T©w¦b¤HÃþªÎD©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C T1R3 ªºªí¹F¦bªÎD©M¿}§¿¯f¤¤[°§C]¡C½T©w¦b¤HÃþªÎD©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C ----------------------------------------------------------------------------------------- (¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²ÓM] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯) 2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i: ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? À³¸Ó«Ü¦³½ìªº! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤U¤È 09:23:01²Ä 3877 ½g¦^À³
|
SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!? (¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²ÓM] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯) 1.2024.5.21-¤G¤Q¦~¬ã¨s¡G²¢¨ý¨üÊ^¼v响¤HÊ^¥N谢¸²µå¿}ªº¤è¦¡ m.ebiotrade.com/newsf/2024-5/20240518052435596.htm ¥L们发现¡A将TAS1R2-TAS1R3¿E动剂(¤T´â½©¿}¡A¤@Ïú¹s热¶q²¢¨ý剂)©ÎTAS1R2-TAS1R3«ú§Ü剂(¨Å»Äà¡A¤@Ïú§í¨î²¢¨ýªº钠盐)ÉO¸²µå¿}²V¦X¡A会¥H¤£¦Pªº¤è¦¡剧¯P§ï变¤HÊ^ªº¸²µå¿}@¶q¡C ¤@个¤Hªº°·±d状úGÉO¨äTAS1R2-TAS1R3¨üÊ^ªº¬¡©Ê¤§间¬O§_¦s¦b关¨t?该¬ã¨sªº§@ªÌ说¡A¡§¥i¯à¡¨¡A这ªí©ú¨üÊ^¿E¬¡ªºµ{«×对¦å¿}©M¯Ø岛¯À¤ô¥¤Î¨ä发¯f时间¦³严«¼v响¡A这对¥N谢°·±d«Ü«n¡C 2.2024.5.18-¿}§¿¯f¡A¦Þ¦y¤Wªºªv·U¡C²¢¨ý¨üÊ^¬O关键吗¡H zh-cn.futuroprossimo.it/2024/05/diabete-la-cura-sulla-punta-della-lingua-la-chiave-e-il-recettore-del-dolce/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 09:32:23²Ä 3876 ½g¦^À³
|
¿}§¿¯f·s[¶t]©À!!! 1.2024.3.20-¿}§¿¯f¤¤±w¯fªº £] ²ÓM¡G«æ¶E«Ç¤§®Èªº¨£¸Ñ¡G2023 ¦~³Ç¥X¬ì¾Ç¦¨´N¼úÁ¿®y 2.2009¦~-¯ØŦ £] ²ÓM¤¤ªí¹Fªº²¢¨ý¨üÅé·|¬¡¤Æ¶t©MÀô AMP °T¸¹¨t²Î¨Ã¨ë¿E¯Ø®q¯À¤Àªc journals.plos.org/plosone/article?id=10.1371/journal.pone.0005106 ¤T´â½©¿}¹ï [Ca 2+ ] c©M [cAMP] cªº¼vÅT¡C ----------------------------------------------------------------------------------- 2½g¬ã¨s°Â¦b¤@¶ô¡A·Q¤@¤USNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 07:26:47²Ä 3875 ½g¦^À³
|
1.2024.4.15-¥[¤J £] ²ÓM¨ë¿EªvÀø[²Ä1«¬]¿}§¿¯fªº¸ÕÅç ¤@¶µ¸ÕÅ祿¦b©Û¶Ò±w¦³²Ä 1 «¬¿}§¿¯fªº¦¨¦~¤H¨Ó¬ã¨s BMF-219¡A³o¬O¤@ºØ¨ë¿E £] ²ÓM¥Íªøªº·s«¬¤fªAÃĪ«¡C¸ÓÃĪ«¤w¦b [²Ä2«¬]¿}§¿¯fªvÀø¤¤Åã¥Ü¥X¥i³ßªº®ÄªG¡A¥i§ïµ½½d³ò®É¶¡©M¦å¿}±±¨î¡C 2.2024.6.7-FDA ¹ï Biomea Fusion ªº BMF-219 ¿}§¿¯f¸ÕÅç¶i¦æ¥þ±Á{§ÉÀÁ¸m ¸Ó¨M©w¬O°ò©ó COVALENT-111 ¸ÕÅ礤µo²{ªº¼ç¦bÃĪ«¤Þ°_ªº[¨x¬r©Ê]¤ô¥¡C ------------------------------------------------------------------------------------------ ¤p¤À¤lÃÄ¥\¯à©Êªv¡1«¬»P2«¬¿}§¿¯fªºÁ{§É¸ÕÅç¡Aº§å2¦W1«¬¿}§¿¯f±wªÌ£]细M¥\¯à±o¨ì§ïµ½¡A¦³®Ä¦ý¦]¬°[¨x¬r©Ê]À³¸Ó¬O¨SÀ¸¤F! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 07:10:50²Ä 3874 ½g¦^À³
|
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i: ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? ------------------------------------------------------------------------------------------------- www.sinewpharma.com/Upload/download/20240606-video.MP4 40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ µ²½×:±q¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ¡A8¦¨´N¬O¦³ÅãµÛ¼Æ¾Ú¬°¨Ì¾Ú! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 06:57:58²Ä 3873 ½g¦^À³
|
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i: ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? [oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f??? ----------------------------------------------------------------------------------------------- [oral insulin]¤fªA¯Ø®q¯À--->¿}§¿¯f·s[¶t]©À??? ª`·N¤£¬O²ÓM»P°Êª«¹êÅç¡A¦Ó¬O¤HÅéÁ{§É¸ÕÅç¼Æ¾Ú!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 06:44:13²Ä 3872 ½g¦^À³
|
2023.10.13-£]²ÓM·s¥Í¡G¬@±Ï¿}§¿¯fªº«á°_¤§¨q!!! www.sciencedirect.com/science/article/pii/S2090123223003120 ----------------------------------------------------------------------------------------- ¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²ÓM] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 06:31:33²Ä 3871 ½g¦^À³
|
¿}§¿¯f·s[¶t]©À!!! 2024.3.20-¿}§¿¯f¤¤±w¯fªº £] ²ÓM¡G«æ¶E«Ç¤§®Èªº¨£¸Ñ¡G2023 ¦~³Ç¥X¬ì¾Ç¦¨´N¼úÁ¿®y diabetesjournals.org/diabetes/article/73/4/545/154111/The-Ailing-Cell-in-Diabetes-Insights- From-a-Trip ²§±`ªº[£]²ÓM] [¶t] °T¸¹¶Ç¾É¾ÉP T1D µo¯f¾÷¨î....... ¥O¤HÅå³Yªº¬O¡A¶tªº´î¤Ö»PÅãµÛªº¤º½èºôÀ£¤Oªí«¬µLÃö¡A¦Ó¬O¾ÉP[¤º½èºô¶t]ªºÅܤơA¾ÉP[²É½uÅé¶t]¤ô¥¤É°ª©M²É½uÅé¥\¯à»Ùê¡A³Ì²×¥[³t¿}§¿¯fªºµo¯f¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/12 ¤U¤È 05:09:10²Ä 3805 ½g¦^À³ 2023.7.27-²ÓM¤º[¶t]°T¸¹¶Ç¾É¡G±`¨£¶ûºÃ¤Hªº·N·Q¤£¨ìªº[·s¨¤¦â]!!! www.ncbi.nlm.nih.gov/pmc/articles/PMC10413985/ ...§ïÅܲÓM¾¹¶¡ Ca 2+³q¶qªº·L§®¥¿Å¥i¯à¾ÉP¦M¤Î¥Í©Rªº¯e¯f¡A¨Ò¦pAD¡BÀù¯g©M·»酶Åé¶J¿n¯g¡A¨Ã¥B¦b¥¼¨Ó¥i¯à·|µo²{§ó¦h¯e¯f... ------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 09:22:24²Ä 3751 ½g¦^À³ ¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!ªºÅܤơC ---------------------------------------------------------------------------------- Nature¥D¥Z(¿¯¹²¢¨ý¾¯¤T´â½©¿}¬O T ²ÓM¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯--(¤T´â½©¿}´î¤Ö¤FT²ÓM¤¤TCR¨Ì¿à©Ê¶t³q¶q¡A¦Ó¤£§ïÅܾãÅé²ÓM¤º¶tÀx¦s) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/2 ¤W¤È 09:36:35²Ä 3870 ½g¦^À³
|
2024.2.20-P©Rªº¯×ªÕ¡G¯ØŦ¤º¯×½è¾ÉP¯ØŦÀù www.cell.com/cell-reports-medicine/fulltext/S2666-3791(24)00051-X ¦b©s¼wº¸ÀH¾÷¤Æ©M«e¤©Ê¶¤¦C¬ã¨s¤¤¡A1¯ØŦ¤º¯×ªÕ·|¼W¥[¯ØŦÀùªº·ÀI¡C³o¬°¯×½è»P¯ØŦÀù¯g¤§¶¡ªº¦]ªGÃö«Y´£¨Ñ¤F¦³»¡ªA¤Oªº¤HÃþÃÒ¾Ú¡A[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]¡C [ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú] |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/7/2 ¤W¤È 09:22:30²Ä 3869 ½g¦^À³
|
www.sinewpharma.com/Upload/download/20240606-video.MP4 40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ °ê»Ú3¤j³»¥ZCNS:Cell¡BNature¥H¤ÎScience¡C ¡u¥|¤jÂå¾Ç³»¥Z¡v¡G·s^®æÄõÂå¾ÇÂø»x(NEJM)¡B¬h¸¤M(Lancet)¡B¬ü°êÂå¾Ç·|Âø»x(JAMA)¥H¤Î^°êÂå¾Ç´Á¥Z(BMJ)¡C 1.2023.4.21-¯ØŦªº¯×ªÕÅÜ¡G¯ØŦ¾Çªº¼ï¦·©ÔÅ]²° www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00064-X/abstract 2.2024.2.7-¤ñ¯×ªÕ¨x§óÄY«ªº¯×ªÕ¯Ø¡Iwww.edh.tw/article/25090 ¯×ªÕ¯Ø¬OÃöÁ䨤¦â ¯Ø®q¯À¬O¥Ñ¯Ø¸¢ªºBeta²ÓM©Ò¤Àªc¡A¦Ó¯×ªÕ¹ï¯Ø¸¢¬O¦³¬r©Êªº¡C¬ã¨sµo²{¡A¦³¨Ç¤H¦b¯Ø¸¢¯×ªÕ§t¶q¶W¹L5¢Hªº®ÉÔ¡A´N±w¦³ ¤G«¬¿}§¿¯f¤F¡C [¯×ªÕ¨x] ¥[¤W[¯×ªÕ¯Ø]´N¬O³y¦¨¿}§¿¯fµLªk±±¨îªº¨â¤jì¦]¡A¤]ºÙ¬°[Âù´`Àô²z½×¡C] --------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/30 ¤U¤È 05:53:57²Ä 3431 ½g¦^À³ 1.¸É¤W¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºPÈ: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Îp¤WÅãµÛ®t²§) 2.§ïµ½¯×ªÕ¯Ø¤Þ°_ªº¯Ø¯fÅÜ¡B[¿}§¿¯f] ©Î¨ä¥L¬ÛÃö¯f¯g¤§²Õ¦Xª«¤Î¤èªk±M§Q (SNP-6ÃĪ«) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/30 ¤U¤È 07:18:40²Ä 3868 ½g¦^À³
|
·sÃĶ}µoªº®Ú¥»:¨ä¥Hªk¥O¨î«×¬°¸g¡B¹êÃÒ¬ì¾Ç(Á{§É¸ÕÅç)¬°½n¡AÁa¾î¥æ´¦¨¬ì§Þ»Pªk«ß¥æ¬yªºÀ³¥Î¬ì¾Ç¡C ¦h°µÂI¥\½Ò¼W±j²´¥ú¡A³zµø©Ò§ë¸ê¤½¥qªº¸¬Äª¸Ì½æªº¬O¬Æ»òÃÄ?¿ï¾Ü¦³¼ç¤Oªº¤½¥q¡A´N¥i¥H´£°ª³Ó²v! ¤£nªÈµ²©ó²{¦b¡A®æ§½©ñ¤j¤@ÂI¡A¦A©¹«e¬Ý·Q¹³¤@¦~«á¡B¤¦~«á¡A¤@¤Á³£·|Åܱo¤£¤@¼Ë¡C ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/11 ¤W¤È 08:01:05²Ä 2430 ½g¦^À³ ¸¨¤«¤U¥Û??? §Ú¦b¹j¤é1/6°ê¹©ªÑ»ù¿ÄÂ_®É¦Ñ¦Äµ¥Ü!!!(°ê¹©¤G´ÁPȵS¥¼ª¾?) ¡u¤½µL´çªe¡A¤½³º´çªe¡C¼Zªe¦Ó¦º¡A·í©`¤½¦ó¡I¡v ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 07:50:51²Ä 1878 ½g¦^À³ ...¤µ¤Ñ±q¸Ñª¼¼Æ¾Ú¨Ó¬Ý [¥h¦~ªº¥[¦¬«¯gªÌ] ´N¬O[»´¤¤¯g¦³®Ä©Ê«Ü¤£©úÅã¡A©Ò¥H¥[¤J«¯g±wªÌÁ{§É] --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³ ...°ê¹©:DMC«Øij¼W¥[¦¬ªv»Ýn®ñ®ð¤ä«ù¤§«¯g¦í°|¯f±w¡C ³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J«¯g±wªÌÁ{§É¬Ý¬Ý¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/30 ¤U¤È 06:58:03²Ä 3867 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/2/3 ¤W¤È 10:56:59²Ä 662 ½g¦^À³ J&J»PGSKªº°ª¼h¬OÄø³J?¥H«e¹C»¡°ê·|ijûªý¼¸FDA¡A²{¦b¤£ª¾¹D¤Ï¹L¨Ó§Q¥Î³o±ø¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n???¬°½T«OOTCÃÄ«~ªº[¦w¥þ©Ê]¡A FDA¥u»Ý¤@¯È¦æ¬F©R¥O... ------------------------------------------------------------------------------------------------- 2023.7.28www.gao.gov/assets/gao-23-106570.pdf ¬ü°êFDA[«D³B¤èÃÄ]¤¤±Æ¥L©Ê±ø´Ú(¥«³õ¿W¦ûÅv) ...2018 ¦~1 ¤ë¼gµ¹°ê·|»â¾É¤Hªº¤@«Ê«H¤¤¡A¤@Ó¥Nªí®ø¶OªÌ§Q¯qªº²Õ´¤½¶}´£¥X¤F³o¼Ëªº¾á¼~¡G«D³B¤èÃĤ½¥q¥i¯à·|¨î¸û¦Ñ¦ý¦P¼Ë¦³®Äªº«D³B¤èÃĪº¨ÑÀ³¡A±q¦Ó¢¨Ï®ø¶OªÌÁʶR¸û·s¡B¸û¶Q¥BÀò±o[¿W®a¸gÀçÅv]ªºÃĪ« Ó¤Hµ²½×:¤jÃļt©ñ±ó[¿W®a¸gÀçÅv]? ©ñ±ó±q®ø¶OªÌ¤f³U±Ç§ó¦h¿ú? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/30 ¤W¤È 09:21:00²Ä 3866 ½g¦^À³
|
ªYÄ£ªº¥Ø¼Ð¬O´Â¦V¥H°ª¨x¦w¥þ©Êªº¤AñQÓi×ô¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C ¤jÃļt·|«ç¼Ëª¾ªkª±ªk¡A¥HOTC±M½×q³æ½Ð¨D¦J÷ÅýFDAµo¥¬¦æ¬F©R¥O.....???? ³o¬OµL¨x¬rSNP-810ªºOTC«D³B¤èÃÄ»ùÈ¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/30 ¤W¤È 08:53:22²Ä 3865 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 07:05:38²Ä 3781 ½g¦^À³ ...§ï²ªk®×¤º¤å¦³¹ªÀy«D³B¤èÃÄ[¦w¥þ³Ð·s]! -------------------------------------------------------------------------------------------------- ªYÄ£ªº¥Ø¼Ð¬O´Â¦V¥H°ª¨x¦w¥þ©Êªº¤AñQÓi×ô¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C Ãļt¥i¥Hn¨DFDA§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À.....µ¥--->´£¥æ(OTC±M½×q³æ½Ð¨DOMOR¡^ sbiaevents.com/files2024/OMUFA-Webinar-June-2024-Slides.pdf ¹ï©ó·s¼W©Î¥[±j¥H¤U [¦w¥þ¬ÛÃö] «D³B¤èÃıMµÛÅܧó¡AµL½×µ¥¯Å¬°¦ó¡AOMOR §¡¤£¦¬¨ú¥ô¦ó¶O¥Î(¨ä¾lÅܧón¦¬¿ú)¡G ¸T§Ò¯g¡Bĵ§i©Î¹w¨¾±¹¬I Ãö©ó¨Ï¥Î©ÎÀݥάÛÃöªº·ÀIªºÁn©ú ¦³Ãö¾¯¶q©Mµ¹ÃĪº»¡©ú¡A¦®¦b´£°ª«D³B¤èÃıMµÛÃĪ«ªº¦w¥þ¨Ï¥Î Ó¤Hµ²½×:´Á«Ý¹Ú¹Ò¦¨¯u¡A¥@¬É¦]¹Ú¦Ó§ïÅÜ! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/30 ¤W¤È 08:35:24²Ä 3864 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/25 ¤U¤È 10:58:33²Ä 3854 ½g¦^À³ ...Ãļt§ä¥Á¥N¬IÀ£FDA-[¥P©é¥P]À¸½Xµ²§ô! 2024.6.14-¬ü°êקï«áªº«D³B¤èÃıMµÛp¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô¥Ö½§¤ÏÀ³Äµ§i¶}©l ¤µ¤Ñ¡AFDA µo¥¬¤F¤@¶µÀÀijªº[¦æ¬F©R¥O].... -------------------------------------------------------------------------------------------------- Ãļt¥i¥Hn¨DFDA§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À.....µ¥--->´£¥æ(OTC±M½×q³æ½Ð¨DOMOR¡^ FDAn¨DÃļt¥[µùĵ§i»y.....µ¥--->¥Îªº¬O(¦æ¬F©R¥O) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/30 ¤W¤È 08:21:31²Ä 3863 ½g¦^À³
|
www.sinewpharma.com/Upload/download/20240606-video.MP4 39¤À30¬í:¤À§O¦V¨äFDA»PEMA±N¨ä¾Ö¦³¨x¬r©Ê......²¾¥X¥«³õ.... Ó¤Hµ²½×:¤jÃļtªºª¾ªkª±ªk¡A§ó¥i©È!!! ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 08:31:15²Ä 3782 ½g¦^À³ ªYÄ£±N¥Ó½Ð¦w¥þ·sÃij\¥iÃÒ(¥«³õ±MÀçÅv?)¨Ã´£¨Ñµ¹°ê»Ú¤jÃļt(°ê»Ú¤jÃļt¤£¥Î«·s°µÁ{§É¥Ó½ÐÃÄÃÒ) 3.[FDA...¦æ¬F©R¥O±Â¤©[¥«³õ±MÀçÅv][¥«³õ±MÀçÅv][¥«³õ±MÀçÅv] ...OTCÃÄ«~§ï² (SNP-810¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡C¥iקï©Î§R°£FDA¨x¬rĵ»y) 1.³Ì²×¦æ¬F©R¥Oµo¥¬«á¡AFDA ¥i¥H§ó§ï¶Ü¡H ¦³¤@¶µ±ø´Ú¤¹³\ FDA ¦b¦³·sÃÒ¾Úªí©ú¯S©wÃĪ«©Î¬YÃþÃĪ«ºc¦¨[¤£¨}¨Æ¥ó]ªº[¤£¦X²z·]ÀI¨Ã»Ýn¼ÐÅҩΨä¥LÃþ«¬ªº§ó§ï ®É¡A¤¹³\FDA ¹ï¥ô¦ó³Ì²×¦æ¬F©R¥O¶i¦æ§ó§ï¡C 2.»s³y°Ó¦p¦ó½Ð¨D§ó§ï±M½×¡H »s³y°Ó¥i¥Hn¨D§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À¡A¨Ò¦p³z¹L´£¥æ OTC ±M½×q³æ½Ð¨D¡]¡uOMOR¡v¡^¡C 3.¦b·sªº«D³B¤èÃĺʺޮج[¤U¡A§Úªº«D³B¤èÃĦ³¸ê®æÀò±o¯S³\¸gÀçÅv¶Ü¡H ¦pªG·sªº¤HÅé¬ã¨s¹ïµo¥¬³Ì²×¦æ¬F©R¥O¦ÜÃö«n¡A¨º»òFDA ¥i¥H¦bµo¥¬¥Ñ¥Ó¿ìªÌµo°_ªº°w¹ï·s«D³B¤èÃĬ¡©Ê¦¨¤À¡]¤§«e¥¼ ¦C¤J¦U½×©Î©R¥O¡^ªº³Ì²×¦æ¬F©R¥O©Î°w¹ï¤£¦P¨Ï¥Î±ø¥óªº¦æ¬F©R¥O«á±Â¤©¥«³õ±MÀçÅv¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/29 ¤U¤È 03:27:16²Ä 3862 ½g¦^À³
|
2024.6.6-ªk»¡·|¼vµÀÉ httpd://www.sinewpharma.com/Upload/download/20240606-video.MP4 ¯u¹ê.°È¹ê.¥¹ê |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/27 ¤U¤È 01:25:35²Ä 3861 ½g¦^À³
|
¥ÌÅS¾J¥i¯à«ì´_¨ã¦³¦h¥\¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²ÓM¾÷¨î??? °ªº¯³zÀ£[¥ÌÅS¾J]«á¦å¼ß[¹[¿@«×]¤É°ª¬O¥Ñ©ó[K+¹[]±q²ÓM [²¾¥X] ¶i¤J²ÓM¥~²G... -------------------------------------------------------------------------------------- 1.2016.9.14(Nature¥D¥Z)¸~½F·LÀô¹Ò¤¤ªºÂ÷¤l§K¬Ì§í¨î¨î¤F T ²ÓM®ÄÀ³¥\¯à www.nature.com/articles/nature19364 ¸~½F¤ºT²ÓMªº±þÀù¬¡©Ê©¹©¹·|¨ü¨ì¼vÅT¡A¾ÉP¯e¯f¶i®i¡C§ÚÌ¥ý«eµo²{¡A¸~½F¤º²ÓM [¥~] K+ ªº¤É°ª»P¥¿¦b¶i¦æªº²ÓM¦º¤`¦³Ãö¡A³o¨î¤F CD8+ T ²ÓMªº Akt-mTOR °T¸¹¶Ç¾É©M®ÄÀ³¥\¯à¡C¬°¤F½w¸Ñ K+ ¤¶¾Éªº T ²ÓM§í¨î¡A§Ú̳z¹L°ò¦]¤â¬q¨Ó°§C²ÓM[¤º]K+¡C 2.2019.3.29-¸~½F¤¤ªºT²ÓM·F©Ê©M¥\¯à»Ùê¬O¥Ñ¦@¦P¾÷¨îIJµoªº www.science.org/doi/full/10.1126/science.aau0135 §Ú̵o²{¸~½F·LÀô¹Ò¤¤¹L¶qªº [¹[]¬O³oºØ [¤G¤Àªk] ªº°ò¦¡A¦b«O«ù·F©Êªº¦P®ÉIJµo T ²ÓM®ÄÀ³¥\¯àªº§í¨î¡C°ª¤ô¥ªº²ÓM [¥~] ¹[³z¹L¨îÀç¾i§l¦¬¨Ó¨îT ²ÓM®ÄÀ³µ{§Ç¡A±q¦Ó»¤¾É¦Û¾½§@¥Î¨Ã´î¤Ö®ÄÀ³¾¹©M¯ÓºÜ¦ìÂIªº²Õ³J¥Õ¤AñQ¤Æ¡A ¶i¦Ó²£¥Í¨ã¦³§ïµ½ªºÅ餺«ù¤[©Ê¡B¦h¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²ÓM¡C ¶i¦Ó²£¥Í¨ã¦³§ïµ½ªºÅ餺«ù¤[©Ê¡B¦h¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²ÓM¡C ³oºØ¾÷¨îª¾ÃѼW¶i¤F§Ú̹ï T ²ÓM¥\¯à»Ùꪺ²z¸Ñ¡A¨Ã¥i¯à±a¨Ó·sªº¤èªk¡A±q¦Ó¯à°÷¶}¾v¥Î©óÀù¯g§K¬ÌªvÀøªº¼W±j T ²ÓMµ¦²¤¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/27 ¤W¤È 11:52:21²Ä 3860 ½g¦^À³
|
¥ÌÅS¾J(º¯³zÀ£½Õ±±NFAT5ªº¬¡¤Æ¥[¼@¸~½F®û¼íCD8+T²ÓMªº¯ÓºÜ?)+¤T´â½©¿}(§í¨îCD4+ CD8+ T ²ÓM¼W´Þ)ªº¨ó¦P®ÄÀ³!!! 1.2023.10.9-¡m¦ÛµM§K¬Ì¾Ç¡n¡G¬¥®á¤j¾Ç¹Î¶¤µo²{±Mªù½Õ¸`¸~½F¤¤T²ÓM¯ÓºÜªº¯S®í³J¥Õ¡I www.nature.com/articles/s41590-023-01614-x ¬ã¨s´¦¥Ü¡ANFAT5ªº°ªªí²{¯à°÷¥[¼@¸~½F®û¼íCD8+T²ÓMªº¯ÓºÜ¡A©Î¥i§@¬°¼ç¦bªº§K¬ÌªvÀø¹vÂI¡A³z¹L¤¶¤JNFAT5ªº[ªí¹F©Î ¬¡©Ê]¨Ó´£°ªCD8+T²ÓM¹ï¸~½Fªº¤ÏÀ³¡A±q¦Ó§ïµ½Àù¯gªvÀøªº®ÄªG¡C NFAT5ªº¬¡¤Æ¨ü²ÓM¥~ [º¯³zÀ£½Õ±±] NFAT5ªº¬¡¤Æ¨ü²ÓM¥~ [º¯³zÀ£½Õ±±] NFAT5ªº¬¡¤Æ¨ü²ÓM¥~ [º¯³zÀ£½Õ±±] ......NFAT5¹ï©ó¨ä¥¦¨ë¿E±ø¥ó¡A¦p®ñ¤ÆÀ£¤O¡B¯Ê®ñ¡B²ÓM¿E¯À¡B¨ë¿E¤£±Ó·P¡C 2.2013.7.19-¬¡©Ê®ñ½Õ¸` NFAT5 ¼Ð¹v°ò¦]ªºÀô¹Ò¨Ì¿à©Ê§í¨î www.nature.com/articles/emm201361 [°ªº¯³zÀ£] ¥ÌÅS¾J]¾¯¶q¨Ì¿à©Ê»¤¾É NFAT5 ¬¡©Ê¡A¦ý´î¤Ö LPS »¤¾Éªº IL-6 ²£¥Í¡C 3.2016.7.28-¾AÀ³©Ê§K¬Ì¨t²Î¦b¨x·l¶Ë©M¨x²ÓMÀùµo®i¤¤ªºÂù«§@¥Î www.cell.com/cancer-cell/fulltext/S1535-6108(16)30269-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1535610816302690%3Fshowall%3Dtrue CD8 +²ÓMªº¬¡¤ÆÅãµÛ«P¶i¨xÀùªºµo¥Í¡C CD8 +²ÓM¯ÓºÜªº¤p¹«ÀH«á§¡¥¼¥X²{¨x¸~½F §Ú̪º¼Æ¾Ú½T©w CD8 + T ²ÓM¬Oµoª¢¬ÛÃö¨xÀùµo¥ÍªºÃöÁä²ÓM¦¨¤À¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 05:31:04²Ä 3847 ½g¦^À³ 1. 2023.3.15-Nature¥D¥Z-¿¯¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²ÓM]¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯ ¤T´â½©¿}Åã²{§í¨îCD4+ CD8+ T ²ÓM¼W´Þªº¾¯¶q¨Ì¿à©Ê¯à¤O |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/27 ¤W¤È 09:40:22²Ä 3859 ½g¦^À³
|
2023/08/17 10:24 ¡e°OªÌ·¨°ê¤å¡þ¥x¥_³ø¾É¡f³Ò°Ê³¡³Ò°Ê°òª÷¹B¥Î§½°ê¤º§ë¸ê²Õ«e²Õªø´å°i¤å¡A³Q±±©ó¥ô¤º»P®É¥ôÄ_¨Î¶°¹Î°õ¦æªø𷡯Pµ¥¤H¦X§@¡A¾Þ±±³Ò°Ê°òª÷¡A°ª»ù©Ó±µÄ_¨Î¶°¹Î¡u˳f¡v¥X²æªº18¸U±i»·ªF¦Ê³fªÑ²¼¡A¨ÏÄ_¨ÎÀò§Q¬ù4.5»õ¤¸¡A¤@¼f¨Ì¶¡±µ¾ÞÁaªÑ»ù¸o«§P´å°i¤å9¦~¡B𷡯P8¦~.... ------------------------------------------------------------------------------------------------- ¬ÝµÛ·ÀY»¡¸Ü¡A¤jªÑªF¤£§C½Õ? ¨S±ÂÅv«e·Q¦³¬ßÀY¡A¬Ýú³°Ó·Q³y¶Õ§_? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/27 ¤W¤È 09:30:17²Ä 3858 ½g¦^À³
|
¥xÆW°·«O¸p¤½§G ¥h¦~2023¥xÆW¤Hªº°·«O¥ÎÃıƦæ: [¨Ï¥Î¤H¼Æ³Ì¦h]ªºÃĪ«¬O¦¨¤À¬°¤AñQ®ò×ôªº¤îµhÃÄ¡A¨Ï¥Î¤H¼Æ¹F898¸U¤H¡A±Æ¦W²Ä¤@ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/27 ¤W¤È 09:12:14²Ä 3857 ½g¦^À³
|
¦Aµ¹¥D¤O¤@¦¸¥X³fªº¾÷·|¡A¥þ¥x¬y·P¡B¤º~ªÍª¢¤S¨Ó¤F¡C¤îµhÃħ½¨Ó¬Ý¬Ý |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/26 ¤W¤È 07:48:54²Ä 3856 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/19 ¤W¤È 08:18:34²Ä 3698 ½g¦^À³ 2017.9.14-¬ü°ê°ê·|¼f¬d«D³B¤èÃÄ ¨âÄҥߪk¯ó®×±N¹ý©³§ï² FDA ¹ï«D³B¤è²£«~ªººÊºÞ¤è¦¡(¦]¬°¤¾ªøªk³Wµ{§Ç¡AFDA ªá¤F¤C¦~®É¶¡¤~n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i) ---------------------------------------------------------------------------------------------- ¤T¶¥¬q³W«h¨î©w¬yµ{¡]ANPR¡BTFM ©M FM¡^¤¾ªøªk³Wµ{§Ç-->FDA ªá¤F¤C¦~®É¶¡¤~n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i) 2024¦~6¤ë14¤é¤@¯È[¦æ¬F©R¥O]--->[«D³B¤èÃÄ]±MµÛp¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô [¥Ö½§¤ÏÀ³]ĵ§i¶}©l¡C §ñÃö¦w¥þ©Êªº¨x¬r¦p¦ó¸Ñ?????? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/26 ¤W¤È 07:36:27²Ä 3855 ½g¦^À³
|
1.2017.09.13-«eFDA¥N²z§½ªøJanet Woodcock¦b²³Ä³°|³Æ¸ß¸ê®Æ: We could start with the skin reactions to acetaminophen. (§ÚÌ¥i¥H±q¹ï¤AñQ®ò°ò×ôªº¥Ö½§¤ÏÀ³¶}©l) 2.2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n¥´³qFDA¥ô·þ¤G¯ß!!! ¤T¶¥¬q³W«h¨î©w¬yµ{¡]ANPR¡BTFM ©M FM¡^±N³Q¦æ¬F©R¥O¬yµ{¨ú¥N¡C 3.2024.6.14-¬ü°êקï«áªº[«D³B¤èÃÄ]±MµÛp¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô [¥Ö½§¤ÏÀ³]ĵ§i¶}©l ------------------------------------------------------------------------------------------------- µL¨x¬r¹ï¤AñQ®ò°ò×ô²Å¦X¤Þ¥Î3.³o±øªk³W??? 3.¦b [·sªº«D³B¤èÃÄ] ºÊºÞ®Ø¬[¤U¡A§Úªº«D³B¤èÃĦ³¸ê®æÀò±o¯S³\¸gÀçÅv¶Ü¡H ¦pªG [·sªº¤HÅé¬ã¨s] ¹ïµo¥¬ [³Ì²×¦æ¬F©R¥O] ¦ÜÃö«n¡A¨º»òFDA ¥i¥H¦bµo¥¬¥Ñ¥Ó¿ìªÌµo°_ªº°w¹ï·s«D³B¤èÃĬ¡©Ê¦¨¤À¡]¤§«e¥¼¦C¤J¦U½×©Î©R¥O¡^ªº³Ì²×¦æ¬F©R¥O©Î°w¹ï¤£¦P¨Ï¥Î±ø¥óªº¦æ¬F©R¥O«á±Â¤© [¥«³õ±MÀçÅv]¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/25 ¤U¤È 10:58:33²Ä 3854 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤W¤È 09:39:52²Ä 646 ½g¦^À³ Ãļt¸òFDA [¥P©é¥P]À¸½Xµ²§ô! 2017.09.13 ²{¥N¤ÆFDAªk³W«D³B¤èÃĪ« FDAÃĪ«µû¦ô»P¬ã¨s¤¤¤ß¡]CDER ¡^¥D¥ôJanet Woodcock¦b²³Ä³°|³Æ¸ß¸ê®Æ www.govinfo.gov/content/pkg/CHRG-115hhrg27228/html/CHRG-115hhrg27228.htm ...Dr. Woodcock. OK. Well, we could start with the skin reactions to acetaminophen. ------------------------------------------------------------------------------------------------- Ãļt§ä¥Á¥N¬IÀ£FDA-[¥P©é¥P]À¸½Xµ²§ô! 2024.6.14-¬ü°êקï«áªº«D³B¤èÃıMµÛp¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô¥Ö½§¤ÏÀ³Äµ§i¶}©l www.fda.gov/drugs/drug-safety-and-availability/fda-issues-agency-initiated-proposed-order-regarding-otc-monograph-drugs-containing-acetaminophen ¤µ¤Ñ¡AFDA µo¥¬¤F¤@¶µÀÀijªº[¦æ¬F©R¥O]¡A¥H¸Ñ¨M»P§t¦³¹ï¤AñQ®ò°ò×ôªº«D³B¤è (OTC) ±MµÛÃÄ«~¬ÛÃöªº¦w¥þ°ÝÃD¡C ...FDA ÃĪ«µû¦ô»P¬ã¨s¤¤¤ß«D³B¤èÃĿ줽«Ç¥D¥ô Theresa Michele Âå¾Ç³Õ¤hªí¥Ü¡G¡§¤µ¤Ñªº¦æ°Ê¥Nªí¤F FDA ¹ê¬I°ê·|·s±ÂÅv¡]§@¬° OTC ±M½×§ï²ªº¤@³¡¤À¡^ªº«n¨½µ{¸O¡C¡¨ ¡§¤µ¤Ñ´£¥Xªº©R¥O¦³§U©ó½T«O§ÚÌ¥«³õ¤W«D³B¤èÃĪº¦w¥þ©Ê©M¦³®Ä©Ê¡C¡¨ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/25 ¤W¤È 07:25:44²Ä 3853 ½g¦^À³
|
2024.4.2--³o³U²ÓM¥i¥H¦b¤HÅ餺ªø¥X·sªº¨xŦ(IIa´Á¸ÕÅç²×¥½´Á¨x¯f(ESLD) --------------------------------------------------------------------------------------------- ¹L¥hªº¤Q¦~......¥L̪º¤èªk¦b¦Ñ¹«¡B½Þ©Mª¯¨¤W°ö¨|·sªº°g§A¨xŦ-->8¦¨¾÷²v¦b¤HÅ餺ªø¥X·sªº°g§A¨xŦ! ±µ¨ü¨x²ÓM²¾´ÓªÌ²×¥Í»ÝnªA¥Î§K¬Ì§í¨î¾¯(´N¹³±µ¨ü²¾´Ó¾¹©xªÌªA¥Î§Ü±Æ¥¸ÃĪ«¤@¼Ë)-->³oÂI·¥¤j¨î¤F¾A¥Î±wªÌ! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/25 ¤W¤È 06:59:39²Ä 3852 ½g¦^À³
|
¦PºØ²§Åé²ÓMÀøªk! ±N°·±dªº¨ÑÅé¨x²ÓM²¾´Ó¨ì¨x°IºÜ±wªÌªº²O¤Úµ²¤¤¡C¨xŦ¨ã¦³Åå¤Hªº¦A¥Í¯à¤O¡A¦pªG¦³®Ä¥i¯à·|¹ý©³§ïÅܨx¯fªºªvÀø¤èªk¡C 1.¨xŦ 2024.4.2--³o³U²ÓM¥i¥H¦b¤HÅ餺ªø¥X·sªº¨xŦ(IIa´Á¸ÕÅç²×¥½´Á¨x¯f(ESLD) www.wired.com/story/cells-grow-liver-inside-patient/ ¬ì¾Ç®aº¦¸¹Á¸Õ¦b¤HÅ餺°ö¨|·sªº·L«¬¨xŦ.... (2023.4.12--LyGenesis ©M Imagine Pharma ¦X§@¶}µo[1«¬¿}§¿¯f]Àøªk (¨S³zº|ª÷ÃB) -------------------------------------------------------------------------------------------------- 2.¯ØŦ: Lantidra¬O±N¨Ó¦Û[¦º¤`®½ÃتÌ] ªº¯Ø®q[£] cell]´£¨ú¥X«á¡Aª`®g¦Ü±wªÌ--->¥h¦~§åã¤W¥«! VX-880[²§Åé·F²ÓM]¾DFDA¼È°±! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 07:13:08²Ä 3851 ½g¦^À³
|
¥h¦~1«¬¿}§¿¯fªº¹Ú¨º»ò¤j! ³o½g The dietary sweetener [sucralose]is a negative modulator of T cell-mediated responses ¤Sµn¤WNATURE¥D¥Z ¸U¤@ ¦pªGSNP-6¤p¹«¹êÅç½T©w[¦A²{©Ê]¥BÀu©ó³æ¤è¤T´â½©¿}¡A¤jÃļt¤K·§j¤£°Ê??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 06:33:18²Ä 3850 ½g¦^À³
|
¦A¬Ý¤@¦¸¥h¦~ªº[1«¬¿}§¿¯f]ªº¹Ú¦³¦h¤j! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/9/14 ¤U¤È 08:32:08²Ä 3445 ½g¦^À³ ¤µ¦~¤j«¬»sÃĤ½¥q¹ï[1«¬¿}§¿¯f]ÃĪ««Ü·P¿³½ì!!! 1.2023.3.13--Áɿյ᥸¸ê [29 »õ¬ü¤¸] ¦¬ÁÊ Provention Bio¡A¶ix[1«¬¿}§¿¯f]»â°ì ...ÁɿյẮu°õ¦æ©x Paul Hudson ¤WÓ¤ëªí¥Ü¡A¤½¥q¬Ý¨ì¤F[1«¬¿}§¿¯f]ÃĪ«¶}µoªº¥¨¤j«e´º¡A¨Ã«¥Ó¤F¥L±N[¤£¦A]P¤O©ó[2«¬¿}§¿¯f]©MªÎD¯gªº¶i¤@¨B¬ã¨s¡C 2. 2023.4.12--LyGenesis ©M Imagine Pharma ¦X§@¶}µo[1«¬¿}§¿¯f]Àøªk (¨S³zº|ª÷ÃB) 3.2023.6.12--AZÄâ¤âQuellªñ [21»õ¬ü¤¸] Treg²ÓMÀøªk§ð[²Ä1«¬¿}§¿¯f]»PIBD news.gbimonthly.com/tw/article/show.php?num=59502 4. 2023.6.29-§¨Ó±N¦¬ÁÊSigilon©Ò¦³³Ñ¾lªÑ¥÷ ¥HÂX¤j¨ä¿}§¿¯fªvÀø²£«~(1«¬¿}§¿¯f) Sigilion ªºªÑ»ù¦b½L«e¥æ©ö¤¤ öt¤É[¶W¹L 8 ¿]¦Ü 34.48 ¬ü¤¸¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 06:25:05²Ä 3849 ½g¦^À³
|
2023.3.15-Nature¥D¥Z-¿¯¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²ÓM]¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯ ¡§¥Î´¶³q¤ôÁý¾iªº¤p¹«100% ±w¦³1«¬¿}§¿¯f¡A¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºPÈ: 35%(§C¿@«×P=0.021)¡A50%(°ª¿@«× P=0.012) ------------------------------------------------------------------------------------------ ªYÄ£·|¤£ª¾³o½gNature¥D¥Zªº¤p¹«¹êÅç¡AÅçÃÒSNP-6ªvÀø1«¬¿}§¿¯f¦A²{©Ê¦p¦ó?(²z½×¤W¡A¥ÌÅS¾J»P¤T´â½©¿}¦³¨ó¦P®ÄÀ³¡AÀ³¸ÓÀu©ó³æ¥Î¤T´â½©¿}ªº®ÄªG) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 05:40:57²Ä 3848 ½g¦^À³
|
¡§¥Î´¶³q¤ôÁý¾iªº¤p¹«100% ±w¦³1«¬¿}§¿¯f¡A¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºPÈ: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Îp¤WÅãµÛ®t²§) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 05:31:04²Ä 3847 ½g¦^À³
|
1. 2023.3.15-Nature¥D¥Z-¿¯¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²ÓM]¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯ ¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºPÈ: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Îp¤WÅãµÛ®t²§) ¤T´â½©¿}Åã²{§í¨îCD4+ CD8+ T ²ÓM¼W´Þªº¾¯¶q¨Ì¿à©Ê¯à¤O 2.¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²ÓM©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯ www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12 3.2017¦~-T ²ÓM¤¶¾Éªº £] ²ÓM¯}Ãa¡G1 «¬¿}§¿¯fI´º¤Uªº¦ÛÅé§K¬Ì©M¦PºØ§K¬Ì www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2017.00343/full 1«¬¿}§¿¯f¬O§K¬Ì¨t²Î T ²ÓM¯}Ãa¯ØŦ £] ²ÓMªºµ²ªG...º¥ý¡A§ÚÌ´yz¤F¥Ø«e¹ï £] ²ÓM¦ÛÅé§K¬Ì¯}Ãaªº²z¸Ñ¡A¥]¬A CD4 ©M CD8 T ²ÓMªº§@¥Î¥H¤Î§Üì¯S²§©Ê@¨ü»¤¾Éªº´XºØ¥i¯à©Ê¡C £]²ÓM¦A¥Íªº«e´£¬O¡A¦pªG¦ÛÅé¤ÏÀ³©ÊT²ÓM³Q²¾°£©Î§í¨î¡A²{¦³ªº£]²ÓM¥i¥H¼W´Þ... --------------------------------------------------------------------------------------- 1+2+3=¦nÄÀ³s³s!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 01:49:09²Ä 3846 ½g¦^À³
|
2024.1.9--Vertex[²Ä¤@«¬¿}§¿¯f]²ÓMÀøªkÁ{§É¶Ç2¦º¡B¼È°±¸ÕÅç! ....VX-880¬O¤@ºØ[²§Åé·F²ÓM]¨Ó·½¡B§¹¥þ¤À¤Æ¡B²£¥Í¯Ø®q¯Àªº[£] cell]Àøªk.... ------------------------------------------------------------------------------------------ Lantidra¬O±N¨Ó¦Û[¦º¤`®½ÃتÌ] ªº¯Ø®q[£] cell]´£¨ú¥X«á¡Aª`®g¦Ü±wªÌ--->¥h¦~§åã¤W¥«! VX-880[²§Åé·F²ÓM]¾DFDA¼È°±! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 01:36:42²Ä 3845 ½g¦^À³
|
¹ê²{¯u¥¿ªº¿}§¿¯f[ªv¡]¨ú¨M©ó«ì´_¥\¯à©Ê£]²ÓM½è¶q¡A¦A¥Í¤ñ²¾´Ó¨ã¦³Àu¶Õ¡A¦ý¤´Ãø¥H¹ê²{¡C -------------------------------------------------------------------------------------- 1.2024.4.21-§Q¥Î £] ²ÓM¦A¥Í¥Íª«¾ÇªvÀø¿}§¿¯f www.sciencedirect.com/science/article/pii/S1043276024000821 2.2023.6.28-º´Ú²Ä¤@«¬¿}§¿¯f²ÓMÀøªkÀòFDA§åã news.gbimonthly.com/tw/article/show.php?num=60226 Lantidra¬O±N¨Ó¦Û[¦º¤`®½ÃتÌ] ªº¯Ø®q[£] cell]´£¨ú¥X«á¡Aª`®g¦Ü±wªÌ.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/20 ¤W¤È 09:59:24²Ä 3844 ½g¦^À³
|
«ì´_£]²ÓMªº¼Æ¶q©M¥\¯à¥i¯à¬O§ïµ½¬Æ¦Üªv¡¿}§¿¯fªº¦³®Ä¤â¬q!!! ¤@ºØ¦³§l¤Þ¤Oªºµ¦²¤¬Oª½±µ¦b¯ØŦ¤º¦A¥Í £] ²ÓM¡CµM¦Ó¡AÁöµM¹L¥h¤w¸g´£¥X¤F´XºØ£]²ÓM¦A¥Í¤èªk¡A¦ýÁ{§ÉÂà¤Æ³QÃÒ©ú¨ã¦³¬D¾Ô©Ê... 2023.8.1-°fÂà¯ØŦ £] ²ÓM¥h¤À¤ÆªvÀø²Ä 2 «¬¿}§¿¯fwww.nature.com/articles/s12276-023-01043-8 -------------------------------------------------------------------------------------- ¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²ÓM©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯ www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/20 ¤W¤È 09:20:29²Ä 3843 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/30 ¤U¤È 05:53:57²Ä 3431 ½g¦^À³ 1.¸É¤W¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºPÈ: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Îp¤WÅãµÛ®t²§) 2.§ïµ½¯×ªÕ¯Ø¤Þ°_ªº¯Ø¯fÅÜ¡B[¿}§¿¯f] ©Î¨ä¥L¬ÛÃö¯f¯g¤§²Õ¦Xª«¤Î¤èªk±M§Q (SNP-6ÃĪ«) patentimages.storage.googleapis.com/53/7b/9d/922137f38251d0/TW201720461A.pdf --------------------------------------------------------------------------------------------------- ±q±M§Q»PP2¨Ó±ÀÂ_:¦¶¸³9/24¦b²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|¤fÀY³ø§i: ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? [oral insulin]´N¬OSNP-6µL»~!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/19 ¤W¤È 09:13:56²Ä 3842 ½g¦^À³
|
¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³! ¥ÌÅS¾J¬¡¤ÆmKATP³q¹D(²É½uÅéATP¹[³q¹D) ATP¬O²ÓMªº¥Dn¯à¶q¨Ó·½¡A¥²¶·»P[ÁâÂ÷¤l]µ²¦X¤~¯à¨ã¦³¥Íª«¬¡©Ê¡C©Ò¿×ªº ATP ¹ê»Ú¤W³q±`¬O[Mg-ATP]¡C ---------------------------------------------------------------------------------------- 2024¦~Rolf Luft¼ú:Professor Frances Ashcroft Frances Ashcroft (Oxford) 2: ATP-sensitive potassium channels & neonatal diabetes www.youtube.com/watch?v=AVG4V9ur39c MgATP |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤U¤È 11:23:36²Ä 3841 ½g¦^À³
|
www.sinewpharma.com/Upload/202312/news_2023122509345208.pdf Type 2 diabetes or pre-diabetes Present, n=18 Not present, n=17 ------------------------------------------- ¦³ÁôÂꩼƾڦb9/24ªi¤h¹y¤fÀY³ø§i??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤U¤È 11:10:06²Ä 3840 ½g¦^À³
|
¦pªG[oral insulin]=SNP-610¡A¥i¯à·|¦³¡m¬ü¦nªº·N¥~¡n??? Ä´¦p½÷·çÃļtªº¬ã¨s¤Hû¬O·N¥~µo²{«Â¦Ó¿û¯àªv¶§·õ»Ùê¡Aì¥ý»sÃĪº¥Ø¼Ð¬O¥Î¨ÓªvÀø¤ßµ±µh¡C ²É½uÅé¿}§¿¯f¬O¥Ñ©ó[ATP]²£¥Í¨ü¨ì§í»s¦Ó¾ÉP¯Ø®q¯À¤Àªc¥\¯à»Ùê¦Ó¤Þ°_ªº²Ä¤G«¬¿}§¿¯f¡C 2023.8.21--II«¬¿}§¿¯f¤Î¨ä¨Öµo¯gªº [·sªvÀø¤è¦V]¡G²É½uÅé°Ê¤O¾Ç www.ncbi.nlm.nih.gov/pmc/articles/PMC10475949/ (Ãø©Ç2024¦~Rolf Luft¼ú¹{µ¹Professor Frances Ashcroft) -------------------------------------------------------------------------------------------------- ¦¶¸³9/24¦b²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|¤fÀY³ø§i: ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? [oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f??? ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/26 ¤U¤È 07:56:54²Ä 3426 ½g¦^À³ ..²z½×¤W¡ASNP-6ÃĪ«¥iªvÀø[1«¬]¿}§¿¯f»P [2«¬]¿}§¿¯f¡A´N¬Ý¤p¹«¹êÅçµ²ªGÂà¤Æ¦b¤H¨¤W¦³¦h°ª??? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/18 ¤U¤È 03:25:40²Ä 3839 ½g¦^À³
|
r¤j«È®ð¤F ¬Û¸û¨Ó¬Ý¡A¤½¥q¤~¬O¯È¤W½Í§L¡A¦nÅ¥¬O¾Ç³N¬£¡C¤£¦n´N¬O¤£¾ÇµL¼Æ nµ¹¥L³½¦ººô¯}¡AÃC¦â¬Ý¬Ý ============= «¥®a´N·|¯È¤W½Í§L¡A¨º¬O¤Uµ¦¡A¦³ÂI³½¦ººô¯}¤§¨ý~ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤W¤È 11:15:11²Ä 3838 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 04:33:45²Ä 3829 ½g¦^À³ ...¬Ý2024.5.17ªº½u¤WµøÀW(5¦ìªÎD©M¿}§¿¯f¾ÇªÌ) www.youtube.com/watch?v=Fo0pWsnDgwA ......(¥ÌÅS¾J+¤T´â½©¿})¾÷¨î¡ASNP-610¦³À¸¨SÀ¸µ¥Á{§É´¦¾å? ------------------------------------------------------------------------------- ²Ä¤K©¡ªi¤h¹yMASH ÃĪ«¶}µo°ª®p·| September 24-26, 2024 | Boston, MA ......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? [oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤W¤È 11:00:02²Ä 3837 ½g¦^À³
|
9¦~«eªº¹¦w¨Æ¥ó¡A¨ý¥þªº¡u·À³»·¼É¡v³ô¥iÉÃè¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤W¤È 10:53:50²Ä 3836 ½g¦^À³
|
«¥®a´N·|¯È¤W½Í§L¡A¨º¬O¤Uµ¦¡A¦³ÂI³½¦ººô¯}¤§¨ý~ |
|
|
·|û¡GJames10139245 µoªí®É¶¡:2024/6/18 ¤W¤È 10:39:08²Ä 3835 ½g¦^À³
|
R¤jªº¾Þ½L°ª©ú¡AÀ³¸Ó¨Ó¥X¥ôÁ`¸g²z¡C¤½¥qªº©R¯ß¬O·~°È²{ª÷¬y¡A¬ãµo§Þ³N¨ä¦¸ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤W¤È 10:18:04²Ä 3834 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/9 ¤W¤È 09:16:38²Ä 3790 ½g¦^À³ ¤jÃļt¡u¤U¤£¤F¥x¡v§óÁ}Ãø¦a¤@¤Ñ¡AÅý¶D³^«ß®v¾ß¨ìºj¡A¯à´Á«Ý¤£µo¥Í¤j¨Æ??? ¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®a/ªk©x¦b½æ³õ¬[¤W¬Ý¨£SAFETYNADOL(µL¨x¬r)¡A¹j¾ÀªºTylenol(¦³¨x¬r) ------------------------------------------------------------------------------------------- §Ú¾Þ½L«h¥ý±ÂÅv¤@®a23½u¼t¡AɤO¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®aµ¥µ¥ÁÖ½×À£¤O¡AÅý¤jÃļt³QÅF¦¨¸ÁºÛ...... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤W¤È 10:08:54²Ä 3833 ½g¦^À³
|
²Ä¤K©¡ªi¤h¹yMASH ÃĪ«¶}µo°ª®p·| September 24-26, 2024 | Boston, MA 11:30 am Workshop D: Exploring Non-Invasive Tests & Biomarkers for MASH in Action Kai-Min Chu Chief Executive, Sinew Miriam Kidron Chief Scientific Officer, Oramed Synopsis Delving into promising results for SNP-6 Series in treating MASH with multi-functional effects and a POC Quantitative Non-Invasive Test for MASH: Insights from animal and clinical trials. Showing clinically significant improvements in biomarkers of liver injury, inflammation, and fibrosis in a Phase 2 study in patients with MASH. Also exploring a case study of this in a phase 2 oral insulin versus placebo study ------------------------------------------------------------------------------------------------ ©ñ¨ì²Ä¤T©uªi¤h¹y³oÓ¤fÀY³ø§i¡A²´¤U°£¤F±ÂÅv¥~³£¤£°÷«G! Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study? |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/18 ¤W¤È 08:49:19²Ä 3832 ½g¦^À³
|
¹ï¤£°_¦U¦ì(¦ý§Ú·Q¦³²¼ªº¤H¤]«Ü¤Ö¤F)¡A¦aº»Ë¾`°¡A§Æ±æ§âÃa¹B¥Î¥ú ¦A¨£60«O½Ã¾Ô ========================== §¹¤F¡A§Ú¤â½â¨Ó¶R¤F~©ñ¨ì²Ä¤T©u ªGµM¤S±Y¤F |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 05:12:17²Ä 3831 ½g¦^À³
|
¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²ÓM©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯-->§Ö³tÅãµÛ¼W¥[²ÓM¤ºATP¤ô¥ ¥ÌÅS¾J¬¡¤ÆmKATP³q¹D(²É½uÅéATP¹[³q¹D) ¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!ªºÅܤơC «Ü²M·¡Åo! ------------------------------------------------------------------------------------------------- 2024 ¦~ Rolf Luft ¼ú [£]²ÓM] [KATP]³q¹D¡A³z¹L¸²µå¿}¥NÁ¬°[ATP]¨ÓÃö³¬¸Ó³q¹D.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 05:02:07²Ä 3830 ½g¦^À³
|
¥ÌÅS¾J+¤T´â½©¿}ªº¾÷¨î??? 2024 ¦~ Rolf Luft ¼ú ki.se/en/mmk/research/rolf-luft-award/professor-frances-ashcroft-receives-the-rolf-luft-award-2024 Frances Ashcroft µo²{¤F¦b[ £]²ÓM]¤¤ªí¹Fªº[KATP]³q¹D¡A¥¦¬OÅTÀ³¦å¿}¤É°ª¦Ó¨ë¿E¯Ø®q¯À¤Àªcªº«H¸¹³q¸ôªºÃöÁä²Õ¦¨³¡¤À¡C¦oµo²{¡A³z¹L¸²µå¿}¥NÁ¬°[ ATP ]¨ÓÃö³¬¸Ó³q¹D¦b¯Ø®q¯ÀÄÀ©ñ¤¤°_µÛ¦ÜÃö«nªº§@¥Î¡C ------------------------------------------------------------------------------------------------ Rolf Luft ¼ú:¥Ñ·ç¨åµÛ¦WÂå¬ì¤j¾Ç¥dùªL´µ¥d¾Ç°|¹{µo¡A¤]¬O¿Õ¨©º¸¤j·|ªº©Ò¦b¦a¡A¨C¦~³£·|ªí¹ü¥þ²y¤@¦ì¹ï¤º¤Àªc¾Ç©M¿}§¿¯f¬ã¨s°µ¥X³Ç¥X°^Ämªº¬ì¾Ç®a¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 04:33:45²Ä 3829 ½g¦^À³
|
¤£¬Ý60¦~ªºATP¤å¡C ¬Ý2024.5.17ªº½u¤WµøÀW(5¦ìªÎD©M¿}§¿¯f¾ÇªÌ) www.youtube.com/watch?v=Fo0pWsnDgwA £] ²ÓM KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O®Éԫإ߷s¼Ò«¬¤F!!! £] ²ÓM KATP ³q¹Dªº¸²µå¿}½Õ¸`¡G¬O§_»Ýn·s¼Ò«¬??? ------------------------------------------------------------------------- ·s¼ҫ¬¦³ª§Ä³¡A²`¶ø¤£À´¥¿±`¡C ¥u®ø§âµøÀWªºÃöÁä¦r:£]-Cell/KATP /ATP /Caicium...¡A¤Þ¤J§Ú¶K¹Lªº(¥ÌÅS¾J+¤T´â½©¿})¾÷¨î¡ASNP-610¦³À¸¨SÀ¸µ¥Á{§É´¦¾å? ¸É¥R:¥ÌÅS¾J¬¡¤ÆmKATP³q¹D´£¨Ñ¤ßŦ«OÅ@§@¥Î¡Cwww.mdpi.com/1422-0067/22/5/2395 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/16 ¤W¤È 11:48:21²Ä 3828 ½g¦^À³
|
60¦~«eªºNature¥D¥Z¤åÄm¡Aª`®g¤TÁC»Ä¸¢苷(ATP¡^²G¼W¥[¨xŦATP§t¶q¡A¥i¥H¹w¨¾ø¥¾¦Ãþ°Êª«¯×ªÕ¨xªºµo®i¡C ¦¹¥~«D°sºë©Ê¯×ªÕ©Ê¨xª¢±wªÌ¦bµu¼È¯ÓºÉ«á¸É¥R¨xŦ ATP Àx³Æªº¯à¤OÅãµÛ¨ü·l¡C 1964.12.1-¤TÁC»Ä¸¢苷ATP¹w¨¾¯×ªÕ¨x www.nature.com/articles/2041196a0 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤U¤È 08:41:22²Ä 3827 ½g¦^À³
|
¨x²ÓM²£¥Í§¿»Äªº³t²v¬O²ÓM ATP úA¨ü·lªº±Ó·P«ü¼Ð www.journal-of-hepatology.eu/article/S0168-8278(24)00145-4/fulltext ----------------------------------------------------------------------------------------- ¦pªGSNP-810(APAP+¥ÌÅS¾J+¤T´â½©¿})--->¯à¸Ñ¨MAPAPªº¨x¬r©Ê ¨ºSNP-610(¥ÌÅS¾J+¤T´â½©¿})--->¥i¯àªvÀøMASH(NASH)ªº·§²v??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤U¤È 08:33:35²Ä 3826 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 04:05:55²Ä 3793 ½g¦^À³ §A¾á¤ßªº¨Æ90% ¤£·|µo¥Í¡I ¥ÌÅS¾J+¤T´â½©¿}ªºAPAP¥h¬r¨¾¬r¾÷¨î¬O....§Ö³tÅãµÛ¼W¥[²ÓM¤ºATP¤ô¥)->³o¾÷¨î¦bªvÀøMASH(NASH)¤]«Ü«n! ----------------------------------------------------------------------------------------------------- ¨x²ÓM²£¥Íªº[§¿»Ä]¬O [ATP®ø¯Ó]ªº¤@Ó«D±`±Ó·Pªº«ü¼Ð!!! ¤åÄm¸ê®Æ: 1.2016¦~¦å²M§¿»Ä»P¤¤°êªÎD¦¨¤H«D°sºë©Ê¯×ªÕ¨xªº[·ÀI¿W¥ß]¥B[½u©Ê¬ÛÃö] www.nature.com/articles/srep38605 2.2024.3.5-¨à¬ì MASLD(¥NÁÂ¥\¯à»Ùê¬ÛÃöªº¯×ªÕ©Ê¨x¯f) ©w¸q¤¤ªº§¿»Ä¡G¬O®ÉÔ¹ê¬I¶EÂ_¼Ð·Ç¤F¶Ü¡H www.journal-of-hepatology.eu/article/S0168-8278(24)00145-4/fulltext 3.2023.6.20-³z¹L¨ü±±°I´î°Ñ¼ÆÀË´ú¬ü°ê¤H¸s¦å²M§¿»Ä»P¨x¯×ªÕÅܩʪºÃöÁp www.ncbi.nlm.nih.gov/pmc/articles/PMC10280954/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤U¤È 08:06:29²Ä 3825 ½g¦^À³
|
¥h¦~Nature¤l¥Z2023.11.24- «D³W½d BIM ½Õ¸`ªº¯à¶q¥NÁ¨M©wÃĪ«¤Þ°_ªº¨xŦÃa¦º(BIMªº®ø¯Ó¥i¨¾¤îAPAP»¤µoªº¨xÃa¦º) www.nature.com/articles/s41418-023-01245-7 BIM ¯Ê¥F¼W±j¤FÁ` ATP ªº²£¥Í¡A¨Ã±N¥Íª«¯àÃÐÂà¦V¿}¸Ñ¡A±q¦Ó«ù¤[«OÅ@§K¨ü APAP »¤¾Éªº¨x·l¶Ë¡C ä¤`²É½uÅé¥~½¤³z¤Æ·|¾ÉPAPAP»¤¾Éªº²É½uÅ駹¾ã©Ê³à¥¢¡A±q¦Ó¥[¼@ ATP ®ø¯Ó©M ROS §Î¦¨ APAP¤Þ°_ªº¨xÃa¦º¥Dnµo¥Í¦b¨xŦ¤¤¥¡ÀR¯ß©P³ò¡C³o¥i¥H³z¹L§½³¡CYP2E1 °ªªí¹F¡]±NAPAP Âà´«¬°NAPQI¡^¨Ó¸ÑÄÀ ...¤F¸Ñ APAP ¤¤¬r»¤¾Éªº¥Ù¬Þ²ÓM¦º¤`¨Æ¥ó¹ï©ó·sªºªvÀø¤èªk¦ÜÃö«n¡C §Ú̦b³o¸Ì´¦¥Ü¤F¤@Ó¤@¯ë³W«h¡A§Y¨x²ÓMªº¥Íª«¯à¯S¼x¨M©w¤F AILI ªºµ²ªG¡A ¥Dn¨Ì¿à²É½uÅé ATP ¥Í¦¨ªº²ÓM¹ï APAP ¬r©Ê±Ó·P¡C ¥Dn¨Ì¿à²É½uÅé ATP ¥Í¦¨ªº²ÓM¹ï APAP ¬r©Ê±Ó·P¡C ¥Dn¨Ì¿à²É½uÅé ATP ¥Í¦¨ªº²ÓM¹ï APAP ¬r©Ê±Ó·P¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤U¤È 07:34:34²Ä 3824 ½g¦^À³
|
[³æ²ÓMªÅ¶¡Âà¿ý²Õ¤ÀªR]-2020¦~¤J¿ï[Nature]´Á¥Z³Ì¨Î§Þ³N¡A¬Oªñ¤Q¦~¨Ó¥Íª«Âå¾Ç»â°ì³Ì¨üÆf¥Øªº§Þ³N¤§¤@ ¡C 2021.5.12-¨Ï¥Î[³æ²ÓMRNA©w§Ç]¹ï¤AñQ®ò°ò×ô¹L¶q«á¦´Á¨xŦÂà¿ý²Õ´ºÆ[¶i¦æªÅ¶¡««Ø academic.oup.com/toxsci/article/182/2/327/6275242 ...¦¹¦X¦¨ ATP ¯à¤Oªº¼W±j¬O¦³§Qªº¡A¨Ã¥B¥i¯à¬° PP(ªùÀR¯ß©P³ò)²ÓM´£¨ÑÃB¥~ªº«OÅ@¤â¬q¡C¦b³o¤è±¡AAPAP-PC¨x²ÓMªí²{¥X»P¯à¶q²£¥Í¬ÛÃöªº°ò¦]ªº±j¯P»¤¾É¡A¥i¯à¬O¬°¤F¼W¥[ATPªº²£¥Í¡A¥Hº¡¨¬APAP¤ÏÀ³¤Þ°_ªº¼sªx¥NÁ»ݨD¡C»Pµ¥¼¯º¸¾¯¶qªº NAC ¬Û¤ñ¡AAPAP ¼ÉÅS«á¬I¥Î GSH ¥i¥H§ó¤jµ{«×¦a´î¤Ö¨x·l¶Ë¡A³¡¤Àì¦]¬O GSH §ó¦³®Ä¦a¼W¥[¤F§J¹p¥¬´µ´`Àô¤¤ªº¤¤¶¡²£ª«¡A¥i¯à·|¼W¥[ ATP¡C PC(¤¤¥¡©P³ò)¨x²ÓM¼W¥[¯à¶q²£¥Í©M¦X¦¨¥Íª«¯à¬ÛÃö³J¥Õ½èªº ATP ®ø¯Ó©Ò»ÝªºÃB¥~®É¶¡¹ï³o¨Ç²ÓM¦³®`.... ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 04:05:55²Ä 3793 ½g¦^À³ §A¾á¤ßªº¨Æ90% ¤£·|µo¥Í¡I ¥ÌÅS¾J+¤T´â½©¿}ªºAPAP¥h¬r¨¾¬r¾÷¨î¬O?°£¤F§í¨îcyp2e1¥~¡AÃöÁä¥i¯à¦b¥¨¾½²ÓM[¦´Á¥B¥i¯àª½±µ]ªº§ó¦n«OÅ@¾÷¨î:§Ö³t ÅãµÛ¼W¥[²ÓM¤ºATP¤ô¥)->³o¾÷¨î¦bªvÀøMASH(NASH)¤]«Ü«n! 1.2009.12.23--GSH»PNAC«OÅ@¤p¹«§K¨ü¹ï¤AñQ®ò°ò×ô¨x¬r©Êªº·s¾÷¨î ...»P GSH ¬Û¤ñ¡ANAC ³B²z¦b«ì´_ ATP ©M²É½uÅé GSH ¤ô¥¤è±®ÄªG¸û®t.... 2.2013.2.5--¹ï²ÓM[¥~]ATPªº¤ÏÀ³©Ê§ïÅÜ·|¼W±j¹ï¤AñQÓi×ôªº¨x¬r©Ê APAP¤Þ°_ªº¨x·l¶Ë¨Ì¿à²ÓM¥~ATP°T¸¹¶Ç¾É ...·í²ÓM¥~ATP§@¥Î¨ü¨ì§í¨î®É¡AªA¥Î¹L¶q¹ï¤AñQ®ò°ò×ôªº¤p¹«ªº¨x·l¶Ë©úÅã´î¤Ö¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤U¤È 12:25:30²Ä 3823 ½g¦^À³
|
½aÁ|ªk±À½×¤@¤U: Q1: GSK¥i¯à¤£¥i¯à±À¥X(OTC«D³B¤è¤fªA)Advil:¤AñQ®ò°ò×ô¡]1000mg¡^+¥¬¬¥ªâ¡]300mg¡^??? Q2: SNP-810¯àÅýGSK¥Ï¶}Advil Âù®Ä¤ù¾¯ OTC[¥é»sÃÄ]??? ------------------------------------------------------------------------------------------- A1:µS¥¼¥iª¾? A2:SNP-810¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤U¤È 12:08:02²Ä 3822 ½g¦^À³
|
1.2011¦~-¸¯Äõ¯À¥v§J²£¥ÍªºÁ{§É¼Æ¾Ú¤ä«ù 1,000 ²@§J¹ï¤AñQ®ò°ò×ô¤ñ 500 ²@§J©M 650 ²@§J¾¯¶q¨ã¦³§ó¦nªº¤îµh¥\®Ä¡A ´°«PFDA ºû«ù°ª¾¯¶qªº OTC ª¬ºA¡C´°«P FDA ºû«ù°ª¾¯¶qªº OTC ª¬ºA¡C pink.citeline.com/PS104947/Glaxo-Acetaminophen-Efficacy-Studies-Fill-FDAs-1000MG-Dose-Data-Gaps ¥Ø«e¬ü°êOTCªºAPAP¾¯¶q500mg¬°¥D¡A¤Ö¼Æ650mg¡C --------------------------------------------------------------------------------------------------- 2. 2020.3.2-FDA§åãGSK(OTC«D³B¤è¤fªA)Advil:¤AñQ®ò°ò×ô¡]500mg¡^+¥¬¬¥ªâ¡]250mg¡^ ---------------------------------------------------------------------------------------------- 3.2023.10.18- FDA§åã(³B¤èª`®g¾¯)Maxigesic IV¹ï¤AñQ®ò°ò×ô1000mg +¥¬¬¥ªâ300mg¡A¥Î©óªvÀø³N«á¯kµh¡C ----------------------------------------------------------------------------------------------- 4.2023.7.17- ¬ü°ê FDA §å㸯Äõ¯À¥v§J Advil Âù®Ä¤ù¾¯ªºÁû²É[¥é»sÃÄ] www.thehindu.com/business/us-fda-gives-nod-for-granules-copy-of-glaxosmithklines-advil- dual-action-tablets/article67080704.ece --------------------------------------------------------------------------------------------- ½aÁ|ªk±À½×¤@¤U: Q1: GSK¥i¯à¤£¥i¯à±À¥X(OTC«D³B¤è¤fªA)Advil:¤AñQ®ò°ò×ô¡]1000mg¡^+¥¬¬¥ªâ¡]300mg¡^??? Q2: SNP-810¯àÅýGSK¥Ï¶}Advil Âù®Ä¤ù¾¯ OTC[¥é»sÃÄ]??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤W¤È 10:58:11²Ä 3821 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/14 ¤W¤È 05:56:18²Ä 3814 ½g¦^À³ ¥þ²y³ÌüL医药Ë爷现¥@¡A³Q¡§³Î¡¨ªº¥u¦³ùÚ·ç吗¡Hxueqiu.com/5666183627/274295175 ¦n®ø®§¬O¡AAiolos Bio°_码没¦b¥æ©ö¥»¨骗ùÚ·ç¡F§¥®ø®§¬O¡A结ªG¤ñ³Q¥¦骗¤F还难¨ü ------------------------------------------------------------------------------------------------ ²´¥ú¬r»¶ªºË·Ý¬Ýªº¬O:¦P¾÷¨îªºÃĪ«¡A§O¤H1Ó¤ë1°w¡A«í·ç6Ó¤ë1°w¡C SNP-810µL¨x¬r¡AOTC¥«³õ°ª¾¯¶q¦b²Îp¾Ç¤WÀu©ó¸û§C¾¯¶q¡A»ù®æ¨S¦³¸û¶Q¡A¨S¦³Ävª§Àu¶Õ? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤W¤È 10:16:06²Ä 3820 ½g¦^À³
|
2020.10.28-°ê®a¬rª«¤¤¤ß©IÆ~·ç¤h¤j¾¯¶q¹ï¤AñQ®ò°ò×ô¡]¼³¼ö®§µh¡^¤ù¾¯¤W¥««e»P¤W¥««á¹ï¤ñ www.ncbi.nlm.nih.gov/pmc/articles/PMC7593813/ µ²½×©M¬ÛÃö©Ê ³o¶µ¬ã¨sµo²{¡A¦Û2003 ¦~§åã1000 ²@§J¤ù¾¯«á¡A·ç¤hªº¹ï¤AñQ®ò°ò×ô°tÃÄ©M»P¹ï¤AñQ®ò°ò×ô¬ÛÃöªº¤¤¬r¨Æ¥ó[ÅãµÛ¼W¥[]¡C ---------------------------------------------------------------------------------------------------- ªvÀø«æ©Ê»´«×¦Ü¤¤«×¯kµh¡A°ª¾¯¶q(1000mg)¦b²Îp¾Ç¤WÀu©ó¸û§C¾¯¶qªº(500mg)¡C ¦³¨x¬rªºAPAP´N¬O³½»Pºµ´x¤£¥iݱo¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/15 ¤W¤È 10:09:26²Ä 3819 ½g¦^À³
|
OTC«D³B¤èAPAPªº¤îµh®ÄªG¬O§_¦s¦b[¾¯¶q¨Ì¿à©Ê] Âíµh§@¥Î??? 2018.9.28-«D³B¤è¼³¼ö®§µhªº¾¯¶q¦³§U©ó¦³®Ä½w¸Ñ«æ©Ê»´«×¦Ü¤¤«×¯kµh openpainjournal.com/VOLUME/11/PAGE/12/FULLTEXT/ µ²½× ¸û°ª¾¯¶qªº³tÄÀ¹ï¤AñQ®ò°ò×ô¡]1000 ²@§J¡^¡Aµu®É¶¡¡]4-5 ¤Ñ¡^¨Ï¥Î¨Ã¿í´`¼ÐÅÒ¤¤°w¹ï¦MÀI¤H¸sªº«Øij¡A¹ï©ó±w¦³»´«×¦Ü¤¤«×ªº¦¨¤H¨Ó»¡¡A¤ñ§C¾¯¶q´£¨Ñ¦w¥þ¡B§ó¦³®Äªº¤îµh®ÄªG«æ©Ê¯kµh¡C 2006 ¦~µoªíªº¤@¶µ¹ïª½±µ¤ñ¸û¤£¦P¾¯¶qªº¼³¼ö®§µhªvÀø«æ©Ê»´«×¦Ü¤¤«×¯kµhªºÀH¾÷¡BÂùª¼¸ÕÅ窺¤j«¬¨t²Îµû»ùµo²{¡A¸û°ª¾¯¶qªº¼³¼ö®§µh(1000mg) ¦b²Îp¾Ç¤WÀu©ó¸û§C¾¯¶qªº¼³¼ö®§µh(500mg)¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/14 ¤W¤È 10:53:33²Ä 3818 ½g¦^À³
|
§¹¤F¡A§Ú¤â½â¨Ó¶R¤F~©ñ¨ì²Ä¤T©u ªGµM¤S±Y¤F =================================================== ·|û¡G´MÄ_10151381 µoªí®É¶¡:2024/6/13 ¤U¤È 02:17:17²Ä 3806 ½g¦^À³ ªÑ²¼ªº»ù®æ¬OnÅý¥«³õ¦³·Q¹³ªÅ¶¡¡A¤£n»¡ÃĦ³¤°»ò½ÆÂøªº¾÷Âà¡AÃø¹DÄvª§¹ï¤â¨S¦³¡H ªYÄ£¦bªÑªF·|¤W³£¤wÄÀ¥X¦p¦¹ªº¤j§Q¦h¡Aµ²ªG.... ¤§«eªº¥«³õ¥D¤O¨é°Ó¡G´I¨¹-¢æ·R¡A´¿¸g«ù¦³¹O2000±i¥H¤W¡A§¡»ù±µªñ80¤¸¡A¥i±¤©ê¤W¤S©ê¤U¡A ªñ´Á¤w¶}©l¥X²æ¡A¬Ý¨Ó¬O·Ç³Æ±ó¦u¤F¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/14 ¤W¤È 07:15:28²Ä 3817 ½g¦^À³
|
¤£¥i¯à¥i¯à!? ºÖº¸¼¯´µ:¡§±Æ°£¤@¤Á¤£¥i¯àªº¡A³Ñ¤Uªº§Y¨Ï¦A¤£¥i¯à¡A¨º¤]¬O¯u¬Û¡¨--³oºØ[¤£¥i¯àªº¥ô°È]´N¥Ñ´ö©i¡P§J¾|´µ¸Ñ¨M¡C ¤Z¤H¤@Ó¡A§Ú´N·|¼É¤O¯}¸Ñªk(½aÁ|ªk)¡A³v¤@¦C¥X©Ò¦³¥i¯à±¡ªp(¾÷¨î)¡AÂk¯Ç±À²z¥Xµ²½×! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/14 ¤W¤È 06:47:03²Ä 3816 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/11 ¤W¤È 10:53:28²Ä 3801 ½g¦^À³ ¤µ¦~µoªíªº·s¬ã¨sÃÒ¹êSNP-810(¥ÌÅS¾J+¤T´â½©¿})µL¨x¬r£]-arrestin·s¾÷¨î! §Ú̪º¬ã¨s¬O²Ä¤@Ó´¦¥Ü ARRB1 ¹ï APAP »¤¾Éªº¨x¬r©Êªº«OÅ@§@¥Îªº¬ã¨s¡C ARRB1ªº[¹L«×]ªí²{´î»´¤F APAP »¤¾Éªº ER À£¤O©M²ÓMä¤`¡C .§Ú̪º¬ã¨sÃÒ¹ê¤FARRB1´î»´¹ï¤AñQ®ò°ò×ô¤Þ°_ªº¨x¬r©Êªº°²³]... ------------------------------------------------------------------------------------ ¤T´â½©¿}¥i[¼W¥[] £]-arrestin(ARRB1)°T¸¹¶Ç¾É¡A¤£¥i¯à´î»´APAP»¤¾Éªº ER À£¤O©M²ÓMä¤`?¤£¥i¯à¬O«OÅ@§@¥Î·s¾÷¨î? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/14 ¤W¤È 06:37:16²Ä 3815 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 08:44:33²Ä 3808 ½g¦^À³ ¹vÂI¾÷Âà¸Ô²Ó½T¥ßÃö¥G¿ú! Aiolos»Pùڷ祿¬O¦b§÷®Æ§¹¾ã«×ªºã备¤W¡AùÚ·çÉOAiolos¤§间产¥Í¤F®t¶Z¡C(¡§Aiolos¦b这个项¥Ø¤W¡A§ë¤J¦Ü¤Ö¤L¦ÊÉE¬üª÷¡¨¡F¥]¬A寻§ä¹v点...§ä¨ìÚÌ证©Ê数Õu¡B°µ©Ò¦³ªº计¦E¡B«t询µ¥µ¥....) ------------------------------------------------------------------------------------------------ mops.twse.com.tw/nas/STR/663420240606M001.pdf SNP-810¤§§@¥Î¾÷Âà 1. ¥H¥i¨¾¤î㇠ñQÓi×ô¬r©Ê¥NÁª«NAPQI²£¥Í¤§³Ì·s¾÷Âà¡A¯à°÷ÁקK¶Ë¨x 2. ¬O¡u¥h¬r¡B¨¾¬r¡v¦Ó«D¡u¸Ñ¬r¡v °£¤F§í¨îcyp2e1¡A´N¨S¦³¨ä¥L©ú½T¥h¬r¨¾¬r¾÷¨î¶Ü? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/14 ¤W¤È 05:56:18²Ä 3814 ½g¦^À³
|
¥v¸Ö¯Åºë±mªº¡u³Î´µæ¡v¹Lµ{~ ¥þ²y³ÌüL医药Ë爷现¥@¡A³Q¡§³Î¡¨ªº¥u¦³ùÚ·ç吗¡H xueqiu.com/5666183627/274295175 ¦n®ø®§¬O¡AAiolos Bio°_码没¦b¥æ©ö¥»¨骗ùÚ·ç¡F§¥®ø®§¬O¡A结ªG¤ñ³Q¥¦骗¤F还难¨ü |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 09:40:24²Ä 3813 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2023/7/2 ¤U¤È 01:30:38²Ä 3273 ½g¦^À³ [²£¥ÍTNF-£\]¥i¥H¬Ý¦¨¿@«×¼W¥[§a! 2020.1.27(Nature¤l¥Z)TNF-£\ªº¿@«×¨M©w¨ä¹ï¨x·l¶Ëªº«OÅ@©Î¯}Ãa§@¥Î (ªí©úTNF-£\ªº§@¥Î¬O¿@«×¨Ì¿à©Êªº) www.nature.com/articles/s41419-020-2264-z ¦b¥»¬ã¨s¤¤¡A§Ú̪í©ú TNF-£\ ªº¿@«×¹ï©ó²ÓM©R¹Bªº¨M©w¦ÜÃö«n¡C°ª¿@«×ªºTNF-£\·|¤Þµo¨x²ÓM¦º¤`¡A¦ý§C¿@«×ªºTNF-£\¥i¥H«P¶i¨x²ÓM¦s¬¡¡C ------------------------------------------------------------------------------------------------ CYP2E1-LPS-TNF-£\- NF-£eB-->Ãö«Y¨x²ÓMªº¦s¬¡¡A«n¤£? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 09:30:20²Ä 3812 ½g¦^À³
|
113¦~·s¼W³oÓ¾÷Âà: (4) §Ü¸z¤º¬r¯À¯g (ANTI-DYSBIOSIS) SNP-6 ½Õ±±¸z¹D²ÓM«Ì»Ù§¹¾ã©Ê¥H°§C¦å¤¤¯×¦hÁÞ (LPS)§t ¶q¡A¶i ¦Ó ¹w¨¾ »P ªvÀø¯×¦hÁÞ¤Þ°_¨xŦ¤ºµoª¢¤ÏÀ³ www.sinewpharma.com/Upload/202312/news_2023122509345208.pdf (¼Æ¾Ú©úÅã§í¨îLPS¡A°£«D¤½¥q³y°²) ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/8 ¤W¤È 10:20:54²Ä 3376 ½g¦^À³ 将¥ÑHiAlc Kpn¤Þ°_ªº[«D°sºë]©Ê¯×ªÕ¨xNAFLD©R¦W为[内·½©Ê°sºë]©Ê¯×ªÕ¨x--³oÀ³¸Ó¬Oµ¹SNP-6ÃĪ«¥[¤À! 1.¦´Á¨x·l¶ËªºÃöÁä¨BÆJ:ªø´Á±µÄ²°sºë·|·l®`¸zÖß½¤ªº«Ì»Ù¥\¯à¡A±q¦Ó¼W¥[¤HÃþ©M¤p¹«¦å²G¤¤ªº¯×¦hÁÞ¿@«× [LPS]...LPS¿@«×¥i«P¶i TLR4 ªº¿E¬¡¨Ã¼W±j KC ¤¤«Pª¢²ÓM¦]¤lªº²£¥Í¡C [[«ùÄòªº]] LPS ¼ÉÅS·|¾ÉP®w´¶¥±²ÓM¿E ¬¡¡A±q¦Ó²£¥Í TNF-£\ (TNF-£\ªº¿@«×¨M©w¨ä¹ï¨x·l¶Ëªº«OÅ@©Î¯}Ãa§@¥Î¡Aªí©úTNF-£\ªº§@¥Î¬O¿@«×¨Ì¿à©Êªº... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 09:22:22²Ä 3811 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2023/7/2 ¤U¤È 01:24:04²Ä 3272 ½g¦^À³ CYP2E1¹Lªí¹F : ¨ë¿EKupffer cells²£¥ÍTNF-£\¡A¨Ï¨xŦ¹ï TNF-£\ ¬r©Ê±Ó·P¡A±N¨x²ÓMTNF-£\ªº¤ÏÀ³±q [¼W´Þ] ÂàÅܬ° [ä¤`©MÃa¦º] ¡C ...¦ÓCYP2E1 ªº¹L«×ªí¹F±N¨x²ÓM TNF-£\ ¤ÏÀ³±q [¼W´Þ] ÂàÅܬ°²ÓM [ä¤`©MÃa¦º]---·N¨ýµÛ CYP2E1 ¹Lªí¹Fªº¼vÅT [¶W¶V] ¤F NF-£eB ¨Ì¿à©Ê«OÅ@¤ÏÀ³©Î§@¥Î©ó NF-£eB ¨Ì¿à©Ê«OÅ@¤ÏÀ³ªº¤U´å) -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/12 ¤W¤È 10:21:27²Ä 3804 ½g¦^À³ 2023.3.19-Resmetirom ¥H RGS5 ¨Ì¿à©Ê¤è¦¡§í¨î STAT3 ©M NF-£eB °T¸¹¸ô®|¨Ó§ïµ½ NASH ¼Ò«¬¤p¹« ...°ª¿@«×ªº¤T´â½©¿}¥i¯à§í¨î¤F¨x²ÓM¤¤ NF-£eB ©M STAT3 ªº¬¡¤Æ ¥i¯à¦³®ÄªºÃĪ«¾÷¨î¤£¥i¤Ö! ----------------------------------------------------------------------------------------------- ¨x²ÓMTNF-£\ªº¤ÏÀ³±q¼W´Þ [ÂàÅÜ]¬°ä¤`©MÃa¦º--¨DÃÒNF-£eB¹vÂI¾÷Âà½T¥ß!? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 09:12:57²Ä 3810 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/11 ¤W¤È 10:53:28²Ä 3801 ½g¦^À³ ¤µ¦~µoªíªº·s¬ã¨sÃÒ¹êSNP-810(¥ÌÅS¾J+¤T´â½©¿})µL¨x¬r£]-arrestin·s¾÷¨î! 2024.1.22-ARRB1(£]-Arrestin1)³z¹L»Pp-eIF2£\µ²¦X§í¨î ER À£¤O°T¸¹¡A[¤U½Õ]¹ï¤AñQ®ò°ò×ô»¤¾Éªº¨x¬r©Ê link.springer.com/article/10.1007/s10565-024-09842-z §Ú̪º¬ã¨s¬O²Ä¤@Ó´¦¥Ü ARRB1 ¹ï APAP »¤¾Éªº¨x¬r©Êªº«OÅ@§@¥Îªº¬ã¨s¡C ----------------------------------------------------------------------------------------------- §Ú̪º¬ã¨s¬O²Ä¤@Ó´¦¥Ü ARRB1 ¹ï APAP »¤¾Éªº¨x¬r©Êªº«OÅ@§@¥Îªº¬ã¨s¡C §Ú̪º¬ã¨s¬O²Ä¤@Ó´¦¥Ü ARRB1 ¹ï APAP »¤¾Éªº¨x¬r©Êªº«OÅ@§@¥Îªº¬ã¨s¡C §Ú̪º¬ã¨s¬O²Ä¤@Ó´¦¥Ü ARRB1 ¹ï APAP »¤¾Éªº¨x¬r©Êªº«OÅ@§@¥Îªº¬ã¨s¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 09:06:35²Ä 3809 ½g¦^À³
|
112¦~«×-SNP-6 ¨t¦C¨ã¦³·¥¼eªº¦w¥þ¾¯¶q¡A¦w¥þµL¸·¡A¦P®É¦³§¹¾ã ªº ±M§Q «O Å@¡A¨Ã ¾Ö¦³ ·¥ ¨ã¥@ ¬É Ävª§ ©Ê¿W ¯S ªº¤T «§@¥Î¾÷Âà ¦p¤U... 113¦~«×-SNP-6 §@¥Îªº¥|Ãþ¾÷Âà¡A§¡¦³¥R¨¬ªº¤åÄmÃÒ©ú¨ä¾Ç²z¨Ì¾Ú¡G ---------------------------------------------------------------------------------------- ¥Ñ3«¾÷ÂàÅܦ¨4«¾÷Âà! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 08:44:33²Ä 3808 ½g¦^À³
|
¹vÂI¾÷Âà¸Ô²Ó½T¥ßÃö¥G¿ú! ¥HAiolos实际¥X资2400ÉE¬ü¤¸º¥I´Ú¦ôºâ¡A¤@轮¡§Ë¤â¡¨¦^报达¨ìÕa¤Hªº58¿(¤£¨ì5Ó¤ë®É¶¡) Aiolos»Pùڷ祿¬O¦b§÷®Æ§¹¾ã«×ªºã备¤W¡AùÚ·çÉOAiolos¤§间产¥Í¤F®t¶Z¡C(¡§Aiolos¦b这个项¥Ø¤W¡A§ë¤J¦Ü¤Ö¤L¦ÊÉE¬üª÷¡¨¡F¥]¬A寻§ä¹v点...§ä¨ìÚÌ证©Ê数Õu¡B°µ©Ò¦³ªº计¦E¡B«t询µ¥µ¥....) 2024.1.10-¥þ²y³ÌüL医药Ë爷现¥@(Ë爷:¤j³°¦a°ÏºÙ±q¨Æ§ë¾÷¨Æ·~¡A¥H¦¹¦È¨ú¼É§Qªº¤H) ¤Q亿¬ü¤¸学费¡GùÚ·ç争议BDI¦Z finance.sina.cn/2024-01-19/detail-inaczksk0970879.d.html 内¦æ¤Hªº门¹D ¤@条ºÞ线¡AÆÓ论¬O¥æ©ö¡A还¬O¥Ó报临§É©Î¤W¥«¡A³£»Ýn¤j¶q数Õu«H®§¡C¨ä¤¤³Ì«nªº´N¬OÉO尽职调¬d¬Û关ªº§÷®Æ¡A¨ä¤¤¥]¬A°Ó业计¦E书¡B临§É数Õu¡B¥Í产资®Æ¡B专§Q¤À¤lµ¥¡C ¦ÓªL¨}认为¡AÉOMNC°µ¥Í·Nªº关键¡A´N¬O§â这¨Ç§÷®Æ¡§¾ã²z¦¨对¤è³ß欢ªºý©¤l¡¨¡C ¡§MNC³Ì³ß欢ªº¡A´N¬O¦b±µ¤â¤@条ºÞ线¦Z¡A¯àªá³Ì¤Öªº¤OÉa¥h¾ã§ï¡C®³¤F¥H¦Zª½±µ´N¥i¥H¤W¤â¥h°µ¡A这¬O³Ì¦nªº¡C¦]¦¹packageªº§¹¾ã«×«D±`«n¡C¡¨ªL¨}说¡CMNC°µBDªº¤H¡A¥L们ªº«ä维逻辑¬O¡A¥L们¤£会§V¤O¥h«õ±¸n购买ªººÞ线ªºÉ²È¡A¡§³£¬O®³¦º¤u资ªº¡A¤£会¦]为¥D动«õ±¸¤FɲȦӱo¨ìMNCªº¤Ñɲ奖ª÷¡A¥un¥L们觉±o¦Û¤v©Óü®ªº风险¤£¤j¡A¤~º@·N±À进¡C¡¨ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 05:27:50²Ä 3807 ½g¦^À³
|
´M¤j®ðºÆ¤F?(6/21ªÑªF·|) ¦p¦ó°í¦u¤º¤ßªº¡§§ë¸ê¸`«µ¡¨¡H ªÑ»ù¤Wº¦®É¿³¾Ä¡A§Ô¤£¦í·Qn¥[Ü¡F¤U¶^®É¤S¼~¼{¡A§Ô¤£¦í¤S»°ºò³Î¦×¡A¸¨³U爲¦w¡A©ó¬O¤@º¦´N¶R¡A¤@¶^´N½æªº¦æ爲µL´`Àô! ªYÄ£¦^À³11¤j´£°Ý www.genetinfo.com/investment/featured/item/80405.html?start=1 °Ý1±ÂÅv¡A¤jÃļt[n]©Î[¤£n]¡A¥þ¾ÌÓ¤H¦a«H©À¡C |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2024/6/13 ¤U¤È 02:17:17²Ä 3806 ½g¦^À³
|
ªÑ²¼ªº»ù®æ¬OnÅý¥«³õ¦³·Q¹³ªÅ¶¡¡A¤£n»¡ÃĦ³¤°»ò½ÆÂøªº¾÷Âà¡AÃø¹DÄvª§¹ï¤â¨S¦³¡H ªYÄ£¦bªÑªF·|¤W³£¤wÄÀ¥X¦p¦¹ªº¤j§Q¦h¡Aµ²ªG.... ¤§«eªº¥«³õ¥D¤O¨é°Ó¡G´I¨¹-¢æ·R¡A´¿¸g«ù¦³¹O2000±i¥H¤W¡A§¡»ù±µªñ80¤¸¡A¥i±¤©ê¤W¤S©ê¤U¡A ªñ´Á¤w¶}©l¥X²æ¡A¬Ý¨Ó¬O·Ç³Æ±ó¦u¤F¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/12 ¤U¤È 05:09:10²Ä 3805 ½g¦^À³
|
2023.7.27-²ÓM¤º[¶t]°T¸¹¶Ç¾É¡G±`¨£¶ûºÃ¤Hªº·N·Q¤£¨ìªº[·s¨¤¦â]!!! www.ncbi.nlm.nih.gov/pmc/articles/PMC10413985/ ...§ïÅܲÓM¾¹¶¡ Ca 2+³q¶qªº·L§®¥¿Å¥i¯à¾ÉP¦M¤Î¥Í©Rªº¯e¯f¡A¨Ò¦pAD¡BÀù¯g©M·»酶Åé¶J¿n¯g¡A¨Ã¥B¦b¥¼¨Ó¥i¯à·|µo²{§ó¦h¯e¯f... ------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 09:22:24²Ä 3751 ½g¦^À³ ¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!ªºÅܤơC ---------------------------------------------------------------------------------- Nature¥D¥Z(¿¯¹²¢¨ý¾¯¤T´â½©¿}¬O T ²ÓM¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯--(¤T´â½©¿}´î¤Ö¤FT²ÓM¤¤TCR¨Ì¿à©Ê¶t³q¶q¡A¦Ó¤£§ïÅܾãÅé²ÓM¤º¶tÀx¦s) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/12 ¤W¤È 10:21:27²Ä 3804 ½g¦^À³
|
2023.3.19-Resmetirom ¥H RGS5 ¨Ì¿à©Ê¤è¦¡§í¨î STAT3 ©M NF-£eB °T¸¹¸ô®|¨Ó§ïµ½ NASH ¼Ò«¬¤p¹« www.mdpi.com/1422-0067/24/6/5843 ¾Ú§ÚÌ©Òª¾¡A«Ü¤Ö¦³µoªíªº¬ã¨sÃöª`·ç¬üùªvÀø NASH ªº¤À¤l¾÷¨î¡C §Ú̪º¼Æ¾Úªí©ú¡ANF-£eB ©M Jak-STAT3 «H¸¹³q¸ô¦b NAFLD/NASH ²ÓM¼Ò«¬¤¤§¡³Q¿E¬¡¡A¦P®É³Q·ç¬üùªvÀø©Ò§í¨î¡C¦b°Êª«¹êÅ礤¤]Æ[¹î¨ìÃþ¦üªºµ²ªG¡C³o¨Ç¬ã¨sµ²ªGªí©ú¡A·ç¬üù¥i¥H³z¹L¡]¦Ü¤Ö³¡¤À¦a¡^·À¬¡ NF-£eB ©M Jak-STAT3 °T¸¹³q¸ô¨Ó§ïµ½ NASH¡C --------------------------------------------------------------------------------------------- FDA©ó2024.3.14§åãRezdiffra¡]resmetirom¡^ªvÀøMASH(F2~F3). °ª¿@«×ªº¤T´â½©¿}¥i¯à§í¨î¤F¨x²ÓM¤¤ NF-£eB ©M STAT3 ªº¬¡¤Æ ¥i¯à¦³®ÄªºÃĪ«¾÷¨î¤£¥i¤Ö! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/12 ¤W¤È 09:49:41²Ä 3803 ½g¦^À³
|
Naldebain¬O¤£¬O¥Ø«e¬ü¤¤³£¨S¹L? ------------------------------------------------------------ «Ü¤[«eªº¶K¤å¤w°Q½×¹L¡A¤£¦AÂØz¤F¡C Nature¥D¥Z(¿¯¹²¢¨ý¾¯¤T´â½©¿}¬O T ²ÓM¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯_-->°ª¿@«×ªº¤T´â½©¿}¥i¯à¾ÉPPLC-£^1»P(¬¡¤Æªº¡^T²ÓM¨üÅ骺ªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡C(©Ò¥H°ª¿@«×ªº¤T´â½©¿}§í¨î¤F¨x²ÓM¤¤ NF-£eB ©M STAT3 ªº¬¡¤Æ) ----------------------------------------------------------------------------------------- 2022.9.25- PLC£^1ªº¯Ê¥¢³z¹LªýÂ_STAT3¤¶¾ÉªºÀù¯gµo®i¨Ó§í¨î¨x²ÓMÀùµo¥Í www.ncbi.nlm.nih.gov/pmc/articles/PMC9592768/ ...ȱoª`·Nªº¬O¡APLC£^1 ªº®ø°£¤]§í¨î¤F¨x²ÓM¤¤ NF-£eB ©M STAT3 ªº¬¡¤Æ¡C NF-£eB ³z¹L»¤¾É¦UºØ«Pµoª¢°ò¦]ªºªí¹F¡A§@¬°µoª¢¤ÏÀ³ªºÃöÁ䤶½è¡C[ 33 ] STAT3¦b´c©Ê²ÓM¤¤¸g±`³Q¿E¬¡¡A½Õ¸`¸~½F·LÀô¹Ò¤¤¹ïÀù¯gµoª¢«Ü«nªº³\¦h°ò¦]¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/11 ¤W¤È 11:21:11²Ä 3802 ½g¦^À³
|
¦pªGµª®×¬OB´N¦nª±¤F¡A¼Q¨ì¥~¤ÓªÅ?(¦Ü¤Ö²]¶¶ÃÄ) A:¤fªA¦w¼¢¾¯A+ Naldebain (¤fªA) B:¤fªA¦w¼¢¾¯B+ SafeTynadol (¤fªA) C: Naldebain (¤fªA)+ SafeTynadol (¤fªA) ============================== Naldebain¬O¤£¬O¥Ø«e¬ü¤¤³£¨S¹L? ĬÂå¥Í¥H«e´£¨ì===>³o¼Ë»¡§a¡A¨ä¹ê¦b¦³§ó¦nªº³N«á¤îµh³Â¾K¤è¦¡¿ï¾Ü¤§¤U³o¤£·|¬Oº¿ï |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/11 ¤W¤È 10:53:28²Ä 3801 ½g¦^À³
|
¤µ¦~µoªíªº·s¬ã¨sÃÒ¹êSNP-810(¥ÌÅS¾J+¤T´â½©¿})µL¨x¬r£]-arrestin·s¾÷¨î! 2024.1.22-ARRB1(£]-Arrestin1)³z¹L»Pp-eIF2£\µ²¦X§í¨î ER À£¤O°T¸¹¡A[¤U½Õ]¹ï¤AñQ®ò°ò×ô»¤¾Éªº¨x¬r©Ê link.springer.com/article/10.1007/s10565-024-09842-z §Ú̪º¬ã¨s¬O²Ä¤@Ó´¦¥Ü ARRB1 ¹ï APAP »¤¾Éªº¨x¬r©Êªº«OÅ@§@¥Îªº¬ã¨s¡C ARRB1ªº[¹L«×]ªí²{´î»´¤F APAP »¤¾Éªº ER À£¤O©M²ÓMä¤`¡C ¤@¶µ¬ã¨sªí©ú¡A¤º½èºôÀ£¤O§í¨î¾¯¤ûÁDºµ¥h®ñÁx»Ä©M NACÁp¦XÀ³¥Î¹ïAPAP©ÒP¨x·l¶ËªºªvÀø®ÄªG[Àu©ó][Àu©ó][Àu©ó] ±`³WÀøªk¡C³o¨Çµo²{ªí©ú¡A½Õ¸` ER À£¤O°T¸¹¥i¯à¬OªvÀø APAP ¤Þ°_ªº¨x·l¶Ëªº¤@ºØ¤èªk... ARRB1ªº¹L«×ªí¹F·|[§í¨î]¨x¥¨¾½²ÓM¤¤¯×¦hÁÞ¡]LPS¡^»¤¾Éªº¤º½èºô¡]ER¡^À³¿E¡A¦ÓARRB1¯Ê¥F·|¥[¼@¸z¹D·F²ÓM¤¤¿ç®g»¤¾ÉªºERÀ³¿E(SNP-6ªvÀøMASH¦h«¾÷Âध¤@) §Ú̪º¬ã¨sÃÒ¹ê¤FARRB1´î»´¹ï¤AñQ®ò°ò×ô¤Þ°_ªº¨x¬r©Êªº°²³]... ------------------------------------------------------------------------------------ ·|ûROGER588910148151 µoªí®É¶¡:2023/9/29 ¤W¤È 10:06:39²Ä 3460 ½g¦^À³ 2023.8.9-Nature¥D¥Z½×¤å:发现ªý¹K³J¥Õ(§í¨î³J¥Õ)¥þ·s§@¥Î¼Ò¦¡ 将±À动°¾¦V©Ê药ª«¬ã发 www.nature.com/articles/s41586-023-06420-x ------------------------------------------------------------------------------------- ¤T´â½©¿}¥i[¼W¥[] £]-arrestin °T¸¹¶Ç¾É--->£]-arrestin(§í¨î³J¥Õ) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/11 ¤W¤È 08:21:55²Ä 3800 ½g¦^À³
|
2023.2.2-BIO °õ¦æªø¤p²ÕÀ³¹ï¯kµhªvÀø¬D¾Ô plumbpharma.com/new-bio-analysis-reveals-declining-pain-drug-pipeline-and-underinvestment-in-new-addiction-therapies/ ¯kµhªvÀøÃĪ«Àò±o FDA ³Ì²×§å㪺¾÷·|§C©ó¥§¡È¡C¥u¦³ 0.7% ªº·s¤îµhÃıq I ´ÁÁ{§É¸ÕÅç¶i®i¨ì FDA §åã¡A¦Ó©Ò¦³¯e¯f»â°ì·sÃĪº¥§¡¦¨¥\²v¬° 6.5%¡C¾¨ºÞ³Ð·s·sÃĤw³Q§åã¥Î©óªvÀø°¾ÀYµh¡A¦ý¦b¹L¥h¤¦~¤¤©|¥¼§åã¥ô¦ó¨ä¥L·s«¬¼Ð¹v¡B«D¦¨Å}©ÊºC©Ê¯kµhÃĪ«¡C --------------------------------------------------- ¯kµhªvÀøÃĪ«¦¨¥\²v: [0.7%] VS.[6.5%]¡C ¯f¤H¯kµh¯S½è®t²§¤j¡A¯kµh·P¯uªº«Ü¥DÆ[ªº~ Ãö¤½¨í°©Àø¶Ëªº¶Ç©_¬O¯u¬O°²¡H ¬°¤°»ò¯kµhÃø¥H¿Å¶q¡X¡X¤]Ãø¥HªvÀø¡Hwww.bbc.com/ukchina/trad/vert-fut-38827135 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/11 ¤W¤È 07:23:43²Ä 3799 ½g¦^À³
|
classic.clinicaltrials.gov/ct2/show/NCT05842733?term=Sinew+Pharma&draw=2&rank=2 A:¤fªA¦w¼¢¾¯A+ Naldebain (¤fªA) B:¤fªA¦w¼¢¾¯B+ SafeTynadol (¤fªA) C: Naldebain (¤fªA)+ SafeTynadol (¤fªA) ------------------------------------------------------------------------------------------ ¤£t³d¥ô¦aÓ¤HÆ[ÂI:1.C²Õ©úÅãÀu©óA²Õ»PB²Õªº¾÷²v«Ü°ª(¦ýÂùª¼¸ÕÅç³]p¡A¸Ñª¼«e¨S¤H»¡±o·Ç)¡C SafeTynadol¬O¬ü°êOTC³\¥i¾P°â¤îµhÃÄ¡A¯Ç¯k¸Ñ[¤fªA]ªº¤îµh®ÄªG¥i¯à¬OÃöÁä¦]¯À¡C 2.Áö»¡SNP-810¾¯¶q¬O650mg(¶W¹LFDA³B¤èAPAP325mg³W©w)¡A¦ý§Úı±o¸û¤j¨ü¯qªÌ¥i¯à¬O¶¶ÃÄ(°w¾¯§ï ¦¨¤fªA¾¯«¬) 3. SNP-810+¯Ç¯k¸Ñ(¯Ç¯k¸Ñ¬ONalbuphineÃþ¾~¤ù¦¨¤À¤§«eÅXª«)-->SNP-830/SNP- 840(SNP-810+oxycodone©Îdrocodone)¾~¤ùÃþ¦¨¤À½Æ¤è±M§Q³B¤èÃÄ¡C ¯Ç¯k¸Ñ¶Wµªi¾É¤Þª`®g±Ð¾Ç www.youtube.com/watch?v=AarHS0WQuYo&list=PLMXRfeDbuuAbhm2-R3_OKdC5zOw4KfnLj&index=10 |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/10 ¤U¤È 11:41:48²Ä 3798 ½g¦^À³
|
½Ð°ÝR¤j(§Ú·Q¥»ª©¥u³Ñ¤U¤Ö¼Æ¤H¡Anµ¥¨ì¤W¦ÊªÑ»ù¤~·|§l´¸)©Î¦U¦ìª©¤Í¹ï©ó8¤ë¥i¥H§¹¾ã¤½§G¸ÕÅçµ²ªG¦³¨S¦³«H¤ß~~ ÁöµM¹ïªÑ»ù¤£¤@¬O¥¿± ============================================== ¤£¦¨Å}¤î¼@µhÃĥΩó³æ°¼©ÎÂù°¼½¥Ãö¸`¸m´«¯f¤H³N«á¯kµh±±¨îÁ{§É¸ÕÅç |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 09:18:12²Ä 3797 ½g¦^À³
|
2. 2020.3.12- ATP¦X¦¨¼W¥[¥i¯à·|[©è®ø]ªÏºÝªÎ¤j¯gªº¨xŦ¯×½è¿n²Ö www.ncbi.nlm.nih.gov/pmc/articles/PMC7141383/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 09:11:25²Ä 3796 ½g¦^À³
|
1.1999 ¦~ 11 ¤ë 3 ¤é¤HÃþ«D°sºë©Ê¯×ªÕ©Ê¨xª¢¨xŦ ATP úAªº§ïÅÜ jamanetwork.com/journals/jama/fullarticle/192062 µ²½×:³o¨Ç¼Æ¾Úªí©ú¡A°·±d¹ï·ÓªÌ¤¤¡AÀHµÛÅ髪º¼W¥[¡A¨xŦ ATP ¯ÓºÜªº«ì´_®Ä²v³vº¥°§C¡A¦ÓªÎD¬ÛÃö«D°sºë©Ê¯×ªÕ©Ê¨x ª¢±wªÌªº«ì´_®Ä²v«hÄY«¨ü·l¡C 2. 2020.3.12- ATP¦X¦¨¼W¥[¥i¯à·|[©è®ø]ªÏºÝªÎ¤j¯gªº¨xŦ¯×½è¿n²Ö §Ú̳̪ñµo²{¡A¥Íªø¿E¯À¡]GH¡^¹L¶qªÏºÝªÎ¤j¯gªº±wªÌ¾¨ºÞ [¦³©úÅ㪺¯Ø®q¯À§Ü©Ê] ¡A¦ý¨x¤º¯×½è§t¶q«o[¹L§C]¡C »P¨xŦ²É½uÅé¥\¯à¾AÀ³·í«e¯×½èt²üªºÆ[ÂI¤@P¡A»P°t¹ï¹ï·Ó¬Û¤ñ¡A¬¡°Ê©ÊªÏºÝªÎ¤j¯g±wªÌªºATP ¦X¦¨¸û§C¡A¨Ã¥B¦bªÏºÝ ªÎ¤j¯g±wªÌ¤¤Æ[¹î¨ì¨xŦ¯×½è§t¶q¸û§C... --------------------------------------------------------------------------------------------- ¯×ªÕ¨xªº«n¦¨¦]¡G¯Ø®q¯Àªý§Ü->¯×ªÕ¦b¨xŦ[¹L«×]°ï¿n ªÏºÝªÎ¤j¯g±w:¦³©úÅ㪺¯Ø®q¯À§Ü©Ê->¦ý¨x¤º¯×½è§t¶q«o[¹L§C] ²ÓM¤º¥~ATPúA??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 07:55:15²Ä 3795 ½g¦^À³
|
¦bµoª¢©M¸~½F²ÓM¥Íªø¹Lµ{¤¤¡A²ÓMÃa¦º¾ÉP²ÓM [¤º]ATP ÄÀ©ñ¨ì ²ÓM[¥~]ªÅ¶¡¡A¨Ï²ÓM[¥~]ATP ¿@«×±q§C (1-10 nM) ¼W¥[¨ì°ª (5-10 mM)¡C¦]¦¹¡A²ÓM¥~ ATP ¿@«×ªºÅܤƥi¯à·|¬¡¤Æ/§í¨î§K¬Ì¨t²Î¡C ³æ¦ìnM-->mM¬O¼É¼W¦h¤Ö??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 07:42:31²Ä 3794 ½g¦^À³
|
¸É¥R»¡©ú³o¬q(¤T´â½©¿}§Ö³tÅãµÛ¼W¥[²ÓM¤ºATP¤ô¥)->³o¾÷¨î¦bªvÀøMASH(NASH)¤]«Ü«n! ²ÓM[¤º]ATP¥Í²z¿@«×½d³ò2-8 mM ²ÓM[¥~]ATP¥Í²z¿@«×½d³ò1¡V50nM-->¯f²z±ø¥ó¤U¿@«×¼É¼W!(±j¤jªºµoª¢¤¶½è) 2011.11.18-CD4+T²ÓM¥\¯à¨ü²ÓM(¥~)ATP¿@«×½Õ¸` www.sciencedirect.com/science/article/pii/S0006497119601205 §ÚÌÃÒ©ú²ÓM[¥~]ATPªº[¥Í²z¿@«×]§Y1¡V50 nM¤£·|¼vÅT¬¡¤ÆªºCD4 + T ²ÓM©MT reg¡C¬Û¤Ï¡AATPªº [¶W¥Í²z¿@«×] ¹ï¬¡¤Æªº CD4 + T ²ÓMÅã¥Ü¥XÂù®p®ÄÀ³¡C 250 nM ATP ·|¨ë¿E¼W´Þ¡B²ÓM¿E¯ÀÄÀ©ñ¡BÂHªþ¤À¤lªí²{©MÂHªþ¡A¦Ó°ª ATP ¿@«×¡]§Y 1 mM¡^·|»¤¾É²ÓMä¤`¨Ã§í¨î¬¡¤Æªº CD4 + T ²ÓM¥\¯à¡C¬Û¤Ï¡A¦b¬Û¦P°ª¿@«×¤U¡AATP¼W±jT regsªº¼W´Þ¡BÂHªþ¡B¾E²¾©M§K¬Ì§í¨î¯à¤O... (Nature¥D¥Z½×¤å:¼w°ê¬ì¾Ç®a¤]µo²{CXCR6+CD8 T²ÓM¨ü¨ì²ÓM¥~ATPªº¼vÅT) ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/8 ¤U¤È 12:36:40²Ä 3788 ½g¦^À³ ´Á«ÝSNP-610(¥ÌÅS¾J+¤T´â½©¿}+?)¦bMASH(NASH)ªºP2Á{§É! 1½gNature¥D¥Z½×¤å:¼w°ê¬ì¾Ç®aµo²{¡ANASH¨Ï¨xŦ¤º²§±`T²ÓM¼W¦h(¦b©w¦V²M°£´¶³q¤p¹«Å餺ªºCD8+T²ÓM«á¡A§Y¨Ï¦³°ª¯×¶¼¹ªº»¤¾É¡A¨x·l¶Ë©M¨xÀùµo¥Í¤]©úÅã´î¤Ö) 1½gNature¥D¥Z½×¤å:¨Ï¥Î¤T´â½©¿}Åã¥Ü¥X [§í¨î]CD8 +©M CD4 +T²ÓM[¼W´Þ]ªº [¾¯¶q¨Ì¿à©Ê]¯à¤O!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/10 ¤U¤È 04:05:55²Ä 3793 ½g¦^À³
|
§A¾á¤ßªº¨Æ90% ¤£·|µo¥Í¡I ¥ÌÅS¾J+¤T´â½©¿}ªºAPAP¥h¬r¨¾¬r¾÷¨î¬O?°£¤F§í¨îcyp2e1¥~¡AÃöÁä¥i¯à¦b¥¨¾½²ÓM[¦´Á¥B¥i¯àª½±µ]ªº§ó¦n«OÅ@¾÷¨î:§Ö³t ÅãµÛ¼W¥[²ÓM¤ºATP¤ô¥)->³o¾÷¨î¦bªvÀøMASH(NASH)¤]«Ü«n! APAP¤¤¬r«á¾¨¦µ¹¤©NAC³Ì¦³®Ä¡CNACªº¥Dn§@¥Î¾÷¨î¬O«P¶i¨xŦ GSH ¦X¦¨¡A¤ä«ù NAPQI ¸Ñ¬r¨Ã´î¤Ö³J¥Õ½èµ²¦X¡C...³o¨ÇÆ[¹îµ²ªGÅã¥Ü¥i¯à¦s¦b¨ä¥L¥¼ª¾ªº«OÅ@¾÷¨î¡C NAC¥i¥H¦b¨S¦³GSH¯ÓºÉªº¼Ò«¬¤¤´£¨Ñ«OÅ@ªº¨Æ¹ê¤]¤ä«ù¤F³o¤@°²³]¡C 1.2009.12.23--GSH»PNAC«OÅ@¤p¹«§K¨ü¹ï¤AñQ®ò°ò×ô¨x¬r©Êªº·s¾÷¨î aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.23267 ...»P GSH ¬Û¤ñ¡ANAC ³B²z¦b«ì´_ ATP ©M²É½uÅé GSH ¤ô¥¤è±®ÄªG¸û®t.... 2.2013.2.5--¹ï²ÓM[¥~]ATPªº¤ÏÀ³©Ê§ïÅÜ·|¼W±j¹ï¤AñQÓi×ôªº¨x¬r©Ê biosignaling.biomedcentral.com/articles/10.1186/1478-811X-11-10 APAP¤Þ°_ªº¨x·l¶Ë¨Ì¿à²ÓM¥~ATP°T¸¹¶Ç¾É ...·í²ÓM¥~ATP§@¥Î¨ü¨ì§í¨î®É¡AªA¥Î¹L¶q¹ï¤AñQ®ò°ò×ôªº¤p¹«ªº¨x·l¶Ë©úÅã´î¤Ö¡C 3. pubmed.ncbi.nlm.nih.gov/8869293/ §Ú̱o¥Xªºµ²½×¬O¡A[¥¨¾½²ÓM]¦b¤¶¾É¹ï¤AñQ®ò°ò×ô¤Þ°_ªº¨x·l¶Ë¤¤µo´§[¦´Á¥B¥i¯àª½±µ][¦´Á¥B¥i¯àª½±µ]ªº§@¥Î¡C³o »P¥¨¾½²ÓM¦b°sºë¤Þ°_ªº¨x·l¶Ëªºµo¯f¾÷¨î¤¤©Ò§êºtªº¨¤¦â¬O¤@Pªº¡C 4.2021.3.10-ATP¼ÉÅS(²ÓM¥~)¨ë¿E¼ÉÅS·|¤Þ°_¥¨¾½²ÓM¤¤GSH¤ô¥ªº«æ¼@¤U° www.sciencedirect.com/science/article/pii/S2213231721000781#bib25 5. T1R3 ªº¦P«¬¤G»EÅé¥i¥H¥R·í°T¸¹¶Ç¾É¨üÅé¡C³z¹L²K¥[¤H¤u²¢¨ý¾¯¤T´â½©¿}¨Ó¬¡¤Æ¦¹¨üÅé¡A¾ÉP²ÓM¤º([ATP] c )§Ö³t¥B ÅãµÛ¼W¥[¼W¥[¡Cwww.ncbi.nlm.nih.gov/pmc/articles/PMC4420555/ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/9 ¤U¤È 10:21:46²Ä 3792 ½g¦^À³
|
¤µ¤Ñ¨Ó¬Ýr¤jªº¤å³¹³sµo¡A·Pı·sÃÄRD¬Oº©ªøªº¸ô¡A¨«¦b5¦~«e¡C ¦ýªÑ»ù©M¶i«×§¹¥þ¤£¦¨¤ñ¨Ò¡An¬O§ë¸ê¨ä¥¦¦Ü¤Ö¬O¤j¦hÀY¡C ¬Ý¤µ¦~¦³¨S¦³¾÷·|ÁÙ¥¦¤½¹D(¤£n¤]¬O¶BÄF¤½¥q) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/9 ¤W¤È 09:39:26²Ä 3791 ½g¦^À³
|
·sÃĶ}µoªº®Ú¥»:¨ä¥Hªk¥O¨î«×¬°¸g¡B¹êÃÒ¬ì¾Ç(Á{§É¸ÕÅç)¬°½n¡AÁa¾î¥æ´¦¨¬ì§Þ»Pªk«ß¥æ¬yªºÀ³¥Î¬ì¾Ç¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/1 ¤U¤È 01:00:55²Ä 3748 ½g¦^À³ µL¨x¬rSNP-810(12g) VS. ¦³¨x¬rAPAP(4g)ªº[¾î¦V¤ñ¸û]: ... 4.FDA Drug Hepatotoxicity Steering Committee: Hepatocellular DILI(ÃĪ«©Ê¨x·l¶Ë) is characterised by an alanine aminotransferase (ALT) ≥3 times the upper limit of normal (ULN) and ALT/alkaline phosphatase (ALP) ratio ≥5 times ULN; cholestatic DILI by an ALP ≥2 times ULN and ALT/ALP ratio of ≤2 times ULN; and mixed DILI with ALT ≥3 times ULN, ALP ≥2 times ULN and ALT/ALP ratio <5 but >2 times ULN ¨x·l®`¤@¯ë©w¸q«üALT¶W¹L¥¿±`數ȤWªº3¿¥H¤W¡A§Y¶W¹L>3¿³q±`³Q»{¬°¨ã¦³Á{§É·N¸q¡C ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/7/2 ¤U¤È 10:09:38²Ä 2165 ½g¦^À³ ·í³sFDA COVID-19ÃĪ««ü«n(superiority:¥ÎÃIJջP¹ï·Ó²ÕªºÀø®Ä«ü¼Ð¹F¨ì²Îp¾Ç¤WªºÅãµÛ·N¸q)³£¤£¬Û«H¡A¹ç¥i¬Û«H[°ê¹©¦¡]¸Ñª¼¡A¯«¥P¤]Ãø±Ï!!! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2022/3/22 ¤W¤È 09:09:37²Ä 1809 ½g¦^À³ 2020.5.11 FDA COVID-19ÃĪ««ü«n www.fda.gov/media/137926/download ...FDA ¡§±j¯P«Øij¨Ï¥ÎÀu®Ä©Ê³]pªºÀH¾÷¡B¦w¼¢¾¯¹ï·Ó¡BÂùª¼Á{§É¸ÕÅçµû¦ô¥Î©óªvÀø©Î¹w¨¾ COVID-19 ªºÃĪ«¡¨¡A¨ÃÀ³¦b©Ò¦³ªvÀø¤è®×¤¤¨Ï¥Î¼Ð·ÇÅ@²z¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/9 ¤W¤È 09:16:38²Ä 3790 ½g¦^À³
|
¤jÃļt¡u¤U¤£¤F¥x¡v§óÁ}Ãø¦a¤@¤Ñ¡AÅý¶D³^«ß®v¾ß¨ìºj¡A¯à´Á«Ý¤£µo¥Í¤j¨Æ??? ¶D³^«ß®v/®ø¶OªÌ/¾ÇªÌ/µû½×®a/ªk©x¦b½æ³õ¬[¤W¬Ý¨£SAFETYNADOL(SNP-810ì¥Äì¨ýªºAPAP-Hepatotoxicity-free)¡A¹j¾ÀªºTylenol(Hepatotoxicity Overdose may cause liver damage) -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/4 ¤W¤È 04:53:01²Ä 3762 ½g¦^À³ ¤jÃļtÁ}Ãø¤§³B¡Añ±ÂÅvµ¥¦P©ó«Å§i©Ó»{¶D³^«ß®vªº¯Á½ß¥D±i??? (FDA«e¥N²z§½ªø»¡ªº¯U¯¶ªºªvÀø«ü¼Æ) --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/26 ¤U¤È 04:06:47²Ä 1247 ½g¦^À³ ¶D³^«ß®v¹ï±j¥Íªº¯Á½ß¥D±i:Tylenol ªº³]p©M¾P°â¦³¯Ê³´¡A¨Ã¥B³B©ó¡§¦³¯Ê³´¥B¤£¦X²zªº¦MÀIª¬ºA¡¨ [¥i¨Ñ®ø¶OªÌ¨Ï¥Îªº²£«~À³¸Ó¨ã¦³¦X²zªº¦w¥þÃä»Ú]=½¦¨¥Õ¸Ü´N¬O:APAPªºªvÀø¾¯¶q»P¦w¥þ¾¯¶q |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/8 ¤U¤È 01:00:32²Ä 3789 ½g¦^À³
|
¤p¹«§í¨îCD8+©MCD4+ T²ÓMÂà¤Æ¦b¤HÅ馳®Ä¥G? 2024.2¤ë--¬¡¤Æ©ÊCD8+ T细M¦b¤£©úì¦]¤Iµ£ [«æ©Ê¨x°IºÜ]¤¤ªº¬ã¨s进®i ....Patelµ¥报¹D¤F7¨Ò¨xª¢¬Û关©Ê¦A¥Í»Ù碍©Ê贫¦å(aplastic anemia, AA)±w¤I³q过IHC¬V¦â发现CD8+ T为¥Dªº¨x¤púí®û润¡C¨ä¤¤¤T¦W±wªÌ±µ¨ü¤F§K¬Ì§í¨îªv疗¡A经随访¡A¯g状¦³©Ò§ïµ½¡A¨x¬¡检显¥ÜCD8+ T显µÛú£¤Ö ¡C这¨Ç发现¤ä«ùCD8+ T参ÉO¤¶导¨x细M损伤ªº°²设¡A¦}¥B¯e¯fªº«ìÎ`ÉO¨x内CD8+ T数¶qú£¤Ö¦³关¡C¤]¦³¬ã¨s发现¡A³q过¥~©P¦å¬y¦¡细M术检测¥XCD4/CD8È°§C¬OiPALF§K¬Ì¥¢调ªí«¬¥H¤Î¨º¨Ç§ó¥i¯à发®iAAªºiPALF±wªÌªº额¥~¥Íª«标§Óª« -------------------------------------------------------------------------------------------------- µ²ªG¡G ©Ò¦³ 7 ¦W HAA ±wªÌ¦bªì¶E®É§¡¥X²{Âà®ò酶ÅãµÛ¤É°ª©Mµ²¦XÁx¬õ¯À¦å¯g¡C»P¨x¥\¯à«ü¼Ð¤@P¡A²Õ´§ÎºA¾Ç¤W¥i¨£Áx¥Ä²J¿n©Ê¨xª¢¦ñÀH¨xÄuªý¶ë«¬¤º¥Ö·l¶Ë¡C©Ò¦³±wªÌªº¦ÛÅé§K¬Ì©Ê¨xª¢¦å²M¾ÇÀË´ú¡A¦p§Ü F-¦Ù°Ê³J¥Õ¡B§Ü¨x/µÇ·L²ÉÅé©M°ª¤þºØ²y³J¥Õ¦å¯g§¡¬°³±©Ê¡CµM¦Ó¡A7 ¦W±wªÌ¤¤¦³ 5 ¦W (71.4%) ªº§Ü®Ö§ÜÅé¤É°ª¡A¥B¥þ³¡§e²{´³ÂIª¬¡C©Ò¦³±wªÌªº¨xª¢¯f¬r¦å²M¾Ç§¡¬°³±©Ê¡C³z¹L§K¬Ì²Õ´¤Æ¾Ç¬V¦â¡A©Ò¦³ªì©l¼Ë¥»¤¤¤p¸ CD8/CD4 ²O¤Ú²ÓM¤ñ²v§¡ÅãµÛ¤É°ª¡A¦Ó 3 ¦W±wªÌ¦bªvÀø¡]ºµ¤G¾J¡B§Ü¥Í¯À©M/©Î§K¬Ì§í¨îªvÀø¡^«á¸Ó¤ñ²vÅãµÛ°§C ( P = 0.03)¡C ------------------------------------------------------------------------------------------------ 1.µo²{¤ä«ùCD8+ T°Ñ»P¤¶¾É¨x²ÓM·l¶Ëªº°²³]¡A¥B¯e¯fªº«ì´_»P¨x¤ºCD8+ T¼Æ¶q´î¤Ö¦³Ãö¡C 2.4¦WCD8+ T¼Æ¶q¨S´î¤Ö¨S«ì´_ÁÙ¬O?(¨S»¡¥¼ª¾) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/8 ¤U¤È 12:36:40²Ä 3788 ½g¦^À³
|
´Á«ÝSNP-610(¥ÌÅS¾J+¤T´â½©¿}+?)¦bMASH(NASH)ªºP2Á{§É! 1½gNature¥D¥Z½×¤å:¼w°ê¬ì¾Ç®aµo²{¡ANASH¨Ï¨xŦ¤º²§±`T²ÓM¼W¦h(¦b©w¦V²M°£´¶³q¤p¹«Å餺ªºCD8+T²ÓM«á¡A§Y¨Ï¦³°ª¯×¶¼¹ªº»¤¾É¡A¨x·l¶Ë©M¨xÀùµo¥Í¤]©úÅã´î¤Ö) 1½gNature¥D¥Z½×¤å:¨Ï¥Î¤T´â½©¿}Åã¥Ü¥X [§í¨î]CD8 +©M CD4 +T²ÓM[¼W´Þ]ªº [¾¯¶q¨Ì¿à©Ê]¯à¤O!!! ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/12 ¤U¤È 10:03:18²Ä 3396 ½g¦^À³ n¹À¤j´In¹À¤jt!? ¥X¤H·Nªíªº2½gNature½×¤å¡AÃöÁp¦r[T²ÓM]/[¤T´â½©¿}]¡C 1. 2021.3.24 NASH ¨î¤F§K¬ÌÀøªkªvÀøªº HCC ªº§Ü¸~½FºÊ´ú (³Q¤Þ¥Î580¦¸) www.nature.com/articles/s41586-021-03362-0 ..³o¥i¯à¬O¥Ñ©ó NASH ¬ÛÃöªº[²§±`T²ÓM]¿E¬¡¾ÉP²Õ´·l¶Ë¡A±q¦Ó¾ÉP§K¬ÌºÊµø¨ü·l¡C 2.2023.3.15-¿¯¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²ÓM]¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯ www.nature.com/articles/s41586-023-05801-6 ¤T´â½©¿}Åã¥Ü¥X§í¨î CD8 +©M CD4 + T ²ÓM¼W´Þªº¾¯¶q¨Ì¿à©Ê¯à¤O |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/8 ¤W¤È 08:15:30²Ä 3787 ½g¦^À³
|
«Dªø®Ä«¬¤îµhÃħð [³B¤èñ] ¥ÎÃÄ쥻´N¬O¿ù»~ªºµ¦²¤¡AÂå¥Í·|¶}¹L¶qªº¤îµhÃÄÅý¯f±w¨x¤¤¬r¡H --------------------------------------------------------------------------------- ¤½¥qºô¶SNP-830/SNP-840²{ªp:Á{§É«e¬ã¨s¶i¦æ¤¤¡A¹wpSNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æ[Á{§É¸ÕÅç§t¥ÍÅé¬Ûµ¥©Ê¸ÕÅç] ´«¦¨¥Õ¸Ü´N¬O SNP-830/SNP-840¤£¬O¡u·s¦¨¤À¡vªº·sÃÄ¡A [¤£»Ý¸g¹L²Ä¤@¡B¤G¤Î¤T´ÁÁ{§É¸ÕÅç] [¤£»Ý¸g¹L²Ä¤@¡B¤G¤Î¤T´ÁÁ{§É¸ÕÅç][¤£»Ý¸g¹L²Ä¤@¡B¤G¤Î¤T´ÁÁ{§É¸ÕÅç] µ¥¨ì SNP-810 Àò±oÃÄÃÒ«á¡A¥H¡u·sÀø®Ä½Æ¤è¡v¤§·sÃļf¬d³~®|¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç¡A§Y¥iÀò±oÃÄÃÒ¡A¥i¥H·¥§Cªº¦¨¥»¡AÀò¨ú³Ì¤jªº¦¨®Ä¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 11:38:27²Ä 3786 ½g¦^À³
|
¡uµ´¹ïÄvª§Àu¶Õ¡v---#¤£¥i¯à#µ´¹ï¤£¥i¯à# SNP-810¤£³æ¸Ñ¨M¤F¨x¬r©Ê¡A»ù®æ¤]¨S¦³¤ñpanadol»PTylenol¶Q¡C ------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/2/2 ¤U¤È 04:03:09²Ä 2825 ½g¦^À³ www.facebook.com/linkingpros/videos/3194947797458964/ ¼v¤ù8¤À~ JP:....§Úªº»ù¿ú¨S¦³¤ñpanadol¶Q³á...¤]¨S¦³¤ñTylenol¶Q³á..... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 10:51:10²Ä 3785 ½g¦^À³
|
2024.6.6-ªYÄ£¹Î¶¤±N¥Ó½Ð¦w¥þ·sÃij\¥iÃÒNDA(¥i¯à¾Ö¦³¥«³õ¿W¥eÅv)¨Ã´£¨Ñµ¹°ê»Ú¤jÃļt¡A§@¬°±ÂÅv¨Ì¾Ú¡C ---------------------------------------------------------------------------------------------- www.taiwan-pharma.org.tw/magazine/97/018-023.pdf ¬ü°êªº«D³B¤èÃijqºÙ¬°OTCdrugs¡A¤À¬°¨â¤j¨t²ÎºÞ²z¡G»Ý¥Ó½Ð·sÃĬdÅçµn°O(NDA)ªºOTCÃÄ«~»P¦C¤JOTC monographªºOTCÃÄ«~¡C ¤@¡B»Ý¥Ó½Ð·sÃĬdÅçµn°O(NDA)ªºOTCÃÄ«~-[¥Ó½ÐªÌ¾Ö¦³ÃÄ«~³\¥iÃÒ¡A¤W¥««á¿W¥eÃÄ«~¥«³õ] ±ý¦b¬ü°ê¤W¥«¤§OTCÃÄ«~¡AY»P¬ü°ê¤w®Ö㤧OTCÃÄ«~¦¨¤À¡B¾¯«¬¡B¾¯¶q©Î¨Ï¥Î³~®|¤£¦P¡A¥²¶·¦V¬ü°ê¹«~»PÃĪ«ºÞ ¨î§½FDA¥Ó½ÐNDA¤~¯à¤W¥«¡F¥ÑÃļt´£¨Ñ¸ê®Æ¡AÃÒ©ú¥Á²³¦Û¦æ¨Ï¥ÎÃÄ«~¤§¦w¥þ©Ê»P¦³®Ä©Ê... ¥Ó½Ð¬dÅçµn°OªºOTCÃÄ«~¥i¯à»Ýn´£¨ÑÁ{§É¸ÕÅç¸ê®Æ°e¼f¨Ãú¥æ¼f¬d¶O¥Î¡A¥B»Ý¨ú±oFDAªº®Öã¤~¯à¤W¥«¡F¬Û¹ïªº¡A¤@¥¹ÃÄ «~®Öã¤W¥««á¡A¥Ó½ÐªÌ¥i¾Ö¦³OTCÃÄ«~Ó§Oªº³\¥iÃÒ»P¥é³æ¡A¨Ã¥i¯à¾Ö¦³¥«³õ¿W¥eÅv ¤G¡B¦C¤JOTC monographªºÃÄ«~-[¥Ó½ÐªÌ¤£¾Ö¦³ÃÄ«~³\¥iÃÒ¡A¤W¥««á¤]µLªk§Q¥Î¸ê®Æ±MÄÝÅv¿W¥eÃÄ«~¥«³õ] |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 09:00:48²Ä 3784 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/5 ¤W¤È 06:11:44²Ä 462 ½g¦^À³ SNP-810ªº¯S©w¡u¤½»{¦w¥þ¡v¤§¦¨¤À:¥ÌÅS¾J+¤T´â½©¿} ...¦Û¼Æ¦ÊºØ [¬ü°êFDA®Öã]¡B[±`¥Î¥B¦w¥þ]¡B[«K©yt¾á±o°_]¡B[¤HÅé¥i¹¥Î¦w¥þ¤Æ¦Xª«] ------------------------------------------------------------------------------------------- ¥ÌÅS¾J+¤T´â½©¿}-FDA(GRAS¤½»{¦w¥þ)! («K©yt¾á±o°_ªº»ù®æ)¤~µ¹SNP-810¦³¡u¨ú¥N¡v²{¦³¤AñQÓi×ô¥«³õªº¼ç¤O! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 08:49:27²Ä 3783 ½g¦^À³
|
Even if the TFM gave some implicit approval of acetaminophen as GRASE, Extra Strength Tylenol could not be considered GRASE because the ... ------------------------------------------------------------------------------------------ §Y¨ÏTFM(¼È©w³Ì²×±MµÛ)Áô§t§åã¹ï¤AñQ®ò°ò×ô¬°GRASE(Generally recognized as safe¤½»{¦w¥þ)¡A¯S±j®õ¿Õ¤]¤£¯à³Qµø¬°GRASE(¤½»{¦w¥þ)¡A¦]¬°... ¦³ÃöExtra Strength Tylenol¤£¯à³Qµø¬°¤½»{¦w¥þ??? ¥i±¤¬Ý¤£¨ì¥þ¤å±Ôz! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 08:31:15²Ä 3782 ½g¦^À³
|
ªYÄ£±N¥Ó½Ð¦w¥þ·sÃij\¥iÃÒ(¥«³õ±MÀçÅv?)¨Ã´£¨Ñµ¹°ê»Ú¤jÃļt(°ê»Ú¤jÃļt¤£¥Î«·s°µÁ{§É¥Ó½ÐÃÄÃÒ) ¥Ó½Ð¦w¥þ·sÃij\¥iÃұĥΩ³¤Uªº³W«h???(¸Û¤ßÅwªï±E±xªÌ¸É¥R«ü¾É) 3.[FDA...¦æ¬F©R¥O±Â¤©[¥«³õ±MÀçÅv][¥«³õ±MÀçÅv][¥«³õ±MÀçÅv] ----------------------------------------------------------------------------------------- OTCÃÄ«~§ï² (SNP-810¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥iקï©Î§R°£FDA¨x¬rĵ»y¡C¥iקï©Î§R°£FDA¨x¬rĵ»y) www.agg.com/news-insights/publications/qa-the-cares-act-and-otc-drug-reform-in-2020/ 1.³Ì²×¦æ¬F©R¥Oµo¥¬«á¡AFDA ¥i¥H§ó§ï¶Ü¡H ¦³¤@¶µ±ø´Ú¤¹³\ FDA ¦b¦³·sÃÒ¾Úªí©ú¯S©wÃĪ«©Î¬YÃþÃĪ«ºc¦¨[¤£¨}¨Æ¥ó]ªº[¤£¦X²z·]ÀI¨Ã»Ýn¼ÐÅҩΨä¥LÃþ«¬ªº§ó§ï ®É¡A¤¹³\FDA ¹ï¥ô¦ó³Ì²×¦æ¬F©R¥O¶i¦æ§ó§ï¡C 2.»s³y°Ó¦p¦ó½Ð¨D§ó§ï±M½×¡H »s³y°Ó¥i¥Hn¨D§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À¡A¨Ò¦p³z¹L´£¥æ OTC ±M½×q³æ½Ð¨D¡]¡uOMOR¡v¡^¡C 3.¦b·sªº«D³B¤èÃĺʺޮج[¤U¡A§Úªº«D³B¤èÃĦ³¸ê®æÀò±o¯S³\¸gÀçÅv¶Ü¡H ¦pªG·sªº¤HÅé¬ã¨s¹ïµo¥¬³Ì²×¦æ¬F©R¥O¦ÜÃö«n¡A¨º»òFDA ¥i¥H¦bµo¥¬¥Ñ¥Ó¿ìªÌµo°_ªº°w¹ï·s«D³B¤èÃĬ¡©Ê¦¨¤À¡]¤§«e¥¼ ¦C¤J¦U½×©Î©R¥O¡^ªº³Ì²×¦æ¬F©R¥O©Î°w¹ï¤£¦P¨Ï¥Î±ø¥óªº¦æ¬F©R¥O«á±Â¤©¥«³õ±MÀçÅv¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 07:05:38²Ä 3781 ½g¦^À³
|
«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n½á¤©FDAªºÅv¤O»P«Â¤O! §ï²ªk®×¤º¤å¦³¹ªÀy«D³B¤èÃÄ[¦w¥þ³Ð·s]! ªYÄ£SNP-810¬O³Ð·s¤S¦w¥þµL¨x¬rAPAP¡A±µ¤U¨ÓºÝ¬ÝFDA«ç»ò§ï²¦³¨x¬rAPAP? --------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 05:55:52²Ä 3776 ½g¦^À³ FDA¶}îÔ¤F! ±µ¤U¨Óªº¤T¦~¤º¸Ñ¨Mªºp¹º±MµÛ¬¡°Ê(2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 06:52:43²Ä 3780 ½g¦^À³
|
FDA¤w¥´³q¥ô·þ¤G¯ßÅv¤O¸õ¼W¡A¡u¥h®ñµÇ¤W¸¢¯À¡v¦]¬°¨S¦³[¦³®Ä©Ê]¤U¬[¡A¤Ïˤ£¸Ñ¨MAPAP¨x°IºÜ(¦w¥þ©Ê)ªº²Ä1¤jì¦]??? «eFDA¥N²z§½ªø:¹ï¤AñQ®ò°ò×ô¬O¬ü°êÃĪ«©Ê¨x°IºÜªº²Ä1¤jì¦]¡C Dr. Woodcock:....acetaminophen. Acetaminophen is the number one cause of drug-induced liver failure in the United States. --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤W¤È 09:39:52²Ä 646 ½g¦^À³ Ãļt¸òFDA [¥P©é¥P]À¸½Xµ²§ô!±µ¤U¨ÓJ&J(GSK)¯à¦A©¯¹B°{¹L¤@¦^? -------------------------------------------------------------------------------------------- 2017.09.13 ²{¥N¤ÆFDAªk³W«D³B¤èÃĪ« FDAÃĪ«µû¦ô»P¬ã¨s¤¤¤ß¡]CDER ¡^¥D¥ôJanet Woodcock¦b²³Ä³°|³Æ¸ß¸ê®Æ www.govinfo.gov/content/pkg/CHRG-115hhrg27228/html/CHRG-115hhrg27228.htm ¤º®e°Ç°Çªø...¦Û¤v¬Ý.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 06:34:41²Ä 3779 ½g¦^À³
|
FDA¥´³q¥ô·þ¤G¯ßÅv¤O¸õ¼W!!! «D³B¤èÃıMµÛ¨î«×ªºþ¨Ç³¡¤À·|§ïÅÜ¡H TFM:¤AñQÓi×ô(acetaminophen) OTC ÃÄ«~?? --------------------------------------------------------------------------------------- ¤F¸Ñ«D³B¤è (OTC) ÃĪ«±M½×¨t²Î cptclabs.com/understanding-the-over-the-counter-otc-drug-monograph-system/ «D³B¤èÃıMµÛ¨î«×ªºþ¨Ç³¡¤À·|§ïÅÜ¡H ¤T¶¥¬q³W«h¨î©w¬yµ{¡]ANPR¡BTFM ©M FM¡^±N³Q¦æ¬F©R¥O¬yµ{¨ú¥N¡C ¼á²M²{¦³ OTC ±MµÛÃĪ«ªºª¬ºA¡A¥]¬A¥ý«e¨ü TFM ©M ANPR ¬ù§ôªºÃĪ«¡C ¾¯«¬·L¤pÅܤƪº¹Lµ{¡C ¬Y¨Ç«D³B¤èÃıMµÛÃĪ«ªº¿W¦û´Á¡C ¹ê¬I³õ¥~¥æ©ö±MµÛ¨Ï¥Î¶O¡C FDA ©M¥Ó¿ìªÌ¤§¶¡ªº¥¿¦¡·|ij¡C FDA ±N¹ï¥Ó¿ìªÌ´£¥æªº¸ê°T«O±K¡C ---------------------------------------------------------------------------------------------- www.cde.org.tw/Content/Files/Knowledge/9646e551-44e8-47c2-a53c-0d6fbb458995.pdf ¬ü°êFDA «Øij¼t°Ó¡A¤Z¬O¨Ì¾ÚTentative Final Monograph (TFM)¤§§t¤AñQÓi×ô(acetaminophen) OTC ÃÄ«~¡A¨ä¥é³æÀ³¥[µù¦³Ãö¤Þ°_ÄY«¥Ö½§¤Ï. ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/8 ¤U¤È 01:21:40²Ä 1193 ½g¦^À³ 2020¦~3¤ë27¤é¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n¥´³qFDA¥ô·þ¤G¯ß? ...¤º®e°Ç°Çªø...¦Û¤v¬Ý¡A¦b3¦~«áªº2020¦~3¤ë27¤é¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n¥´³qFDA¥ô·þ¤G¯ß«á¡AFDA½T«OOTCÃÄ«~ªº[¦w¥þ©Ê]»P[¦³®Ä©Ê]¡A¥u»Ý¤@¯È¦æ¬F©R¥O¡A¤£¥Î¦A¨«¦Ñ®Mªº¤¾ªøªk³Wµ{§Ç¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 06:10:56²Ä 3778 ½g¦^À³
|
2022.10.30-...¦¶³Í¥Á»¡¡A¥@¬É¯Å¤jÃļt³£¬O¥H¡u¤½¦@½Ã¥Íªº»ùÈ¡v¬°³Ì¤j©v¦®¡A¦]¦¹¥¼¨Ó±N±Ä«D±MÄÝ¡B¤À°Ï±ÂÅvµ¦²¤¡A²{¶¥¬q±ÂÅvºN¦¡¤£³]±Ä¨ú¶}©ñºA«×¡ASNP-810¤]¤w¨ú±o¬ü°êOTC¡]«D³B¤èÃÄ¡^¥«³õ¾P°âÅv¡C ¤W±ªº¡u¤½¦@½Ã¥Íªº»ùÈ¡v»P¤U±ªº[¤½¦@½Ã¥Í]Àu¥ý¨Æ¶µ¬O¦P¥ó¨Æ??? ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 05:55:52²Ä 3776 ½g¦^À³ FDA¶}îÔ¤F! ±µ¤U¨Óªº¤T¦~¤º¸Ñ¨Mªºp¹º±MµÛ¬¡°Ê(2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n ...FDA±N¥LÌÃö©ó±Nþ¨Ç¬¡°Ê¦C¤J¹w´úªº¨Mµ¦´yz¬°³q±`¥H [¤½¦@½Ã¥Í] Àu¥ý¨Æ¶µ¬°«ü¾É¡v.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 06:05:41²Ä 3777 ½g¦^À³
|
¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n½á¤©FDAªºÅv¤O»P«Â¤O!!!¡u¥h®ñµÇ¤W¸¢¯À¡v¦]¬°¨S¦³[¦³®Ä©Ê].... ¦³¨x¬rAPAP¬O¦w¥þ¦³®Äªº¦¨¤À???? ------------------------------------------------------------------------------- FDA clarifies results of recent advisory committee meeting on oral phenylephrine www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-results-recent-advisory-committee-meeting-oral-phenylephrine ...³\¦h«D³B¤èÃÄ¡]¥]¬A¥h®ñµÇ¤W¸¢¯À¡^¤§©Ò¥H³Q¥X°â¡A¬O¦]¬°¥¦Ì§t¦³ FDA ³q±`»{¬°¦w¥þ¦³®Äªº¦¨¤À (GRASE)¡A¦pªG«ö·Ó²£«~¼ÐÅÒ¤Wªº«Øij¨Ï¥Î¡A¸Ó¦¨¤À°O¿ý¦b¡§«D³B¤èÃıM½×¡¨¤¤¡C¦pªG FDA ½T©w¤fªA¥h®ñµÇ¤W¸¢¯ÀµL®Ä¡A¸Ó¾÷ºc±Nº¥ýµo¥¬¤@¶µÀÀij©R¥O¡A±q¥»±MµÛ¤¤§R°£¥h®ñµÇ¤W¸¢¯À¡CµM«á¤½²³±N¦³¾÷·|¹ïÀÀijªº©R¥Oµoªíµû½×¡C¦pªG¦b¦Ò¼{³o¨Ç·N¨£«á¡AFDA Ä~Äò¥X¥h®ñµÇ¤W¸¢¯ÀµL®Äªºµ²½×¡A¸Ó¾÷ºc±Nµo¥¬³Ì²×©R¥O¡A±q±MÃD¤¤§R°£¸Ó¦¨¤À¡A¨Ã¥B¥h®ñµÇ¤W¸¢¯À±N¤£¦A³Qµø¬° GRASE¡C .... ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/19 ¤W¤È 11:33:08²Ä 3699 ½g¦^À³ ¥Î¤F´X¤Q¦~ªºOTCÃĪ«¡A¦]¬°¨S¦³[¦³®Ä©Ê]¡AFDA¨M©w§¹¥þ¸T¤î¸Ó¦¨¤À! 2023.9.14-½w¸Ñ»ó¶ë¦¨¤À¡u¥h®ñµÇ¤W¸¢¯À¡v ¬üFDAÅU°Ý»{µL®Ä¡I250´Ú·P«_ÃÄ®£¤U¬[ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 05:55:52²Ä 3776 ½g¦^À³
|
FDA¶}îÔ¤F! ±µ¤U¨Óªº¤T¦~¤º¸Ñ¨Mªºp¹º±MµÛ¬¡°Ê(2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n www.chpa.org/public-policy-regulatory/regulation/fda-annual-forecast 2023 ¦~ 9 ¤ë 19 ¤é¡AFDA µo¥¬¤F¡§p¹º±MµÛ¬¡°Êªº¦~«×¹w´ú¡¨¡A³o¬O¤@¥÷¨C¦~µo¥¬ªº«D¬ù§ô©Ê¦Cªí¡A´yz¤F FDA ¥´ºâ¦b±µ¤U¨Óªº¤T¦~¤º¸Ñ¨Mªºp¹º±MµÛ¬¡°Ê¡C FDA ±N¥LÌÃö©ó±Nþ¨Ç¬¡°Ê¦C¤J¹w´úªº¨Mµ¦´yz¬°¡u³q±`¥H¤½¦@½Ã¥ÍÀu¥ý¨Æ¶µ¬°«ü¾É¡v¡C¹w´ú¤¤ªº¥DÃD¶¶§Ç¨Ã¤£¤Ï¬M FDA ¦æ°Êªºpµe®É¶¡¶¶§Ç©Î¤½¦@½Ã¥Í«n©Êªº¶¶§Ç¡C ¤U±Â²n¦C¥X¤F¥DÃD©MÀÀij¬¡°Ê¡C ¹ï©ó¬Y¨ÇÃþ«¬ªºp¹º¦æ°Ê¡]¨Ò¦p FDA µo°_ªº¦w¥þ©Ê©M¦³®Ä©Ê´¶¹M»{¥iªº³Ì²×½T©w¡]GRASE ³Ì²×½T©w¡^¡AFDA ¥i¯à·|¦b´£Ä³ªº©R¥O¤§«en¨D´£¨Ñ¼Æ¾Ú¡C ³z¹L¿ï¾Ü³æ¿Wªº³sµ²¥i¥H§ä¨ì¤CÓ¥DÃD©M«Øij¬¡°Ê¤¤¨CÓ¥DÃDªº§ó¸Ô²ÓºKn¡C p¹º´£Ä³ªº¦w¥þ©R¥O 1.»P§t¥i«Ý¦]¤î«yÃĪ«¬ÛÃöªº·ÀI¡G±N¥i¸Ñ¨M¥i«Ý¦]¡BÁC»Ä¥i«Ý¦]©M²¸»Ä¥i«Ý¦]§@¬°Âí«y¬¡©Ê¦¨¤Àªº GRASE ª¬ºA¡C 2.¨à¬ì¹ï[¤AñQ®ò°ò×ô]¾¯¶q¡G±N¸Ñ¨M¤fªA³æ¤@¦¨¤À¨à¬ì¹ï¤AñQ®ò°ò×ô²£«~ªº¾¯¶q±j«×¡A¨Ã«Øij°w¹ï 12 ·³¥H¤U¨àµ£¼W¥[°ò©ó Åé«©M¦~ÄÖªº¾¯¶q¡C 3...... ----------------------------------------------------------------------------------------------- ¨º»òOTCÃÄ«~±MµÛ§ï²³Ì²×·|²£¥Í¤°»ò¼vÅT©O¡H ¼á²M²{¦³«D³B¤èÃıMµÛªºª¬ªp¡C ¥Ø«e³Q½T©w¬° I Ãþ (GRASE) ªº¬¡©Ê¦¨¤À¥i¯à¤´·|¯d¦b¥«³õ¤W¡C ¥Ø«e³Q½T©w¬° III Ãþªº¬¡©Ê¦¨¤À¡]GREASE ©|¥¼½T©w¡^¥i¯à·|Ä~Äò¯d¦b¥«³õ¤W¡Aª½¨ì FDA µo¥¬¡u³Ì²×©R¥O¡v¡C ¥Ø«e³Q½T©w¬° II Ãþ¡]«D GRASE¡^ªº¬¡©Ê¦¨¤À±N±q¥«³õ¤W²¾°£ ¦pªG²{¦³±MµÛ¡]ªvÀøÃþ§O¡^¤¤¨S¦³¬¡©Ê¦¨¤À¬O GRASE¡A«h¸Ó±MµÛ¥»¨¥i¯à·|³Q²^¨O¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤W¤È 11:57:42²Ä 3775 ½g¦^À³
|
SNP-810¦X¨Ö«e¤wµo©ú¤W¥«¤§¤£¦¨Å}¤î¼@µhÃĥΩó³æ°¼©ÎÂù°¼½¥Ãö¸`¸m´«¯f¤H³N«á¯kµh±±¨îÁ{§É¸ÕÅç¡A¤w©ó¥h¦~11¤ë¦¬®×§¹¦¨¡A¦@¯Ç¤J36¦ì¨ü¸ÕªÌ¡A¸ÕÅç¹Lµ{¤¤¥¼µo¥Í¥ô¦ó¨x¬r©Ê©Î»P¸ÕÅçÃĪ«¬ÛÃö¤§ÄY«¤£¨}¤ÏÀ³¡C ¦¶³Í¥Áªí¥Ü¡A¹wp¤µ¦~8¤ë¥i¥H§¹¾ã¤½§G¸ÕÅçµ²ªG.... -------------------------------------------------------------------------------- 8¤ëSNP-810³B¤èÃÄ(½Æ¤è)§¹¾ã¤½§G¸ÕÅçµ²ªG! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤W¤È 11:50:02²Ä 3774 ½g¦^À³
|
SNP-810¦bOTCªºµL¨x¬rÃIJz¾÷¨îÁ{§É¹êÃÒ«Ü«n¡A¦]¬°SNP-610ªº¦¨¤À´N¬O¥ÌÅS¾J+¤T´â½©¿}. SNP-610¦¨¤À:www.sinewpharma.com/Upload/202312/news_2023122509330608.pdf --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/4 ¤W¤È 08:13:41²Ä 3764 ½g¦^À³ ¥ÌÅS¾J+¤T´â½©¿}ªº¥[¼®ÄÀ³¤£¬O¥u¦³Åã²{¦bAPAP¡ANASH(MASH)¦P¼Ë¬Ý¨ìªì¨BÃÒ¾Ú: ªvÀø12¶gALT°§Cªº®ÄªG¬°SNP-610°§C29.5 U/L¡AMGL-3196°§C8.6 U/L¡AÅã¥ÜSNP-610 ®ÄªGÀu©ó°ê»Ú¤W³Ì·sµo®i¤§¥NÁÂ¥\¯à»Ùê¬ÛÃö¯×ªÕ©Ê¨xª¢ÃĪ«¡C |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2024/6/7 ¤W¤È 10:44:02²Ä 3773 ½g¦^À³
|
¤S¦^¨ì¢Ý¢â¢Ñ¡H «Dªø®Ä«¬¤îµhÃħð³B¤èñ¥ÎÃÄ쥻´N¬O¿ù»~ªºµ¦²¤¡AÂå¥Í·|¶}¹L¶qªº¤îµhÃÄÅý¯f±w¨x¤¤¬r¡H ¤ÏÆ[ªø®Ä«¬¤îµhÃÄ¢µ¢´¢²¢´ªº¶¶ÃĪѻù¤§«e¤w½Ä¯}¢±¢¯¢¯¤¸¡C ©Ò¥HªYÄ£n¨ú¥N¤AñQÓi×ôªº©w¦ì쥻´NÀ³¸Ó©ñ¦b¢Ý¢â¢Ñ¡A¦]¬°¯f±w¥i¯à¦Û¦æ¶R¤îµhÃĦY¹L¶q¦Ó³y¦¨¨x¤¤¬r¡C ©Ò¥H¤£n¦A®ö¶O®É¶¡¦A¥h¨ú¢Ô¢Ò¢ÏÃÄÃÒ¡A§â¤ß¤O©ñ¦b¢Ý¢â¢Ñ¤~¬O¹ïªº¤è¦V¡C |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/7 ¤W¤È 09:53:01²Ä 3772 ½g¦^À³
|
¥¢±æ½æÀ£¦A¨Ó¤@ªi¡A³Ì¦Z¤W¨®¾÷·| |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/6 ¤U¤È 08:50:00²Ä 3771 ½g¦^À³
|
1. 2022.10.30-¦¶³Í¥Á:¥Ñ©ó¦³®ÄÃIJzªº¥D¦¨¤À(APAP)¨S¦³§ïÅÜ¡AY¦¨¥\±NSNP-810±ÂÅvµ¹¥Ø«e¾P°â¤AñQÓi×ô¦¨¤À¤îµhÃĪº ¤j¼t¡A¤£¥Î«·s°µÁ{§É¥Ó½ÐÃÄÃÒ¡A¥u»Ýn§ó§ï¥]¸Ë¤Î¥é³æ¡A´N¯à¥H³Ì§Öªº³t«×¾P°â¶i¶¥ª©¡]¤£¶Ë¨x¡^²£«~¡C 2.2024.6.6-ªYÄ£ªº¥Ø¼Ð¬O´Â¦V¥H°ª¨x¦w¥þ©Êªº¤AñQÓi×ô¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C ¹Î¶¤±N¥Ó½Ð¦w¥þ·sÃij\¥iÃҨô£¨Ñµ¹°ê»Ú¤jÃļt¡A§@¬°±ÂÅv¨Ì¾Ú¡C ------------------------------------------------------------------------------------------------- OTC«D³B¤èÃÄ«GÂI: °ê»Ú¤jÃļt¤£¥Î«·s°µÁ{§É¥Ó½ÐÃÄÃÒ-->ªYÄ£±N¥Ó½Ð¦w¥þ·sÃij\¥iÃҨô£¨Ñµ¹°ê»Ú¤jÃļt-->¦]¦¹¯à¥H³Ì§Öªº³t«×¾P°â(¤£¶Ë¨x¡^²£«~¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/6 ¤W¤È 07:00:59²Ä 3770 ½g¦^À³
|
2023.3.20--¥²¶·°µ§ó¦hªº¤u§@¨Ó´î¤Ö¹ï¤AñQ®ò°ò×ôªº¨x¬r©Ê(«D³B¤èªº¦í°|²v«D¦ý¨S¦³´î¤ÖÁÙ¼W¥[ ¼W¥[ ¼W¥[)¡C pharmacy.unc.edu/2023/03/hepatotoxicity/ ¡m¬ü°êÂå¾Ç·|Âø»x¡n(JAMA) ³Ìªñµoªí¤F¤@¶µ¬ã¨s¡A±´°Q¤F³o¶µ³W©w¹ï¤½¦@°·±dªº¼vÅT¡A¨Ã±o¥Xµ²½×¡A¥Ñ©ó¹ï¤AñQ®ò°ò×ô/ªü¤ùÃþÃĪ«²Õ¦X¾ÉPªº¤¤¬r¦í°|²v¦³©Ò¤U°(³B¤èÃÄ)¡CµM¦Ó¡A¦Û 2011 ¦~¥H¨Ó¡A¦]³æ¥Î¹ï¤AñQ®ò°ò×ô²£«~(«D³B¤èÃÄ)ªº¬r©Ê¦Ó¦í°|ªº¤H¼Æ³v¦~¼W¥[¡C ¥Ñ¥_¥dù¨Ó¯Ç¤j¾Ç®JÁº¸°ÒÃľǰ| Paul Watkins Âå¾Ç³Õ¤h¡BÃĪ«ªvÀø©M¹êÅçªvÀø¾Ç³¡ Howard Q. Ferguson ³Ç¥X±Ð±Â©M¬ü°ê°ê¥ß½Ã¥Í¬ã¨s°|¨x¯f¤À³¡Âå¾Ç³Õ¤h¡B²z¾ÇºÓ¤h Marc Ghany ¦@¦P¼¶¼gªºµû½× µ²½×:1.FDAªº±j¨î¤âªk¥u¹ï³B¤èÃĦ³®Ä¡AOTC[«D³B¤è]ªºAPAPªº¦í°|²v¹ê»Ú¤W«D¦ý¨S¦³´î¤ÖÁÙ[¼W¥[][¼W¥[][¼W¥[]¡C 2.¦@¦P§@ªÌ§Æ±æ FDA±À¥X·sªº¤½¦@½Ã¥Í¬Fµ¦(¦p¦P^°ê)¨Ó¨î¤AñQÓi×ô¨x·l¶Ë¡A¦ý¬Û«H³Ì¦nªºªø´Á¿ï¾Ü¬O¶}µo§ó¦w¥þ ªº¤îµhÃÄ¡C --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/10/3 ¤U¤È 02:27:57²Ä 3465 ½g¦^À³ 2023.9.11--^°êp¹º¨î¼³¼ö®§µh¾P°â¥H´î¤Ö¦Û±þ (¦A¥[ÄY¨îAPAP«D³B¤èÃĨÑÀ³) www.ndtv.com/world-news/uk-plans-to-restrict-paracetamol-sale-to-reduce-suicides-report-4379038 ^°ê¬F©²¥¿p¹º¨î§t¦³¼³¼ö®§µhªº«D³B¤èÃĪº¨ÑÀ³¡A¥H´î¤Ö¦Û±þ¦º¤`¤H¼Æ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/5 ¤U¤È 11:11:01²Ä 3769 ½g¦^À³
|
2017.7.20-¹ï¤AñQ®ò°ò×ôªº¨x¬r©Ê¡X²{¦b¬O®ÉÔÅý APAP ®ø¥¢¤F¶Ü¡H www.sciencedirect.com/science/article/abs/pii/S0168827817321487 ... 2002¦~©M2009¦~¡AFDA¥l¶}¤F¿Ô¸ß©eû·|·|ij¡A¦®¦b¸Ñ¨MAPAP¨x¬r©Ê°ÝÃD¡CÀ³¸Ó«ü¥Xªº¬O¡A»PFDA¹ï[³B¤èÃÄ]ªºÅv¤O¬Û¤ñ¡AFDA¹ï[«D³B¤èÃÄ]´X¥G¨S¦³±Ä¨ú¦æ°ÊªºÅv¤O-->2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n FDA¹ï[«D³B¤èÃÄ]´X¥G¨S¦³±Ä¨ú¦æ°ÊªºÅv¤O-->2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n FDA¹ï[«D³B¤èÃÄ]´X¥G¨S¦³±Ä¨ú¦æ°ÊªºÅv¤O-->2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/19 ¤W¤È 08:18:34²Ä 3698 ½g¦^À³ 2017.9.14-¬ü°ê°ê·|¼f¬d[«D³B¤èÃÄ]...¨âÄҥߪk¯ó®×±N¹ý©³§ï² FDA ¹ï«D³B¤è²£«~ªººÊºÞ¤è¦¡(¦]¬°¤¾ªøªk³Wµ{§Ç¡AFDA ªá¤F¤C¦~®É¶¡¤~n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i) 2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï²ªk®×¡n½á¤© FDA µo¥¬¦æ¬F©R¥OªºÅv¤O¡A¬°½T«OOTCÃÄ«~ªº[¦w¥þ©Ê]»P[¦³®Ä©Ê]¡AFDAª½µo¤@¯È¦æ¬F©R¥O¡A¤£¥Î¦A¨«¦Ñ®Mªº¤¾ªøªk³Wµ{§Ç¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/5 ¤W¤È 09:59:46²Ä 3768 ½g¦^À³
|
1.2016¦~-®üĦ¿}¥i¥HªvÀø¯×ªÕ¨x¶Ü¡H ¤@¶µ°w¹ï¤p¹«ªº·s¬ã¨sªí©ú¡A®üĦ¿}¥i¦³®Ä°fÂà»PªÎD¬ÛÃöªº«D°sºë©Ê¯×ªÕ¨x¡A¦]¬°¥¦¥i¥H¨ë¿E¨x²ÓM¶i¦æ¦Û¾½¡]¦Û¹¡^¡A±q¦Ó²M°£¦³°ÝÃDªº¦h¾l¯×ªÕ¡Cwww.sciencebase.com/science-blog/trehalose-treats-fatty-liver.html 2.2023.8.15-®üĦ¿}»¤¾Éªº SIRT1/AMPK ¬¡¤Æ½Õ¸` SREBP-1c/PPAR-£\ ¥H[´î»´¦Ñ¤Æ¨xŦ¤¤ªº¯×½è¿n²Ö] ¸É¥R®üĦ¿}¥i¼W¥[¦Ñ¦~°Êª«¨xŦ¤¤ SIRT1¡Bp-AMPK ©M PPAR-£\ ªº¤ô¥¡A¦Ó SREBP-1c ªº¤ô¥«h°§C¡C¦¹¥~¡A®üĦ¿}ªvÀø§ï µ½¤F¦Ñ¤Æ¨xŦªº²Õ´¯f²z¾Ç¯S¼x¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/5 ¤W¤È 09:39:28²Ä 3767 ½g¦^À³
|
¤fªA®üĦ¿}¤w³QÃÒ©ú®Ä²v[§C¤U]¡A³o¬O¦]¬°´X¥G©Ò¦³÷¨Å°Êª«ªº¸zÂH½¤¡BµÇŦ¡B¨xŦ©M¦å²G¤¤³£¦s¦b®üĦ¿}[酶]-->®Ä²v[§C¤U]¬O¦]¬°®üĦ¿}[酶]±N®üĦ¿}¤ô¸Ñ¦¨¨âÓ¸²µå¿}¤À¤l¡C ------------------------------------------------------------- ®üĦ¿}¬O³z¹L§í¨î½è½¤¤¤ªº¸²µå¿}Âà¹B³J¥Õ¨Ó [ªý¤î]²ÓM¹ï¸²µå¿}ªºÄá¨ú¡A±q¦Ó»¤¾É¡u°§¾j¡v¼Ë¤ÏÀ³¡A§Y¨Ï¦b¦s¦b¨¬°÷ªºÀç¾iª«©M¸²µå¿}ªº±¡ªp¤U¤]·|¿E¬¡¦Û¾½¡Cwww.science.org/doi/10.1126/scisignal.aac5472 ²¢¨ý¨üÅé³J¥ÕT1R3¬O·P¨ü®üĦ¿}«á¶Ç»¼°T¸¹.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/5 ¤W¤È 09:20:45²Ä 3766 ½g¦^À³
|
2004¦~-²¢¨ý¨üÅé³J¥Õ T1R3 ¦b¤HÃþ¨xŦ©M¯ØŦªºªí¹F pubmed.ncbi.nlm.nih.gov/15585941/ ....T1R3 ¦b¨xŦ©M¯ØºÞ²ÓM¤¤ªº¦³©w¦ì¥i¯àªí©ú T1R3 °Ñ»PºÊ´ú¨xºÞ©M¯ØºÞ¨t²Î¤¤Áx¥Ä©M¯Ø²G²Õ¦¨ªºÅܤơC ------------------------------------------------------------------------------------------- ²¢¨ý¨üÅ餣´N¦s©ó¦ÞÀY¤fµÄ¡A¦b¤HÃþ¨xŦ©M¯ØŦ·Ù¬O@¤H´M¨ý°µ¤°¥Î??? ¤HÃþ¯à¿ë§O¤ºØ°ò¥»¨ýı¡G»Ä¡B²¢¡BW¡BÄЩMÂA¨ý¡A¤À§O¥Ñ¤£¦Pªº¨ýı¨üÅé¨Ó§e²{¡C¨ýı¨üÅé¥Ñ³J¥Õ½è²Õ¦¨¡A¦ì©ó¨ýı²ÓMªº²ÓM½¤ªí±¡A¥H±µ¦¬¦UºØ¨ý¹D¤À¤l¡A¶i¤@¨B¶Ç»¼°T¸¹ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/5 ¤W¤È 09:09:54²Ä 3765 ½g¦^À³
|
SNP610»PSNP-810ªº(¥ÌÅS¾J+¤T´â½©¿})¤À¤l¯ÅÁp¤ÏÀ³: ²ÓM¤À¸Ñ³J¥Õ½èªº¨â®M¨t²Î¡Gªx¯À(2004¦~¿Õ¨©º¸¤Æ¾Ç¼ú/Cyp2e1)»P²ÓM¦Û¾½(2016¿Õ¨©º¸¥Í²zÂå¾Ç¼ú/¤T´â½©¿}-T1R3(¦s¦b¨xŦ¯ØŦ)-®üĦ¿}¬¡¤Æ¦Û¾½§@¥Î 1.2003¦~§Ú̺¦¸ÃÒ©úT1R3 ¹ï©ó¤G¿}®üĦ¿}ªºÃѧO©M¤ÏÀ³¦ÜÃö«n(·Pª¾¤G¿}®üĦ¿}©Ò¥²»Ýªº¤À¤l) pubmed.ncbi.nlm.nih.gov/12892531/ 2.®üĦ¿}·|¬¡¤Æ[¦Û¾½§@¥Î]¨Ã´î¤Ö³J¥Õ酶Åé§í¨î¾¯»¤¾Éªº¤º½èºôÀ£¤O©M®ñ¤ÆÀ£¤O¤¶¾Éªº¨x²ÓM²ÓM¬r©Ê ¨´¤µ¬°¤î¡A[¤fªA]®üĦ¿}¤w³QÃÒ©ú®Ä²v§C¤U¡A³o¬O¦]¬°´X¥G©Ò¦³÷¨Å°Êª«ªº¸zÂH½¤¡BµÇŦ¡B¨xŦ©M¦å²G¤¤³£¦s¦b®üĦ¿} 酶¡C 3.2013¦~¤¤¥¡¬ã¨s°| ¥Íª«¤Æ¾Ç¬ã¨s©Ò-¸Ñ¶}¡u²ÓM¦Û¾½§@¥Î¡v¹ï§Ü¡u®ñ¤ÆÀ£¤O¡vªº¤À¤l¾÷¨î www.ibc.sinica.edu.tw/Research/ViewRH?DatetimeStr=20221103113558 ÃÒ¹ê¦b®ñ¤ÆÀ£¤O¤U¡A¡u²ÓM¦Û¾½§@¥Î¡v(autophagy) ¤£¥u¯à°÷¤À¸Ñ¦^¦¬¨ü·lªºM¾¹©Î³J¥Õ½è¡A§ó¯à°÷Âǥѽձ±·F²ÓM¼W¥Í ¤Î²ÓM¦º¤`¨Óºû«ù²Õ´ªº§¹¾ã»P¥¿±`¥\¯à¡C 4.¡i2016¿Õ¨©º¸¥Í²zÂå¾Ç¼ú¡j¤é¥»²ÓM¥Íª«¾Ç®a¤j¶¨¨}¨å±Ð±Â-µo²{¦Û¾½§@¥Î¾÷¨î(²ÓM¤j±½°£À°§U¤HÅé¦Û§Ú×´_) case.ntu.edu.tw/blog/?p=26296 ¦Û¾½§@¥Î¯à²¾°£¦s¬¡®É¶¡¸ûªøªº³J¥Õ½è¡A¬O [°ß¤@] ¯à¯}Ãa¾ãÓM¾¹¦p²É½uÅé¡B¹L®ñ¤ÆÅé¡B¤Î¤º½èºôªº§@¥Î¡C ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/26 ¤U¤È 07:31:12²Ä 3424 ½g¦^À³ ¼ö©I©IªºNature¤l¥Z½×¤å. USP14 ¦b LPO ©Mª¢¯g¤¤ªº¥\¯à¨ú¨M©ó CYP2E1 1.2004¦~¿Õ¨©º¸¤Æ¾Ç¼ú(³J¥Õ½èªº¤À¸Ñ¾÷¾¹):¬ã¨s¦b²ÓM¤¤¦p¦ó¹ï¤@¨Ç¤£»Ýnªº³J¥Õ½è¥[¤W¤@ºØºÙ¬°[ªx¯À]ªº¦hÐ`肽¼ÐÅÒ¡A ½Õ¸`³J¥Õ½èªº¦s¦b¡F¥L̪º¬ã¨s¦b¤Æ¾Çª¾ÃѤW¦³«nªº¬ð¯}¡C 2.¦p¦ó¹B¥Î²ÓM¾÷¨î§ïµ½¯×ªÕ¨x¡H¥ý¨Ó»{ÃѤ°»ò¬O[ªx¯À]»P[²ÓM¦Û¾½] research.sinica.edu.tw/ubiquitination-autophagy-liver/ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/4 ¤W¤È 08:13:41²Ä 3764 ½g¦^À³
|
¥ÌÅS¾J+¤T´â½©¿}ªº¥[¼®ÄÀ³¤£¬O¥u¦³Åã²{¦bAPAP¡ANASH(MASH)¦P¼Ë¬Ý¨ìªì¨BÃÒ¾Ú: ªvÀø12¶gALT°§Cªº®ÄªG¬°SNP-610°§C29.5 U/L¡AMGL-3196°§C8.6 U/L¡AÅã¥ÜSNP-610 ®ÄªGÀu©ó°ê»Ú¤W³Ì·sµo®i¤§¥NÁÂ¥\¯à»Ùê¬ÛÃö¯×ªÕ©Ê¨xª¢ÃĪ«¡C 2023.7.6-¸z¹D·L¥Íª«l¥ÍªºµuÃì¯×ªÕ»Ä [¤B»Äà]¦b[¨xÁx]¯e¯f¤¤ªº§@¥Î ajp.amjpathol.org/article/S0002-9440(23)00238-9/fulltext --------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/1 ¤U¤È 01:00:55²Ä 3748 ½g¦^À³ µL¨x¬rSNP-810(12g) VS. ¦³¨x¬rAPAP(4g)ªº[¾î¦V¤ñ¸û]: 1.SNP-810-ALT¤É°ª¤j©ó3~8¿¥¿±`ȤW¤§¤ñ¨Ò¬°0% VS.39% ¤j©ó 3 ¿ (>120 U/L)¡A25% ¤j©ó 5 ¿ (>200 U/L)¡A8 % ¤j©ó8 ¿( >320 U/L) ------------------------------------------------------------------------------------------------- |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/4 ¤W¤È 08:02:19²Ä 3763 ½g¦^À³
|
¥ÌÅS¾J+¤T´â½©¿}(µL¨x¬rµLµÇ¬r)ªº¤B»ÄÆQ¥[¼®ÄÀ³2¡C(T1R3¿E°Ê¶tÁâ¥[¼®ÄÀ³1) 2022.8.9--¤B»ÄÆQ¨¾ªv¿}§¿¯f [µÇ]¯fÅܪº§@¥Î¤Î¾÷Âà www.ncbi.nlm.nih.gov/pmc/articles/PMC9396028/ ...¤B»Ä»¤¾Éªº²Õ³J¥Õ¤BñQ¤Æ§@¬°¤@ºØ·s«¬ªº²Õ³J¥Õ½Ķ«á×¹¢¡A¤wÃÒ©ú¨ä¹ï¦hºØµÇ¯f¨ã¦³µÇŦ«OÅ@§@¥Î¡A³o¬°ÄÄ©ú¤B»ÄªºÃIJz¾÷¨î´£¨Ñ¤F·sªºµø¨¤¡C --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/10 ¤U¤È 03:09:17²Ä 3382 ½g¦^À³ SNP-6ÃĪ«[¥ÌÅS¾J]ªºÀø®ÄÃöÁä¾÷¨î: [¥ÌÅS¾J]²£¥Í[¤B»ÄÆQ]©M[¤þ»ÄÆQ]-->¨xŦ[GLP-1R]-->[¥¨¾½²ÓMM1/M2] .... [¤T´â½©¿}]»P[¥ÌÅS¾J]ªº¥[¼®ÄÀ³(¼x¨D¯q¥ÍµßÀ³¥Î¬ã¨s¤H,§ä¥X°t¤è±ø¥ó¤Uªº±j¤B»ÄÆQ¥Í²£µß) ¤T´â½©¿}Åý²£¥Í¤B»ÄÆQªº¸z¹D²ÓµßÂ׫×ÅãµÛ¼W¥[-->§Q¥Î²Óµß±N¥ÌÅS¾JÂà¤Æ¬°¤B»ÄÆQ»P¤þ»ÄÆQ --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/29 ¤U¤È 06:31:08²Ä 3737 ½g¦^À³ SNP-810:¥ÌÅS¾J+¤T´â½©¿} +APAP ¥ÌÅS¾J¦b¥@¬É¬Y¨Ç¦a°Ï¤´µM¬O[«æ©ÊµÇ°IºÜ]ªºªvÀø¤èªk¡A¤×¨ä¬O¦Ù¬õ³J¥Õ§¿«¬µÇ°IºÜ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/4 ¤W¤È 04:53:01²Ä 3762 ½g¦^À³
|
¤jÃļtÁ}Ãø¤§³B¡Añ±ÂÅvµ¥¦P©ó«Å§i©Ó»{¶D³^«ß®vªº¯Á½ß¥D±i??? (FDA«e¥N²z§½ªø»¡ªº¯U¯¶ªºªvÀø«ü¼Æ) --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/6/26 ¤U¤È 04:06:47²Ä 1247 ½g¦^À³ ¶D³^«ß®v¹ï±j¥Íªº¯Á½ß¥D±i: Tylenol ªº³]p©M¾P°â¦³¯Ê³´¡A¨Ã¥B³B©ó¡§¦³¯Ê³´¥B¤£¦X²zªº¦MÀIª¬ºA¡¨ [¥i¨Ñ®ø¶OªÌ¨Ï¥Îªº²£«~À³¸Ó¨ã¦³¦X²zªº¦w¥þÃä»Ú]=½¦¨¥Õ¸Ü´N¬O:APAPªºªvÀø¾¯¶q»P¦w¥þ¾¯¶qªº¾¯¶q½d³ò¤Ó¯¶¡C -------------------------------------------------------------------------------- ´X¥G©Ò¦³ 85 °_®×¥ó³£ÁnºÙì§i¾¨ºÞ«ö·Ó«ü¥ÜªA¥Î¤F®õ¿Õ¡A¦ý¤´¾D¨ü¤F¨x¥\¯à°IºÜ¡C ...±wªÌªº«ß®vªí¥Ü¡A§Y¨Ï¨Ï¥Î¾¯¶q[¹F¨ì]©Î [²¤°ª]©ó±ÀÂˤô¥¡A®õ¿Õ¤´µM¬O¦MÀIªº¡C ¥NªíTylenol¨ü®`ªÌªº«ß®v³ÒÛ´µ¡P§B°Ò»¡:[¥i¨Ñ®ø¶OªÌ¨Ï¥Îªº²£«~À³¸Ó¨ã¦³¦X²zªº¦w¥þÃä»Ú] --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/1/22 ¤U¤È 12:13:53²Ä 559 ½g¦^À³ ¦bÂå°|¥ÑÂå®v¬IÃĪºª¬ªp¤U¡AÁÙ·|µo¥ÍÄY«ªºP©R©Ê«æ©Ê¨x°IºÜ!°ÝÃDÄpµ²´N¦bAPAPªºªvÀø¾¯¶q»P¦w¥þ¾¯¶qªº¾¯¶q½d³ò¤Ó¯¶¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/4 ¤W¤È 04:45:44²Ä 3761 ½g¦^À³
|
FDA«e[¥N²z§½ªø]»¡ªº[¯U¯¶ªºªvÀø«ü¼Æ]-SNP-810´£°ª¦Ü¤Ö3¿(12g)¥H¤W¸Ñ¨M¡C ¤§«eFDA±j¨î¤z¹w¬O(¹ú¤j©ó§Q--ÅX¨Ï¤H̨ϥÎNSAID)¡A²{¦bFDA±j¨î¤z¹w¬O(§Q¤j©ó¹ú--SNP-810¥i¥N´À)¡A¤£À³¸Ó¦³©Ò§@¬°±¹¬I? ---------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/3 ¤W¤È 08:40:44²Ä 890 ½g¦^À³ Á}Ãøªº¥¿Å-¯kµhºÞ²z¡AÃĪ«¦w¥þ©Ê©MFDA(Janet Woodcock, M.D.) www.nejm.org/doi/full/10.1056/NEJMp0908913 ------------------------------------------------------------------------------------------- (FDA)«e[¥N²z§½ªø] Janet Woodcock¦b2009¦~¼gªº1½g¤å³¹! ÁöµM¹ï¤AñQ®ò°ò×ô¦b«ö¼ÐÅҨϥήɳq±`¬O¦w¥þªº¡A¦ý¸ÓÃĪ«ªº´¶¹M¦s¦b¤Î¨ä¬Û¹ï[¯U¯¶ªºªvÀø«ü¼Æ]¥i¯à·|¦]µL·N©M¬G·N¹L¶qªA¥Î¦Ó³y¦¨ÄY«¶Ë®`.... 2008.02.26 FDAªº«Øij¤z¹w±¹¬I¥H´î¤Ö¹ï¤A酰®ò°ò×ô¨x¬r©Êªºµo¥Í Janet Woodcock www.litigationandtrial.com/files/2011/12/2009-4429b1-02-FDA.pdf ¡K§Ṳ́£§Æ±æFDA±Ä¨ú°®¹w±¹¬I¨Ó¸Ñ¨M¹ï¤A酰®ò°ò×ôªº¨x¬r©Ê·ÀI¡A[³Q»~»{¬°]¬ONSAIDSÃÄ(ªü´µ¤ÇÆF) ¤ñ (APAP)§ó¦w¥þ¡C NSAIDS¡]¤×¨ä¬Oªø´ÁªA¥Î¡^·|¾ÉP«nªºG¸z¹D¯e¯f©MµÇŦ¯e¯f¡C¤z¹w±¹¬Iªº¥Øªº¬O´î¤Ö¹ï¤A酰®ò°ò×ô¬ÛÃöªº¨x¬r©Ê¡A¦Ó¤£¬O [´î¤Ö ] ¹ï¤A酰®ò°ò×ôªº¨Ï¥Î©Î ÅX¨Ï ¤H̨ϥÎNSAID¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/3 ¤U¤È 10:22:58²Ä 3760 ½g¦^À³
|
60¦~«eªº¤Ú¤ñ§´¡A«ç»ò¦b2023¦~´N¦¨¤Ú¤ñQ¤F? ¤å4. ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/6/22 ¤W¤È 11:43:51²Ä 3257 ½g¦^À³ 60¦~«e¼ö¾Pªº¤Ú¤ñ§´ÃþÃĪ«¡A¤µ¤é«ç»ò¤H¤HÁפ§°ß®£¤£¤Î?(¥un¤£¹L¶q¬O¦w¥þªº) 2005.12---www.ncbi.nlm.nih.gov/pmc/articles/PMC2424120/ 1.^°ê¡A1965 ¦~¦Ü 1970 ¦~¶¡¡A¦³ 12 ¤H¦º¤`¡C 354 ¨Ò¦º¤`ª½±µÂk¦]©ó¤Ú¤ñ§´ÃþÃĪ«¡C³o¨Ç¼Æ¾Ú¤£À³¥O§ÚÌ·P¨ìÅå³Y¡A ¦bµuµu¤@¦~¤º¡]1968 ¦~¡^¡A^°ê´N¶}¥X¤F 2470 ¸U±i¤Ú¤ñ§´ÃþÃĪ«³B¤è 2.¤kºtûº¿ÄR½¬¡P¹ÚÅSªº¦º¤`ÃÒ©ú¡A©ó 1962 ¦~ 8 ¤ë 28 ¤éñµo¡C¶ê°éªí¥Ü¦º¦]¡§«æ©Ê¤Ú¤ñ§´¤¤¬r¡CÄá¤J¹L¶q¡¨©M·N¹Ï ¡§¥i¯à¦Û±þ¡¨ ---------------------------------------------------------------------------------------------- ROGER588910148151 µoªí®É¶¡:2023/6/19 ¤U¤È 08:21:28²Ä 3249 ½g¦^À³ 1.2023.6.15--¥®¨à¶éÁýÃĮתº¡u¤Ú¤ñ§´¡v³º¬O¥iÅý¤H©üºÎ©MP©Rªº¬rª«¡I |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/3 ¤U¤È 10:16:35²Ä 3759 ½g¦^À³
|
°ê»Ú¤jÃļtÀË´úÃĪ«»P¼fµø¼Æ¾Ú¡Añ©w±ÂÅv¦X¬ù«e¡A§ë¸ê¤@©w¦³·ÀI¡A³ø¹S»P·ÀI¦Û¤vµû¶q! ¤å3. --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2021/3/8 ¤W¤È 09:53:21²Ä 918 ½g¦^À³ ³Ì¦³§Æ±æªºµ¦²¤¬O´M§ä¤@ºØ·sªº¤îµhÃÄ¡A¸Ó¤îµhÃĪº¯S©Ê»PAPAP¬Û¦P¦ýµL¬r©Ê...³oºØ·s«¬¤îµhÃĪº¦^³ø±N¬O¥¨¤jªº¡I ... §Ú·Q¨ìªº¤@Ó¬Û¦ü¤§³B¬O¦w¯vÃĪº¤Ú¤ñ§´»ÄÆQÃþ¡A¦b1960¦~¥N©M70¦~¥N«D±`¬y¦æ¡A¦ý¬O«o¾ÉP¤FµL¼Æªº¹L¶q¦º¤`¡C f¤G´á¨ôÃþÃĪ«°Ý¥@«á¡A¤Ú¤ñ§´ÃþÃĪ«¨³³t®ø¥¢¡C-----[·N«ü:¥X²{¦w¥þµL¨x¬rSNP-810 ¨º»ò¦³¨x¬r©ÊªºAPAP±N·|®ø¥¢) ------------------------------------------------------------------------------------------------- Ĺ:ã÷®Ø William M. Lee ³o½g¤å:www.journal-of-hepatology.eu/article/S0168-8278(17)32148-7/fulltext (³oºØ·s«¬ÂíµhÃĪº¦^³ø±N¬O¥¨¤jªº!)¥H¯÷ªí´Æg¹|! ¿é:¥h¬ü°ê©îWilliam M. Leeªº¦ª´Î --------------------------------------------------------------------------------------------- |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/3 ¤U¤È 10:11:32²Ä 3758 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/27 ¤W¤È 09:53:25²Ä 424 ½g¦^À³ ...... ¬°¤°»ò2017¦~¬ü°êÃĪ«±M®a»¡:®õ¿Õ¡]Tylenol,APAP)¬O¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«??? ¬°¤°»ò¬ü°êÂå¾Ç±M®aWilliam M. Lee, M.D»¡¦pªG¨S¦³¸Ñ¬r¾¯(N-¤AñQ¥b¯Ö®ò»ÄNAC¡^¡A¹ï¤A酰®ò°ò×ô(APAP)¥i¯à¦´N³Q§¹¥þ¸T¤î¤F??? ¤d¨¥¸U»y¤£¦p¤@±i¹Ïªí²³æ©öÀ´! FDA¸ê®Æ²Ä7¶ www.fda.gov/media/87626/download ALF«æ©Ê¨x¥\¯à°IºÜ:¹ï¤A酰®ò°ò×ô(APAP)¤ñ¨Ò46% ¤W¥«ÃĪ«¤ñ¨Ò11% (¤W¥«ÃĪ«:¥Ñ1,036ºØFDA§å㪺ÃĪ«²Õ¦¨) Why So Much Trouble with Acetaminophen??? --------------------------------------------------------------------------------------------- ¤å2 ALF«æ©Ê¨x¥\¯à°IºÜ:¹ï¤A酰®ò°ò×ô(APAP)¤ñ¨Ò46% Why So Much Trouble with Acetaminophen??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/3 ¤U¤È 10:06:33²Ä 3757 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2021/12/13 ¤W¤È 10:30:50²Ä 1514 ½g¦^À³ ¡§¥v¤W³ÌÁV¿|ªºÃĪ«¡¨¤þ®ñªâ¬O¤@ÓÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡A¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«Acetaminophen¡¨ ¤]¬OÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡C FDA¦b2009¤U¬[¤þ®ñªâ!!! 2006.2.28 ¸T¤î©Ò¦³¤þ®ñªâ (Darvon) ²£«~ªº½ÐÄ@®Ñ www.citizen.org/article/petition-to-ban-all-propoxyphene-darvon-products/ ...°·±d¬ã¨s¤p²Õ³q¹L¸Ó½ÐÄ@®Ñ´°«P¥ß§Y¤À¶¥¬q±q¬ü°ê³B¤èÃÄ¥«³õºM¥X©Ò¦³§t¤þ®ñªâªº²£«~¡C³oÀ³¸Ó¥ß§Y¶}©l¡A¦]¬°³oºØÃĪ«¨ã¦³¬Û·í¤jªº¤HÃþ¬r©Ê¡B¦¨Å}¼ç¤O¡BÀݥζɦV¡A¦ýªvÀø¥Î³~«D±`¦³¡C¦Û 1972 ¦~ 9 ¤ë¥H¨Ó¡A³oºØÃĪ«»P¦Ü¤Ö 7109 ¤H³ø§iªº¦º¤`¦³Ãö¡A¨ä¤¤ 2110 ¤H¬O·N¥~¦º¤`¡A«æ¶E«Ç´N¶E¦¸¼Æ¼W¥[¤F³\¦h¿¡A³o¬O¤@ÓÄY«ªº¤½¦@½Ã¥Í°ÝÃD¡A³o¤@ÂI¬OµL¥iª§Ä³ªº¡C¥u¦³¸T¥Î¤þ®ñªâ¤~¯à®ø°£³oºØ¦MÀI¡C ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/22 ¤U¤È 08:25:07²Ä 408 ½g¦^À³ ¬ü°êÃĪ«±M®a»¡:®õ¿Õ¡]Tylenol,APAP)¬O¡§¨´¤µ¬°¤î³Ì¦MÀIªºÃĪ«! ¤@¥¹¥X²{§ó¦w¥þÃĪ«SNP-810¡AFDA¤£µL¥i¯à±N¥u§t[¤AñQÓi×ô]¦¨¤ÀªºÃĪ«±j¨î¤U¥«¡A ³oÓ¼s¤j¥«³õ·|Åܦ¨¦³¦h¤j??? --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2020/12/22 ¤U¤È 07:53:02²Ä 406 ½g¦^À³ ¦pªG¨S¦³¸Ñ¬r¾¯¡A¹ï¤A酰®ò°ò×ô(APAP)¥i¯à¦´N³Q§¹¥þ¸T¤î¤F!---³o¬OÂå¾Ç±M®aWilliam M. Lee, M.D»¡ªº! ----------------------------------------------------------------------------------------------- ¶X¼ö¥´ÅK«¶K¤å~ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/6/3 ¤U¤È 03:24:51²Ä 3756 ½g¦^À³
|
¤]³\¡B¤]³\?!¤µ¦~¬Osnp¼É¨«¦~? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤U¤È 03:41:16²Ä 3755 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2023/10/8 ¤U¤È 10:32:01²Ä 3473 ½g¦^À³ ªYÄ£¦bÃĪ«¶}µo¤§ªì¡Aµ´¹ïÀ£®Ú¨S·Q¨ìªº·s¾÷¨î(¯à¥Z¦bNature¥D¥Zªº½×¤åªÖ©w¬O¬ã¨s³ø§i¨ã¦³«¤j·N¸q¡B³Ð·s¡B¤Î¨¬¥H§ïÅܬJ©w«äºûµ¥¯S½è) 2023.3.15-¿¯¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²ÓM]¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯ www.nature.com/articles/s41586-023-05801-6 ------------------------------------------------------------------------------------------------ ¤@¶µÀH¾÷¡BÂùª¼¡B¦w¼¢¾¯¹ï·Ó¬ã¨s¡A¦®¦bµû¦ôSNP-610ªvÀø«D°sºë©Ê¯×ªÕ©Ê¨xª¢ªºÀø®Ä©M¦w¥þ©Ê ¬ã¨s°O¿ý§ó·s ´£¥æªº³Ì·s§ó·s²Å¦X«~½è±±¨î¼Ð·Ç 2023-04-28 ³Ì«áµo¥¬ªº§ó·s 2023-05-01 ³Ì«áÅçÃÒ2023¦~4¤ë ±q¦VClinicalTrials.gov´£¥æ§ó§ïªº®É¶¡2023-04-28/2023-05-01 ¨Ó¬Ý¡AºòÀH¦b[¤T´â½©¿}¬OT²ÓM¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯]¥X¥Z¤é«á¡A¥i¯à°µ¨Ç²ÓM°ö¾i°Êª«¹êÅç¨DÃÒ??? SNP-610 ¤w¨ú±o¬ü°ê»P¥xÆW FDA ®Öã°õ¦æÁ{§É¤G´Á¬dÅçµn°O¥Î¸ÕÅç¡A²{«ùÄò¶i¦æ¸ÕÅçpµe®Ñ½Õ¾ã¡BÃÄ«~»s³y¡B¸ÕÅçºÊ´ú©e°U¤Î¦¬®×Âå°|Âå®v·¾³qµ¥§@·~¡A¹wp 114 ¦~²Ä¤@©u±Ò°Ê¦¬®×¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 10:17:46²Ä 3754 ½g¦^À³
|
¤U«B¤Ñ¶K¤å¤Ñ~ ¨â¨â©IÀ³! ¤T´â½©¿}(T1R3¿E°Ê¾¯)->T1R1/T1R3«P¶i[¨xŦ]CD49a+CD49b-(¨xŦ¾n¯dNK²ÓM)->NK²ÓM®ø°£DC¡A±q¦Ót¦V½Õ¸`T²ÓM¤ÏÀ³. -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/10/8 ¤U¤È 10:32:01²Ä 3473 ½g¦^À³ ªYÄ£¦bÃĪ«¶}µo¤§ªì¡Aµ´¹ïÀ£®Ú¨S·Q¨ìªº·s¾÷¨î(¯à¥Z¦bNature¥D¥Zªº½×¤åªÖ©w¬O¬ã¨s³ø§i¨ã¦³«¤j·N¸q¡B³Ð·s¡B¤Î¨¬¥H§ïÅܬJ©w«äºûµ¥¯S½è) .... 2023.3.15-¿¯¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²ÓM]¤¶¾É¤ÏÀ³ªºt½Õ¸`¾¯ www.nature.com/articles/s41586-023-05801-6 |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 10:08:47²Ä 3753 ½g¦^À³
|
T1R1/T1R3«P¶i [¨xŦ] CD49a + CD49b-¦ÛµM±þ¤â²ÓMªº±þ¸~½F¬¡©Ê??? ¨xŦNK²ÓM¦³¨âӨȸs¡GCD49a + CD49b-(¨xŦ¾n¯dNK²ÓM) ©MCD49a-CD49b+(±`³WNK²ÓM) ¦³½ìªº¬O¡A¥u¦³ CD49a + CD49b-(¨xŦ¾n¯dNK²ÓM)ªí¹F T1R1/T1R3 ¨üÅé¡A¦Ó CD49a-CD49b+(±`³WNK²ÓM)«h¤£ªí²{¡C ¦³½ìªº¬O¡A¥u¦³ CD49a + CD49b-(¨xŦ¾n¯dNK²ÓM)ªí¹F T1R1/T1R3 ¨üÅé¡A¦Ó CD49a-CD49b+(±`³WNK²ÓM)«h¤£ªí²{¡C ----------------------------------------------------------------------------------------- 2019.1.29-Cell³»¥Z-¨xŦ¾n¯dNK²ÓM³z¹L PD-1-PD-L1 ¶b±±¨î¨x T ²ÓMªº§Ü¯f¬r¬¡©Ê www.sciencedirect.com/science/article/pii/S1074761318305727. NK²ÓM¥i¥H¤Àªc¥Õ¦å²y¤¶¯À10¡]IL-10¡^¨Ó§í¨îCD4 +©MCD8 + T²ÓM¤ÏÀ³©Îª½±µ±þ¦ºCD4 +©MCD8+T²ÓM¡C¦¹¥~¡ANK ²ÓM ¥i¥H®ø°£ DC¡A±q¦Ót¦V½Õ¸` T ²ÓM¤ÏÀ³. ³Ìªñ¡A§ÚÌ©M¨ä¥L¤HŲ©w¤F¤p¹«¨xŦ¤¤´I¶°ªº¿W¯S NK ²ÓM¨È¸s¡A§Ú̱N¨ä´yz¬°CD49a + CD49b ¡V¨xŦ¾n¯dNK²ÓM... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 09:37:51²Ä 3752 ½g¦^À³
|
쥻§Ú§ë¸êµJÂI¬OSNP-6¡A¦ýMerck¯{30»õ¬ü¤¸¦¬ÁÊEyeBio«á¡ASNP-820(¥ÌÅS¾J+¤T´â½©¿})ªºªvÀø²´¯e·Q¹³¦n¤j... ¦b°ê»Ú¤jÃļtÀË´úÃĪ«»P¼fµø¼Æ¾Ú¡Añ©w±ÂÅv¦X¬ù«e¡A§ë¸ê¤@©w¦³·ÀI¡A³ø¹S»P·ÀI¦Û¤vµû¶q! ¦b°ê»Ú¤jÃļtÀË´úÃĪ«»P¼fµø¼Æ¾Ú¡Añ©w±ÂÅv¦X¬ù«e¡A§ë¸ê¤@©w¦³·ÀI¡A³ø¹S»P·ÀI¦Û¤vµû¶q! ¦b°ê»Ú¤jÃļtÀË´úÃĪ«»P¼fµø¼Æ¾Ú¡Añ©w±ÂÅv¦X¬ù«e¡A§ë¸ê¤@©w¦³·ÀI¡A³ø¹S»P·ÀI¦Û¤vµû¶q! ---------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/1 ¤U¤È 10:31:55²Ä 3719 ½g¦^À³ §@®a§d²H¦p:´I¦³¬O¤@ºØ¿ï¾Ü¡A¦Ó³o¹Lµ{n¾a§Aªº°í«ù¡C½a°¤£·Q°Ê¸£¡A¥u·Q¤£³Ò¦ÓÀò¡C ......................................................................................... ·|û¡GROGER588910148151 µoªí®É¶¡:2020/7/3 ¤W¤È 09:28:01²Ä 45 ½g¦^À³ ´±«À£ªYÄ£¡A¥Dn¬O¤½¥qÁÙ¦³SNP8¨t¦C¡A¶i¥i§ð°h¥i¦u.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 09:22:24²Ä 3751 ½g¦^À³
|
¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¾¯)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³! T1R1/T1R3«P¶i [¨xŦ] CD49a + CD49b-¦ÛµM±þ¤â²ÓMªº±þ¸~½F¬¡©Ê??? 1.2008.7.1-T1R3¬O¨ýı¶tÁâ¨üÅé www.ncbi.nlm.nih.gov/pmc/articles/PMC2519964/ 2.2012.7.6-T1R3¡G¤HÃþ¶t¨ýı¨üÅé www.nature.com/articles/srep00496 3.2012.11.12-¥ÌÅS¾J¥i§ïµ½¶tªº§l¦¬©M«O¯d www.sciencedirect.com/science/article/abs/pii/S0899900712002730... 4.2016.2.5-¿¯¹¥ÌÅS¾J¼W¥[¤j¹«¶t©MÁ⪺§l¦¬ pubmed.ncbi.nlm.nih.gov/26849275/ 5.2018.9.27-¨ýı¨üÅéT1R1/T1R3«P¶i [¨xŦ] CD49a + CD49b-¦ÛµM±þ¤â²ÓMªº±þ¸~½F¬¡©Ê onlinelibrary.wiley.com/doi/full/10.1002/eji.201847688 ....¾Ú§ÚÌ©Òª¾¡A§Ú̬O²Ä¤@Ó³ø§i¸Ó¨üÅé¦b NK ²ÓM¤¤ªí¹Fªº¤H(ªYÄ£¤]¨Sµo²{???)¡C¦³½ìªº¬O... 6.2019.3.5-¶t°T¸¹§@¬°¨xŦ¯×ªÕÅܩʪºªvÀø¼Ð¹v www.sciencedirect.com/science/article/abs/pii/S1043276019300323 §ïÅܪº Ca 2+¥i¯à¬O NASH ©M¨xŦ¯Ø®q¯À©è§ÜªvÀø¤èªkªºÃöÁä¥Ø¼Ð¡C ------------------------------------------------------------------------------------------------ ·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 08:53:28²Ä 3750 ½g¦^À³ SNP-610/SNP-630(CYP2E1¹Lªí¹F§í¨îHepG2²ÓM¤¤·L²ÉÅéCa 2+ ATP¡A¥i¯à·|¾ÉP¶túAªºÅܤơC) ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/10/22 ¤W¤È 09:59:53²Ä 3494 ½g¦^À³ ¤T´â½©¿}¬OT1R3¿E°Ê¾¯.... ---------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/8/9 ¤U¤È 07:55:54²Ä 3380 ½g¦^À³ SNP-6ÃĪ«¿ï¦Û:[¸t¯ó×ô]¡B[¥ÌÅS¾J]¡BÁ¡²ü¾J¡B[¤T´â½©¿}]¡B |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 08:53:28²Ä 3750 ½g¦^À³
|
SNP-610/SNP-630(CYP2E1¹Lªí¹F§í¨îHepG2²ÓM¤¤·L²ÉÅéCa 2+ ATP¡A¥i¯à·|¾ÉP¶túAªºÅܤơC) (¬ì´¶)¹¦w±þ¤â¡u¨¹§J¦C»Ä(¦Ì»Ãµß»Ä)¡v¬°¦óP©R¡H www.taic.mohw.gov.tw/?aid=509&pid=88&page_name=detail&type=1142&iid=4577 ¨¹§J¦C»Ä(BA)¬O±j¯Pªº¬r¯À...¤HÃþ¥un·L¶q(1-1.5 mg)§Y¥i¯àP©R¡C BAP¦ºªº¾÷Âà¥Dn³z¹L¤zÂZ½u²ÉÅ餺³¡ªºATP(¤TÁC»Ä¸¢苷)Â÷¶}²É½uÅé°ò½èªº¹Lµ{¡CATP¬O²ÓM¤º³Ì¥Dnªº¯à¶q¨Ó·½¡A¥Î¥Hºû«ù²ÓM¥\¯à©M¥Í©R¬¡°Ê... ----------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2023/5/4 ¤W¤È 11:26:12²Ä 3154 ½g¦^À³ 2023.5.4-°I°h³t«×´î½w35% §¨Óªü¯÷®üÀq¯g·sÃıN³t°e¼f! ªüº¸¯ý®üÀq¯fªº[¶t]°²»¡!!! ... 1.2002--¶t©M¶t¿E¬¡³J¥Õ酶¦b HEPG2 ²ÓM¤¤ CYP2E1 ¨Ì¿à©Ê¬r©Ê¤¤ªº§@¥Î 2.2009--CYP2E1 ¹Lªí¹F§í¨îHepG2 ²ÓM¤¤·L²ÉÅé Ca 2+ ATP 酶¬¡©Êwww.ncbi.nlm.nih.gov/pmc/articles/PMC2650832 .... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 08:26:19²Ä 3749 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/31 ¤U¤È 09:25:02²Ä 3747 ½g¦^À³ 2024.2.22-¨àµ£¤£©úì¦]«æ©Ê¨xª¢¡G§Ú̬O§_À³¸Ó±N°Q½×±q¯Âºéªº¶Ç¬V©Êì¦]Âà¦V¨ä¥L¥i¯àªºì¦]¡H ...§ÚÌ«Øij¡A¦b¥¼¨ÓªºÄY«AHUO(ÄY««æ©Ê¨xª¢)¯f¨Ò¤¤¡A°£¤F¯f¬r¾Ç¬ã¨s¥~¡AÁÙÀ³³q¹L¹ï¤AñQ®ò°ò×ô[¼ÉÅS¥Íª«¼Ð»xª«]ªº´ú¶q¨ÓÃÒ¹ê¹ï¤AñQ®ò°ò×ôªº¾¯¶q¡A¨Ã¥BÀ³§ó¸Ô²Ó¦aÀˬd©Ò¥Î»s¾¯ªºÃþ«¬©M¨Ó·½¡C ------------------------------------------------------------------------------------------------ ¸É¥R»¡©ú: 1.¦p¤W«Øij¡A2021~2022¦~µo¥Í¨àµ£AHUO®É¡A¥i±À¦ô·í¤U¨SÀË´úAPAPªº[¼ÉÅS¥Íª«¼Ð»xª«]¡A¦]¦¹§Ú»¡Äa®×¾÷²v°ª! 2.¨x¬r©Ê¤§¥NÁª«AAP-Cys adducts¿@«×¤ÎAAP-Cys¿@«×©ó©Ò¦³¾¯¶q²Õ§¡¥¼¹F¨x¬r©Ê¼Ð·Ç-->¦p¯à¤½¥¬¼Æ¾Ú§ó¦n! ¦]¬°APAP-CYS¬OAPAP¼ÉÅSªº¯S²§©Ê¥Íª«¼Ð°O¡C APAP-CYS ¿@«×>1.1 nmol/ml¤w³Q«Øij§@¬° ALT >1000 IU/L ±wªÌ¹ï¤A ñQ®ò°ò×ô¹L¶q¾ÉP¨x·l¶Ëªº¼Ð°O¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/6/1 ¤U¤È 01:00:55²Ä 3748 ½g¦^À³
|
µL¨x¬rSNP-810(12g) VS. ¦³¨x¬rAPAP(4g)ªº[¾î¦V¤ñ¸û]: 1.SNP-810-ALT¤É°ª¤j©ó3~8¿¥¿±`ȤW¤§¤ñ¨Ò¬°0% 2.SNP-810¦³2¦ìALT®pȶW¹L2¿¥¿±`È¡C(¦³¨x¬rAPAP4§Jªº¦w¼¢¾¯²Õ¦³1¦WALT®pȤ]¶W¹L2¿) 3.¨x¬r©Ê¤§¥NÁª«AAP-Cys adducts¿@«×¤ÎAAP-Cys¿@«×©ó©Ò¦³¾¯¶q²Õ§¡¥¼¹F¨x¬r©Ê¼Ð·Ç-->¦p¯à¤½¥¬¼Æ¾Ú§ó¦n! 4.FDA Drug Hepatotoxicity Steering Committee: Hepatocellular DILI(ÃĪ«©Ê¨x·l¶Ë) is characterised by an alanine aminotransferase (ALT) ≥3 times the upper limit of normal (ULN) and ALT/alkaline phosphatase (ALP) ratio ≥5 times ULN; cholestatic DILI by an ALP ≥2 times ULN and ALT/ALP ratio of ≤2 times ULN; and mixed DILI with ALT ≥3 times ULN, ALP ≥2 times ULN and ALT/ALP ratio <5 but >2 times ULN ¨x·l®`¤@¯ë©w¸q«üALT¶W¹L¥¿±`數ȤWªº3¿¥H¤W¡A§Y¶W¹L>3¿³q±`³Q»{¬°¨ã¦³Á{§É·N¸q¡C ¦³Á{§É·N¸q¡]CS¡^«üÀˬd¼ÆÈ©M¥¿±`¼Ð·ÇȦ³®t²§¡A¹ïÁ{§É¯e¯fªº¶EÂ_¨ã¦³¤@©wªº°Ñ¦Ò»ùÈ¡C µLÁ{§É·N¸q¡]NCS¡^´N¬O«üÀˬd¼ÆȪº²§±`¡A¥i¯à¥Ñ©ó¥Í²z©Î¥¿±`±¡ªp¤U¥X²{ªºÅܤơA¹ï¶EÂ_¯e¯f¨S¦³§PÂ_¨Ì¾Ú©M»ùÈ¡C µ²½×:µL(§C)¨x¬r¸ÕÅ禨¥\¡C --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/2/10 ¤U¤È 03:51:12²Ä 3648 ½g¦^À³ ...2006.7.5--°·±d¦¨¤H¨C¤Ñ±µ¨ü(4§J)(4§J)(4§J)¹ï¤AñQ®ò°ò×ôªºÂà®ò酶¤É°ªÀH¾÷¹ï·Ó¸ÕÅç jamanetwork.com/journals/jama/fullarticle/211014 µ²ªG:±µ¨ü¦w¼¢¾¯ªvÀøªº 39 ¦W°Ñ»PªÌ¤¤¡A¨S¦³¤@¤Hªº³Ì°ª ALT ȶW¹L¥¿±`¤Wªº 3 ¿¡C ¨C¤Ñ¤fªA 4 §J¹ï¤AñQ®ò°ò×ôªº 106 ¦W±wªÌ¤¤..53% ªº ALT ¤ô·Ç®pȤj©ó 2 ¿ ULN¡A39% ¤j©ó 3 ¿ (>120 U/L)¡A 25% ¤j©ó 5 ¿ (>200 U/L)¡A8 % ¤j©ó8 ¿( >320 U/L) |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/31 ¤U¤È 09:25:02²Ä 3747 ½g¦^À³
|
2024.2.22-¨àµ£¤£©úì¦]«æ©Ê¨xª¢¡G§Ú̬O§_À³¸Ó±N°Q½×±q¯Âºéªº¶Ç¬V©Êì¦]Âà¦V¨ä¥L¥i¯àªºì¦]¡Hwww.tandfonline.com/doi/full/10.1080/21505594.2024.2318582 ..¤H̤£¸Tn°Ý¡AAAV2 ¡Ó ¸¢¯f¬r©Î¨ä¥L¯f¬r¬O§_·|¾ÉP»´·L¨xª¢¡A¦Ó³oºØ»´·L¨xª¢¤S¬O§_·|¦]a) §t¦³DEG ©Î¨ä¥L¦Ã¬Vª«ªº¦H½è/°²«_¼³¼ö®§µh§å¦¸¡A©M/©Îb) §t¦³¤£¨ü±±¨îªº¸û°ª¿@«×¬¡©Ê¦¨¤À... ------------------------------------------------------------------------------------------- ¦¥ý±À©w¨àµ£¤£©úì¦]«æ©Ê¨xª¢¬O¸¢¯f¬r·P¬V¤Þ°_¡A¦s¦³«Ü¤jª§Ä³¡A¥ÙÀYÂà¦V¦³¨x¬rAPAP! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/31 ¤U¤È 07:49:05²Ä 3746 ½g¦^À³
|
2021~2022¦~¥þ²yÃzµo¡§¤£©ú¨àµ£¨xª¢¡¨¬Ì±¡¡AÄa®×¾÷²v°ª! ¤£¹L¤@¥¹½T»{º×º´N¬O¦³¨x¬rAPAP¡AµL¨x¬rSNP-810???(¬ü°ê109¨Ò¨àµ£¡A5Ó¦º¤`¯f¨Ò 10%«Ý¨xŦ²¾´Ó) 2024.2.19-¼³¼ö®§µh¬O¤£©úì¦]«¯g«æ©Ê¨xª¢«÷¹Ï¤¤¯Ê¤Öªº¤@¶ô¶Ü¡H www.journalofinfection.com/article/S0163-4453(24)00061-6/fulltext --------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/29 ¤W¤È 08:23:21²Ä 3733 ½g¦^À³ APAP¥i¯à¬O2021~2022¦~¥þ²yÃzµo¡§¤£©ú¨àµ£¨xª¢¡¨¬Ì±¡ªº¥Dn¶ûºÃ¹ï¶H! ---------------------------------------------------------------------------------------------- 1.2022.5.6-¬ü°ê¯e¯fºÞ¨î¹w¨¾¤¤¤ß(CDC)6¤éªí¥Ü¡A¥¿¦b½Õ¬d¥þ¬ü109¨Ò¨àµ£¤£©úì¦]¨xª¢¯f¨Ò¡A¨ä¤¤¥]¬A5Ó¦º¤`¯f¨Ò¡C 2.2023.7.-27-¤p¨à«æ©Ê¨xª¢©M¼³¼ö®§µhªºªvÀø¾¯¶qonlinelibrary.wiley.com/doi/10.1111/apa.16920 .....¦]¦¹¦b½TÆwÃÒ¾Úªí©ú±¡ªp¨Ã«D¦p¦¹¤§«e¡A¼³¼ö®§µh¤´µM¬O¦¹¦¸¬Ì±¡Ãzµoªº¥Dn¶ûºÃ¹ï¶H¡C 3 2023.10.11-Ãö©ó¼³¼ö®§µh¨x¬r©Êªºª§½×¤´¦bÄ~Äò(¬ü°ê¨à¬ìÂå¾Ç·|) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/5/31 ¤U¤È 04:31:15²Ä 3745 ½g¦^À³
|
¤½¥q¬£¤]§Ö¥h¥´¼s§i¡A©ñ¦b´¶x¯k¼s§iªº«á± ¹³¥H«eªü«ó¨à¤l¶}¦W¨®¡A»¡¶R¤£°_ªº¼s§i¤@¼Ë ============================== ¦¿¦u¤sÂå®v 2023.11.28 ¤£n¦A»¡´¶®³¯k(¤AñQÓi×ô)¨S¦³µÇ¬r©Ê¤F ÁöµM¥¦¥Dn¬O¥Ñ¨xŦ¥NÁ¡A¦ý¬OµÇŦ¤£¥þªº¯f¤H¥Lªº¨xŦ¥NÁÂ¥H¤AñQÓi×ôªº¯à¤O¬O¤U°ªº¡A¦Y¥¿±`ªº¶q¤]·|¹L¶q¡AµM«á´N¶}©l¥X²{µÇ¥\¯à°I°hªº°ÝÃD¡C ¥X³B¡GNaunyn Schmiedebergs Arch Pharmacol . 2023 Jul 12 «ØijµÇŦ¯fªº¯f¤H¦pªG¦³¥ô¦ó»Ýn¤îµh°h¿NªºÁÙ¬O¥h§ä§AªºµÇŦ¬ìÂå®v¡A»OÆW°·«O¤w¸g¤Ó«K©y¤F¤£¥Î¦Û¤v·íÂå¥Í¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/31 ¤U¤È 04:27:53²Ä 3744 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/6 ¤U¤È 04:40:05²Ä 3608 ½g¦^À³ 2023.10¤ë--P450 ²´·ú¬ã¨sªº¬D¾Ô»P¾÷¹J www.ncbi.nlm.nih.gov/pmc/articles/PMC10506698/ ¦b¤HÅ餤µo²{ªº 57 ºØ²ÓM¦â¯À P450 »Ã¯À¤¤¡A¦Ü¤Ö¦³ 30 ºØ¥H²´³¡²Õ´§@¬°ªí²{¦ìÂI¡CµM¦Ó¡A¹ï³o¨Ç P450 ¦b²´·ú¤¤ªº§@¥Îªº¤F¸Ñ¦³¡A³¡¤Àì¦]¬O¥u¦³·¥¤Ö¼Æ P450 ¹êÅç«Ç±N¨ä¬ã¨s¿³½ìÂX®i¨ì²´·ú¬ã¨s¡C¦]¦¹¡A¥»½gºîzªº¥Øªº¬O¤Þ°_ P450 ¬É¹ï²´·úªºÃöª`¨Ã¹ªÀy§ó¦hªº²´³¡¬ã¨s... ------------------------------------------------------------------------------------------------ ¦¶¸³ ¬Ý¹L¨Ó! ¬Ý¹L¨Ó--->2023.10¤ë--P450²´·ú¬ã¨sªº¬D¾Ô»P¾÷¹J (P450 2E1=CYP2E1) «e¤ÑMerck¯{30»õ¬ü¤¸¦¬Áʲ´¬ìÃĪ«¶}µo°ÓEyeBio(¤ä¥I13»õ¬ü¤¸ªº²{ª÷+ 17»õ¬ü¤¸ªº¥¼¨Ó¨½µ{¸O¦¡¥I´Ú) |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/5/31 ¤U¤È 02:11:57²Ä 3743 ½g¦^À³
|
°ê¨¾Â媺§Öª§¤@¤f®ð¡A¥´Áy¤£¬Ý¦nªº¤H usd20¦¬ÁÊ¡A¦¨¬°¥xÆW¤§¥ú~~~ ±M§Q«OÅ@¦n¡A¤£µM¦A¦hªº¾AÀ³¯g³Q¾ã¸J®³¨« ¤G¤Ñ¦^¨ì7¦rÀY¡A¨ë¿E~ =========================================== ªYÄ£¦n¦n±´¯Á¥ÌÅS¾J+¤T´â½©¿}ªvÀø[²´¯e]ªº·s¾AÀ³¯g¡A¦h°µ¤@¨Ç·s¾AÀ³¯g§â»æ°µ¤j«Ü«n!!! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/31 ¤W¤È 08:50:16²Ä 3742 ½g¦^À³
|
ªYÄ£¦n¦n±´¯Á¥ÌÅS¾J+¤T´â½©¿}ªvÀø[²´¯e]ªº·s¾AÀ³¯g¡A¦h°µ¤@¨Ç·s¾AÀ³¯g§â»æ°µ¤j«Ü«n!!! ¬Ý¬Ý2024¦~4¤ë¼w°ê³o½g±´°Q¹ï[±wªÌ]©M¤p¹«ªººî¦X¬ã¨sµ²½×: ¿}ºë¦ü¥G¹ï±µ¨ü¬Á¼þÅ餺§Ü VEGF ªvÀøªºnAMD[±wªÌ]µo´§«OÅ@§@¥Î¡A¦³§U©ó§ó¦n¦a±±¨î¯f²z¯fÅÜ©M´î¤Ö¬Í²ª... -------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/11 ¤U¤È 10:05:04²Ä 3684 ½g¦^À³ ¤H¤u²¢¨ý¾¯¥i¯à¦¨¬°ªvÀø²´¯eªºÃĪ«? 2024.4¤ë¼w°êµoªíªº¬ã¨s: ±´°Q[¿}ºë]¹ï·s¥Í¦åºÞ©Ê¦Ñ¦~¶À´³³¡¯fÅܪº¼vÅT¡G¹ï±wªÌ©M¤p¹«ªººî¦X¬ã¨swww.ncbi.nlm.nih.gov/pmc/articles/PMC10996979/ ...Á`¤§¡A§ÚÌ»{¬°§Ú̪º¬ã¨sµ²ªG¬°¿}ºë¡]¥H¤Î¨ä¥L¥i¯àªº¤H¤u²¢¨ý¾¯¡^§@¬°²´·ú·s¥Í¦åºÞ¯e¯fªº¼ç¦b½w¸Ñ¾¯´£¨Ñ¤F¥t¤@ӰѦҡA¨Ã¥B¬O·s¥Í¦åºÞ©Ê¦Ñ¦~¶À´³³¡¯fÅܤ¤ªº²Ä¤@ÓÁ{§ÉÃÒ¾Ú.... ------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/8 ¤W¤È 07:29:11²Ä 3612 ½g¦^À³ 2018.10.23- ¤H¤u²¢¨ý¾¯¦p¦ó´î¤Ö¿}§¿¯f¬ÛÃöªº²´³¡¦åºÞ·l¶Ë link.springer.com/article/10.1007/s00417-018-4157-8 ...§Ú̶i¤@¨BÃÒ©ú¡A[¤T´â½©¿}]¥i´î®z VEGF »¤¾Éªº Akt ÁC»Ä¤Æ¡A¶i¦Ó«OÅ@µøºô½¤·L¦åºÞ¨t²Î¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/31 ¤W¤È 08:30:44²Ä 3741 ½g¦^À³
|
Merckªºº¥Iñ¬ùª÷13»õ¬ü¤¸¡AªYÄ£¬O¸Ó±´¯Á¬Ý¬Ý¥ÌÅS¾J+¤T´â½©¿}ªýÂ_ VEGF ªº«ùÄò©Ê(@¥Î)®ÄªG! ------------------------------------------------------------------------------------------- EyeBio º®uÂåÀø©x Jonathan Prenner Âå¾Ç³Õ¤hªí¥Ü¡G¡§AMARONE ¸ÕÅ窺±Ò°Ê¼Ð»xµÛ§Ų́ϩRªº¤@Ó«n¨½µ{¸O¡A§Ú̪º¨Ï©R¬O¸Ñ¨M·s¥Í¦åºÞ©Ê¦~ÄÖ¬ÛÃö©Ê¶À´³ÅÜ©Ê©M¿}§¿¯f©Ê¶À´³¤ô¸~±wªÌ¥¼º¡¨¬ªº¢¤Á»Ý¨D¡C¡¨ ¡u¾¨ºÞ¨Ï¥Î§Ü VEGF ÃĪ«¶i¦æªvÀø¡A¦ý¤´¦³¶W¹L 60% ªº±wªÌ¹w«á¤£¨Î¡A¶W¹L 30% ªº±wªÌ±w¦³¬¡°Ê©Ê¯e¯f¡C Restoret ¥i¯à´£¨Ñ¤@Ó¾÷·|¨Ó¬ð¯}§Ṳ́w¸g¹F¨ìªº§Ü VEGF ªvÀø¼Ð·ÇªºÀø®Ä¤W¡C ¡uªñ¤G¤Q¦~¨Ó¡A§Ü VEGF ³æ¤@Àøªk¤@ª½¬Oµøºô½¤¦åºÞ¯e¯fªº¶Àª÷¼Ð·Ç¡A§ÚÌ«Ü°ª¿³¬ã¨s·s³~®|ªº¼vÅT¡A¡vYsasaga ³Õ¤h»¡¡C ¡u§Ú̧Ʊæ Restoret ¯à°÷¥Nªí¤@±ø·s³~®|¡A¶W¶V§Ú̦bÅ@²z¼Ð·Ç¤è±©Ò¹F¨ìªº¤W¡C@¥Î©Ê¤´µM«Ü«n¡A§ÚÌ«Ü°ª¿³¯à°÷¶i¦æ¬ã¨s¥H´£°ª¥\®Ä©Mµø¤O¡A³o¬O§Ú̪º³Ì²×¥Ø¼Ð¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/30 ¤U¤È 09:18:51²Ä 3740 ½g¦^À³
|
2024.5.29--Merck¯{30»õ¬ü¤¸¦¬Áʲ´¬ìÃĪ«¶}µo°ÓEyeBio(¤ä¥I13»õ¬ü¤¸ªº²{ª÷+ 17»õ¬ü¤¸ªº¥¼¨Ó¨½µ{¸O¦¡¥I´Ú) Merck ±NÀò±o¨äµøºô½¤¯e¯fÃĪ« Restoret ªº¨Ï¥ÎÅv¡C Eyebio¬O¦¨¥ß¶È3¦~ªº·s³ÐBiotech ®Ö¤ßºÞ½uRestoret¬O¤@´Ú¡§FIC¡¨¡A¬O¤T¯S²§©Ê§ÜÅé¡C¨äÀuÂI¦b©ó¡A¬Û¸û©ó¶Ç²Î³z¹LªýÂ_VEGFªº¤è¦¡¡A´î¤Ö²§±`¦åºÞ¥Í¦¨©Mº¯º|¡A±q¦Ó´î½w¯e¯f¶i®i¨Ã§ïµ½µø¤O¡FRestoret«h¬O³z¹L¿E¬¡Wnt°T¸¹³q¸ô¡A±q¦Ó«P¶iµøºô½¤²ÓMªº¦A¥Í©Î«OÅ@¡C -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/1/9 ¤W¤È 09:47:23²Ä 3619 ½g¦^À³ ....¦b³o¨Ç±w¦³µøºô½¤¯fÅܪº±wªÌ¤¤¡A«D±`»Ýn¦Ò¼{´À¥Nªº¼ç¦bªvÀø¤èªk¨Ó°§Cµøºô½¤·L¦åºÞ¨t²Îªº³q³z©Ê©M¦åºÞ¥Í¦¨¡C¦b¥»¬ã¨s¤¤¡A§ÚÌÃÒ©ú [¤T´â½©¿}]¥iªýÂ_ VEGF »¤¾Éªº³q³z©Ê©M¦åºÞ¥Í¦¨¹Lµ{¡C -------------------------------------------------------------------- ¥ÌÅS¾J+¤T´â½©¿}ªýÂ_ VEGF »¤¾Éªº³q³z©Ê©M¦åºÞ¥Í¦¨¡A¥i¯àÀu©ó³æ¤è¤T´â½©¿}??? |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/30 ¤W¤È 05:32:00²Ä 3739 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2022/9/1 ¤U¤È 08:52:35²Ä 2370 ½g¦^À³ SNP-810µLµÇ¬r©Ê³oÓÀuÂI¡A¹ï©ó·m§ðNSAIDs¡]«DÃþ©T¾J®øª¢¤îµhÃÄ¡^ªº¥«³õ¥÷ÃB¤j¦³§U¤O! ¤îµhÃį}ÃaµÇŦ«OÅ@¾÷¨î!!! www.commonhealth.com.tw/article/74087 ½Ð·V¥Î¤îµhÃÄ¡IµÇŦ¬ì¦WÂå¨Iµh§i¥Õ -------------------------------------------------------------------------------------- ¤é«e¤@¦W°ü¤H¦]ºC©Ê°¾ÀYµh¡AªA¥Î¤îµhÃĪø¹F10¦h¦~¡A³Ì«áÅܦ¨¶·¬~µÇ¡A¬Æ¦Ü¦b¬~µÇ®É¦]ÀYµh¤S¦Y¤îµhÃÄ.... ¡u¿Ë·RªºÂå¥Í¡G³o¦ì±wªÌ¦³ºC©ÊµÇ¯f¡]µÇ¯f´Á¼Æ3b¡BµÇ¥\¯à«ü¼Æ38ml/min/1.73¢T¡^¡A½Ð¤Å¶}¥ßNSAIDs¡]«DÃþ©T¾J®øª¢¤îµhÃÄ¡^¡A¦ýAspirin¤ÎAcetaminophen¥i¾A¶q¨Ï¥Î¡A¥HÁקK¼vÅTµÇ¥\¯à¡C¸Û¼°·PÁ¡C¡v ¥Î¤¤^¤å¿Ëµ§¤â¼g«K±ø¯È¡A¬OµÇŦ¬ì¦WÂå¡B¤¤°êÂåÃĤj¾Çªþ³]Âå°|°Æ°|ªø¶À¬îÀA³Ì²`«ªº°U¥I»P¥mÀ{¡C ¡u§Ú´N³o¼Ë¼g¡A¤@±i±i¼gµ¹«DµÇŦ¬ìÂå¥Í¬Ý¡A¡v¶À¬îÀA¥Î¤O¦a»¡¡AµÇŦ¬ìÂå¥Í¦³³d¥ô´£¿ô«DµÇŦ¬ìÂå®v¡C ¦]¬°¦o¬Ý¹L¤Ó¦h¦³ºC©ÊµÇŦ¯fªº¤H¡A¦]¬°·P«_¥þ¨µmµh¥h¡u¦Q¤jµ©¡]ÂIºw¡^¡v¥[¤W¥´¤îµh°w¡Aµ²ªGµÇ«ü¼ÆÅÜ®t¬Æ¦Ü²£¥ÍÄY«µÇ°IºÜ.... «DÃþ©T¾J®øª¢¤îµhÃÄ¡]Nonsteroidal anti-inflammatory drugs¡ANSAIDs¡^¦]¦P®É¨ã¦³¤îµh¤Î§Üµoª¢®ÄªG¦Ó³Q¼sªx¨Ï¥Î©óÃö¸`ª¢¤Î¦UºØ¯kµh¤W¡A¦p¾Ç¦WÃÄIbuprofen¡BNaproxen¡BCelecoxib¡BKetoprofenµ¥¡A³oÃþÃĪ«·|§í¨î«e¦C¸¢¯ÀE¦X¦¨¡A¯}ÃaµÇŦ¦Û§Ú«OÅ@¾÷Âà¡A³y¦¨µÇ°IºÜ¡A¤]·|¯}ÃaµÇ¤pºÞ¡A¤Þµo¶¡½è©ÊµÇª¢.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/29 ¤U¤È 06:37:46²Ä 3738 ½g¦^À³
|
¦¿¦u¤sÂå®v 2023.11.28 ¤£n¦A»¡´¶®³¯k(¤AñQÓi×ô)¨S¦³µÇ¬r©Ê¤F ÁöµM¥¦¥Dn¬O¥Ñ¨xŦ¥NÁ¡A¦ý¬OµÇŦ¤£¥þªº¯f¤H¥Lªº¨xŦ¥NÁÂ¥H¤AñQÓi×ôªº¯à¤O¬O¤U°ªº¡A¦Y¥¿±`ªº¶q¤]·|¹L¶q¡AµM«á´N¶}©l¥X²{µÇ¥\¯à°I°hªº°ÝÃD¡C ¥X³B¡GNaunyn Schmiedebergs Arch Pharmacol . 2023 Jul 12 «ØijµÇŦ¯fªº¯f¤H¦pªG¦³¥ô¦ó»Ýn¤îµh°h¿NªºÁÙ¬O¥h§ä§AªºµÇŦ¬ìÂå®v¡A»OÆW°·«O¤w¸g¤Ó«K©y¤F¤£¥Î¦Û¤v·íÂå¥Í¡C ---------------------------------------------------------------------------------------------- SNP-810:¥ÌÅS¾J+¤T´â½©¿} +APAP --->¥ÌÅS¾J¦b¥@¬É¬Y¨Ç¦a°Ï¤´µM¬O«æ©ÊµÇ°IºÜªºªvÀø¤èªk! |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/29 ¤U¤È 06:31:08²Ä 3737 ½g¦^À³
|
SNP-810:¥ÌÅS¾J+¤T´â½©¿} +APAP ¥ÌÅS¾J¦b¥@¬É¬Y¨Ç¦a°Ï¤´µM¬O[«æ©ÊµÇ°IºÜ]ªºªvÀø¤èªk¡A¤×¨ä¬O¦Ù¬õ³J¥Õ§¿«¬µÇ°IºÜ¡C 1. Mannitol therapy revisited (1940¡X1997) www.kidney-international.org/article/S0085-2538(15)60249-6/pdf 2.2023.7.10-¥L¦Ù¦×¯kµh³º®tÂIn¬~µÇ(¹B°Ê«á§¿²G¥X²{¡u³o1¦â¡v®£P©R) health.udn.com/health/story/5975/7284658 ¾î¯¾¦Ù·»¸Ñ¯g.... -------------------------------------------------------------------------------------------------- ·|û¡Gdk10140377 µoªí®É¶¡:2024/5/14 ¤U¤È 02:54:21²Ä 3731 ½g¦^À³ ´¶x¯k¼s§i¤@ª½¸õ¥X¨Ó[µÇ¬ì]Âå¥Í±¾«Oµý24¤p®É±Æ¥XÅé¥~¡A³o¼ËªYÃĤ£¬Ogg~~~~ |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/5/29 ¤U¤È 05:06:13²Ä 3736 ½g¦^À³
|
°ò¥»±¤S©MªÑ»ù²æ¤Ä~~ ¤@¤é¦æ±¡¡A¬°ªÑªF̸¨²\ ¹q¤l¡Betf³£¸¤Ñ¤F¡A³o¶¡¯}§C¤S¯}§C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/29 ¤W¤È 08:49:31²Ä 3735 ½g¦^À³
|
2023.10.11-Ãö©ó¼³¼ö®§µh¨x¬r©Êªºª§½×¤´¦bÄ~Äò(¬ü°ê¨à¬ìÂå¾Ç·|) ...³o¨Ç¨àµ£¦b¦h¦¸µL·N¡Bpºâ¿ù»~¡B[¶WªvÀø¾¯¶q]ªº¹ï¤AñQ®ò°ò×ô«á¥X²{¼Éµo©Ê¨x°IºÜ J&JªºMcNEIL¼¶¼gªº¹ï¤AñQ®ò°ò×ô¹L¶qºÞ²z«ü«n--¶WªvÀø¶qÄá¨ú! -------------------------------------------------------------------------------------------------- ·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/20 ¤W¤È 11:48:05²Ä 3704 ½g¦^À³ ·s¼W(10g)¥H¤W12¤H¡A¤jÃļtn¬Ý? ¹ï¤AñQ®ò°ò×ô¹L¶qºÞ²z«ü«n (With support from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc) .....ºC©Ê¹L¶qÄá¨ú³QºÙ¬°«½Æ¶WªvÀø¶qÄá¨ú¡]RSTI¡^ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/29 ¤W¤È 08:37:50²Ä 3734 ½g¦^À³
|
2022.4.26-ªñ´Á¼Ú¬üµ¥¦a°Ïµo²{¨àµ£ÄY«¤£©úì¦]¨xª¢Ó®×²§±`¼W¥[¡AÆ~½ÐÂå®v¹ï¨àµ£¤£©úì¦]¨xª¢Ó®×´£°ªÄµÄ±¡A¥[±j¶EÂ_³q³ø(¯e¯fºÞ¨î¸pPÂå¬É³q¨ç²Ä476¸¹) -------------------------------------------------------------------------------------------------- APAP¬O¥Dn¶ûºÃ¹ï¶H¡A¤@¥¹½T»{´N¬OÄY«¨xª¢¯u¥û¡AÀ³¸Ó¦³¦nÀ¸¤W³õ~ |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/29 ¤W¤È 08:23:21²Ä 3733 ½g¦^À³
|
APAP¥i¯à¬O2021~2022¦~¥þ²yÃzµo¡§¤£©ú¨àµ£¨xª¢¡¨¬Ì±¡ªº¥Dn¶ûºÃ¹ï¶H! ---------------------------------------------------------------------------------------------- 1.2022.5.6-¬ü°ê¯e¯fºÞ¨î¹w¨¾¤¤¤ß(CDC)6¤éªí¥Ü¡A¥¿¦b½Õ¬d¥þ¬ü109¨Ò¨àµ£¤£©úì¦]¨xª¢¯f¨Ò¡A¨ä¤¤¥]¬A5Ó¦º¤`¯f¨Ò¡C ¥þ²y¦U¦a³Ìªñ³q³ø¥X²{¨àµ£¤£©úì¦]·P¬V«æ©Ê¨xª¢ ... 2.2023.7.-27-¤p¨à«æ©Ê¨xª¢©M¼³¼ö®§µhªºªvÀø¾¯¶qonlinelibrary.wiley.com/doi/10.1111/apa.16920 ...¦b·¥¤Ö¼Æ±¡ªp¤U¡A¼³¼ö®§µh©M¸¢¯f¬r·P¬V¤§¶¡¬O§_·|²£¥Í¬YºØ¨ó¦P§@¥Î¡H¤£©¯ªº¬O¡A«Ü¤Ö¦³¤H½èºÃ·P¬V´Á¶¡ªº«Øij¾¯¶q ¬O§_·|¤Þµo¨xª¢¡C ....¦]¦¹¦b½TÆwÃÒ¾Úªí©ú±¡ªp¨Ã«D¦p¦¹¤§«e¡A¼³¼ö®§µh¤´µM¬O¦¹¦¸¬Ì±¡Ãzµoªº¥Dn¶ûºÃ¹ï¶H¡C 3 2023.10.11-Ãö©ó¼³¼ö®§µh¨x¬r©Êªºª§½×¤´¦bÄ~Äò(¬ü°ê¨à¬ìÂå¾Ç·|) onlinelibrary.wiley.com/doi/full/10.1111/apa.16992 ±q 2021 ¦~©³º¦¸Äµ³ø¨ì 2022 ¦~ 9 ¤ë´Á¶¡¡A37 Ó°ê®a©Î¦a°Ï³ø§i¤Fªñ1300¨Ò¤£©ú¨Ó·½ªº¤p¨à«¯g«æ©Ê¨xª¢¯f¨Ò¡C¥O¤H¶O¸Ñªº¬O¡A¯f¨Ò¤§¶¡¨S¦³¤@Pªº¬y¦æ¯f¾ÇÃöÁp¡A¦b³\¦h°ê®a¡Aµo¯f²v¨S¦³¼W¥[¨ì¶W¹L¹w´Á°ò½u¡C¤j¦h¼Æ¨àµ£±d´_¡A¦ý¦³¨Ç¨àµ£¥X²{¨x°IºÜ¡A55 ¦W¨àµ£»Ýn¶i¦æ¨xŦ²¾´Ó¡A29 ¦W¨àµ£¦º¤`¡C©¯¹Bªº¬O¡A2022 ¦~¬Ì±¡Ãzµo«á¯f¨Ò¼Æ¶}©l°±º¢¡A¨Ã¤U°¦Ü COVID-19 ¤j¬y¦æ¤§«eªº¤ô¥ ...³o¶µÄµ§i»P¦h¶µÃö©ó¨àµ£«æ©Ê¯f¬r¼Ëµo¿N©Ê¯e¯fªº¬ã¨s¬Û²Å¡A³o¨Ç¨àµ£¦b¦h¦¸µL·N¡Bpºâ¿ù»~¡B¶WªvÀø¾¯¶qªº¹ï¤AñQ®ò°ò×ô«á¥X²{¼Éµo©Ê¨x°IºÜ ----------------------------------------------------------------------------------------- ¦Ü¤µ¨S§ä¨ì¯u¥¿ì¦]¡A§â°²ÃĤ]¦C¥i¯à©Ê¡A¬Ý¨Ó¦¨Äa®×¾÷²v°ª! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/5/28 ¤W¤È 09:41:00²Ä 3732 ½g¦^À³
|
´M´M³V³V¡A§N§N²M²M¡A²Y²YºGºG±± ¨S¤Hª`·N¤]¬O¦n¨Æ?! |
|
|
·|û¡Gdk10140377 µoªí®É¶¡:2024/5/14 ¤U¤È 02:54:21²Ä 3731 ½g¦^À³
|
´¶x¯k¼s§i¤@ª½¸õ¥X¨ÓµÇ¬ìÂå¥Í±¾«Oµý24¤p®É±Æ¥XÅé¥~¡A³o¼ËªYÃĤ£¬Ogg~~~~ ¥´¤£¹L¤F¡A¤j¾ð³£¨S¦³¤F |
|
|
·|û¡G´MÄ_10151381 µoªí®É¶¡:2024/5/9 ¤U¤È 08:52:31²Ä 3730 ½g¦^À³
|
¬°¦ó¤£¥ý§â¢Ý¢â¢Ñªº³q¸ô·d©w©Î±ÂÅv·í¦a¸g¾P°Ó¥h°µ¡H µwn°µ³B¤èñ¥ÎÃÄ¡A¦A¸g¾úº©ªøªº¤T´ÁÁ{§É? ¤£n»¡¬ü°êªº¢Ý¢â¢Ñ¦³¦h¤j¡A¥þ²yªº¢Ý¢â¢Ñ©O¡H ¢Ý¢â¢Ñ¬O¶i¥i§ð¡A°h¥i¦uªº³Ì¨Î¾Ô²¤¡A ¯uªº¬O§â¤@¤â¦nµP¥´Äꪺ¤½¥q¡C ¤£µ¹°ê»Ú¤j¼tÀ£¤O¡A¥¦´N¯ÓµÛµ¥¡Aµ¥§Aªº±M§Q¶V¨Ó¶V¨S¦³»ùÈ¡C |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/9 ¤U¤È 05:02:15²Ä 3729 ½g¦^À³
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/4/3 ¤U¤È 09:00:02²Ä 3682 ½g¦^À³ ...ÄCÀY¦Y¤Ó¦h¡A°Æ§@¥Î¬OÀY©ü²´ªá@... ------------------------------------------------------------------------------ ¦³¬q¶c¨Æ¡AªYÄ£¤é«á¥¿±¦V¤W§Ú¦A»¡¡A¤Ï¤§´N¬O§¾¸Ü¨S¥²n¦AÁ¿¡I ---------------------------------------------------------------------------------- §Ú¤£·R²q´ú½Ö¶R½æªÑ²¼¡A»F¦]¦P¾Ç·|ÄCÀY¤jªº¿ù»~µo¨¥(§â¼W¥[74.5±i»¡¦¨´î¤Ö)¡A¦]§Ú¨S¦b¦P¾Ç·|µù¥U¡A¤è¦b³o¶K¤å¼á²M¡C ¦]¬°¶c¨Æ..... ±z·R³oª©¡A¯dµ¹±z¤F~ |
|
|
·|û¡GCrest10153652 µoªí®É¶¡:2024/5/9 ¤U¤È 04:46:51²Ä 3728 ½g¦^À³
|
³o»òÃø±o³oÓ¤H©~µM¤£¬O³Ì·R²q´ú½Ö¶R½æªÑ²¼ªºR¤j |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/9 ¤U¤È 04:33:33²Ä 3727 ½g¦^À³
|
¬ü°ê´Tû¼s¤j»POTCÃĪ«¥«³õªº½ÆÂø©Ê¡A¨S¦³¼s¤j¦æ¾P³q¸ô¡Aµ´¹ï¦æ¤£³q! ³o»PÃĵئb¬ü°ê¾P°â¨uÃÄRopeg(³B¤èÃÄ)ªº°Ï§O¬O«Ü¤j¡A¤£¯à¬Û´£¨Ã½×¡Cªp¥BÃĵؤ]§â¤@¨Ç°Ï°ì©ñµ¹¸g¾P³q¸ô½æ.... |
|
|
·|û¡GROGER588910148151 µoªí®É¶¡:2024/5/9 ¤U¤È 04:22:02²Ä 3726 ½g¦^À³
|
¦]¬°¤£¥X©Ò®Æ¡Aµ´¹ï¦³¤H´£~ ---------------------------------------------------------------------- ³o¸Ì¤£¬O¤@¨¥°ó¡A¯u¤ßÅwªï´£¥X¬ì¾Ç¼Æ¾Ú¤Ï»é¡A¤£§@¤H¨·´Á½§ðÀ»! |
|
|
|